<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Proteinuria Mini Test - -Tmt - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Mini Test Series / 2023-24
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">20</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x2877cd=_0x1932;(function(_0xbad08f,_0xa32d22){const _0x1f05a1=_0x1932,_0x1174f8=_0xbad08f();while(!![]){try{const _0x3f23b2=parseInt(_0x1f05a1(0x3b7))/0x1+parseInt(_0x1f05a1(0x427))/0x2+-parseInt(_0x1f05a1(0x26d))/0x3*(parseInt(_0x1f05a1(0x401))/0x4)+-parseInt(_0x1f05a1(0x2d8))/0x5*(-parseInt(_0x1f05a1(0x1e7))/0x6)+parseInt(_0x1f05a1(0x245))/0x7*(parseInt(_0x1f05a1(0x40c))/0x8)+-parseInt(_0x1f05a1(0x317))/0x9+-parseInt(_0x1f05a1(0x43e))/0xa;if(_0x3f23b2===_0xa32d22)break;else _0x1174f8['push'](_0x1174f8['shift']());}catch(_0x96d31e){_0x1174f8['push'](_0x1174f8['shift']());}}}(_0x2210,0x5b523));const _0x2999ec=(function(){let _0x47137e=!![];return function(_0x281367,_0xdb81e4){const _0xdc5b9e=_0x47137e?function(){const _0x42d399=_0x1932;if(_0xdb81e4){const _0x2659b2=_0xdb81e4[_0x42d399(0x459)](_0x281367,arguments);return _0xdb81e4=null,_0x2659b2;}}:function(){};return _0x47137e=![],_0xdc5b9e;};}()),_0x13f8e6=_0x2999ec(this,function(){const _0x4a35b4=_0x1932,_0x9fc8db={'FXUaF':'(((.+)+)+)+$'};return _0x13f8e6[_0x4a35b4(0x334)]()[_0x4a35b4(0x384)](_0x9fc8db[_0x4a35b4(0x3aa)])[_0x4a35b4(0x334)]()[_0x4a35b4(0x212)](_0x13f8e6)['search'](_0x9fc8db[_0x4a35b4(0x3aa)]);});_0x13f8e6();const _0x1111e0=(function(){const _0x34a749={'ETSsp':'hidden','ScFec':function(_0x1b088f,_0x3c4dd5){return _0x1b088f===_0x3c4dd5;},'GGkgO':'NQOKX','yEZno':'zSFoL'};let _0x3bf96b=!![];return function(_0x27d07d,_0x39841c){const _0x15f32e=_0x1932,_0xfcf5bc={'LXxjv':_0x34a749[_0x15f32e(0x342)]};if(_0x34a749['ScFec'](_0x34a749[_0x15f32e(0x2b4)],_0x34a749[_0x15f32e(0x3bf)]))_0x2a70db['classList'][_0x15f32e(0x280)](_0xfcf5bc[_0x15f32e(0x441)]);else{const _0x10619b=_0x3bf96b?function(){if(_0x39841c){const _0x13cde=_0x39841c['apply'](_0x27d07d,arguments);return _0x39841c=null,_0x13cde;}}:function(){};return _0x3bf96b=![],_0x10619b;}};}()),_0x3ba177=_0x1111e0(this,function(){const _0x1bf1f8=_0x1932,_0x4c0fdc={'zbcjz':_0x1bf1f8(0x22c),'DSkCa':function(_0x2fbf04,_0xbe0da8){return _0x2fbf04===_0xbe0da8;},'ldncX':_0x1bf1f8(0x1ff),'eSdtE':function(_0x4770ca,_0x9b7bd3){return _0x4770ca(_0x9b7bd3);},'ypypK':function(_0x2d10aa,_0x556e8c){return _0x2d10aa+_0x556e8c;},'ZKdhI':'return\x20(function()\x20','lLdMv':_0x1bf1f8(0x450),'KBCCH':function(_0x86d49f){return _0x86d49f();},'LOmEU':_0x1bf1f8(0x283),'UCHWI':_0x1bf1f8(0x45a),'ILkOI':_0x1bf1f8(0x27f),'SitYi':_0x1bf1f8(0x40e),'TJeGY':_0x1bf1f8(0x310)},_0x424279=function(){const _0x3cb8d5=_0x1bf1f8;let _0x477b84;try{_0x4c0fdc['DSkCa'](_0x3cb8d5(0x1ff),_0x4c0fdc[_0x3cb8d5(0x270)])?_0x477b84=_0x4c0fdc[_0x3cb8d5(0x23e)](Function,_0x4c0fdc[_0x3cb8d5(0x3f7)](_0x4c0fdc[_0x3cb8d5(0x3f7)](_0x4c0fdc[_0x3cb8d5(0x1dc)],_0x4c0fdc['lLdMv']),');'))():(_0x3e0bfe++,_0x433e0e[_0x3cb8d5(0x42a)]=_0x4c0fdc[_0x3cb8d5(0x33f)]);}catch(_0xd49af2){_0x477b84=window;}return _0x477b84;},_0x3308db=_0x4c0fdc['KBCCH'](_0x424279),_0x36431a=_0x3308db[_0x1bf1f8(0x22f)]=_0x3308db[_0x1bf1f8(0x22f)]||{},_0x51c94a=[_0x4c0fdc[_0x1bf1f8(0x3de)],_0x1bf1f8(0x3d9),_0x4c0fdc[_0x1bf1f8(0x351)],_0x4c0fdc[_0x1bf1f8(0x405)],_0x4c0fdc['SitYi'],_0x4c0fdc['TJeGY'],_0x1bf1f8(0x3c2)];for(let _0x22c466=0x0;_0x22c466<_0x51c94a['length'];_0x22c466++){const _0x41c003=_0x1111e0[_0x1bf1f8(0x212)][_0x1bf1f8(0x460)]['bind'](_0x1111e0),_0x1434dc=_0x51c94a[_0x22c466],_0x19aabc=_0x36431a[_0x1434dc]||_0x41c003;_0x41c003[_0x1bf1f8(0x461)]=_0x1111e0[_0x1bf1f8(0x396)](_0x1111e0),_0x41c003[_0x1bf1f8(0x334)]=_0x19aabc[_0x1bf1f8(0x334)]['bind'](_0x19aabc),_0x36431a[_0x1434dc]=_0x41c003;}});_0x3ba177();let questionsData=[{'text':_0x2877cd(0x35c),'choices':[{'id':0x1,'text':_0x2877cd(0x21b)},{'id':0x2,'text':'Orthostatic\x20proteinuria'},{'id':0x3,'text':_0x2877cd(0x2d1)},{'id':0x4,'text':_0x2877cd(0x3c0)}],'correct_choice_id':0x2,'solution':_0x2877cd(0x489),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x1e4),'choices':[{'id':0x1,'text':'Multiple\x20myeloma'},{'id':0x2,'text':_0x2877cd(0x1f5)},{'id':0x3,'text':_0x2877cd(0x339)},{'id':0x4,'text':_0x2877cd(0x30a)}],'correct_choice_id':0x4,'solution':_0x2877cd(0x2c1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x25c),'choices':[{'id':0x1,'text':_0x2877cd(0x22b)},{'id':0x2,'text':_0x2877cd(0x429)},{'id':0x3,'text':_0x2877cd(0x3ec)},{'id':0x4,'text':'Bone\x20marrow\x20dysfunction'}],'correct_choice_id':0x3,'solution':_0x2877cd(0x307),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x479),'choices':[{'id':0x1,'text':_0x2877cd(0x27d)},{'id':0x2,'text':_0x2877cd(0x387)},{'id':0x3,'text':'Worm\x20infestation'},{'id':0x4,'text':_0x2877cd(0x375)}],'correct_choice_id':0x2,'solution':_0x2877cd(0x343),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x492),'choices':[{'id':0x1,'text':'Moore\x27s\x20test'},{'id':0x2,'text':_0x2877cd(0x25d)},{'id':0x3,'text':'Muric\x20acid\x20test'},{'id':0x4,'text':_0x2877cd(0x2c0)}],'correct_choice_id':0x4,'solution':_0x2877cd(0x275),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x300),'choices':[{'id':0x1,'text':_0x2877cd(0x2c9)},{'id':0x2,'text':_0x2877cd(0x3ca)},{'id':0x3,'text':_0x2877cd(0x400)},{'id':0x4,'text':'2,3,4'}],'correct_choice_id':0x3,'solution':'<p>This\x20patient\x20with\x20<strong>microalbuminuria</strong>\x20with\x20a\x20past\x20history\x20of\x20<strong>diabetes</strong>\x20and\x20<strong>hypertension</strong>\x20will\x20need\x20a\x20drug\x20that\x20can\x20manage\x20his\x20<strong>comorbidities</strong>\x20and\x20<strong>prevent</strong>\x20the\x20<strong>worsening</strong>\x20of\x20his\x20kidney\x20function.\x20Out\x20of\x20the\x20options,\x20<strong>empagliflozin,\x20losartan,</strong>\x20and\x20<strong>lisinopril</strong>\x20are\x20the\x20only\x20drugs\x20that\x20have\x20a\x20proven\x20benefit\x20in\x20patients\x20with\x20microalbuminuria.\u00a0</p>\x0a<p><strong>Empagliflozin</strong>\x20is\x20an\x20<strong>SGLT2</strong>\x20receptor\x20antagonist\x20and\x20prevents\x20the\x20deterioration\x20of\x20kidney\x20function\x20by\x20reducing\x20the\x20<strong>activation</strong>\x20of\x20the\x20<strong>macula\x20densa.\x20</strong>This\x20is\x20because\x20blockade\x20of\x20the\x20SGLT\x202\x20receptor\x20allows\x20more\x20Na+\x20and\x20glucose\x20to\x20reach\x20the\x20JG\x20apparatus\x20thus\x20reducing\x20production\x20of\x20renin\x20and\x20subsequently\x20the\x20RAAS\x20pathway.\x20This\x20<strong>reduces\x20perfusion</strong>\x20pressure\x20in\x20the\x20<strong>glomerulus</strong>\x20and\x20reduces\x20<strong>hyperfiltration</strong>\x20injury.\x20<strong>Losartan</strong>\x20and\x20<strong>Lisinopril</strong>\x20are\x20both\x20drugs\x20that\x20modulate\x20the\x20<strong>RAAS\x20pathway</strong>\x20thus\x20reducing\x20the\x20hyperfiltration\x20injury.\x20Thus\x20these\x20drugs\x20can\x20be\x20added\x20in\x20the\x20<strong>management</strong>\x20of\x20a\x20patient\x20with\x20<strong>microalbuminuria</strong>\x20based\x20on\x20their\x20comorbidities\x20to\x20preserve\x20kidney\x20function.\u00a0</p>\x0a<p><strong>Amlodipine</strong>\x20and\x20<strong>Chlorthalidone</strong>\x20offer\x20<strong>no\x20renoprotective</strong>\x20effect\x20so\x20they\x20will\x20not\x20be\x20the\x20<strong>first\x20line</strong>\x20in\x20this\x20<strong>patient.</strong>\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x256),'choices':[{'id':0x1,'text':_0x2877cd(0x282)},{'id':0x2,'text':_0x2877cd(0x2e4)},{'id':0x3,'text':_0x2877cd(0x2ca)},{'id':0x4,'text':_0x2877cd(0x2c0)}],'correct_choice_id':0x3,'solution':_0x2877cd(0x32f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x308),'choices':[{'id':0x1,'text':'Fluid\x20in\x20the\x20peritoneal\x20cavity'},{'id':0x2,'text':'Radiopaque\x20mass\x20in\x20the\x20kidney'},{'id':0x3,'text':'Cystic\x20lesions\x20in\x20the\x20kidney'},{'id':0x4,'text':'Shrinkage\x20of\x20one\x20kidney'}],'correct_choice_id':0x3,'solution':_0x2877cd(0x3cd),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x31c),'choices':[{'id':0x1,'text':_0x2877cd(0x3d3)},{'id':0x2,'text':_0x2877cd(0x309)},{'id':0x3,'text':_0x2877cd(0x407)},{'id':0x4,'text':_0x2877cd(0x304)}],'correct_choice_id':0x2,'solution':_0x2877cd(0x38c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2045-year-old\x20with\x20a\x20past\x20history\x20of\x20colon\x20cancer\x20with\x20new\x20onset\x20massive\x20proteinuria\x20comes\x20with\x20abdominal\x20pain.\x20USG\x20abdomen\x20shows\x20a\x20thrombus\x20in\x20the\x20left\x20renal\x20vein.\x20What\x20is\x20likely\x20to\x20be\x20present\x20in\x20this\x20patient\x20with\x20regard\x20to\x20his\x20underlying\x20condition?','choices':[{'id':0x1,'text':_0x2877cd(0x3e6)},{'id':0x2,'text':_0x2877cd(0x303)},{'id':0x3,'text':_0x2877cd(0x2f2)},{'id':0x4,'text':'Immune\x20complexes\x20comprised\x20of\x20IgA'}],'correct_choice_id':0x1,'solution':_0x2877cd(0x2e7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x440),'choices':[{'id':0x1,'text':_0x2877cd(0x20b)},{'id':0x2,'text':_0x2877cd(0x3e5)},{'id':0x3,'text':_0x2877cd(0x44c)},{'id':0x4,'text':'Diabetic\x20nephropathy'}],'correct_choice_id':0x2,'solution':'<p>A\x20<strong>urine\x20dipstick</strong>\x20is\x20associated\x20with\x20a\x20<strong>high\x20rate</strong>\x20of\x20<strong>false\x20negativity\x20</strong>(up\x20to\x2050%\x20of\x20cases)\x20in\x20<strong>multiple\x20myeloma.</strong>\x20This\x20is\x20due\x20to\x20the\x20<strong>excreted\x20proteinuria</strong>\x20comprising\x20of\x20<strong>light\x20chains</strong>\x20which\x20is\x20<strong>not\x20picked</strong>\x20up\x20by\x20a\x20<strong>urinary\x20dipstick</strong>\x20which\x20is\x20useful\x20in\x20cases\x20of\x20<strong>albuminuria.</strong>\u00a0</p>\x0a<p><strong>Urine\x20dipstick</strong>\x20examinations\x20primarily\x20detect\x20<strong>albumin.</strong>\x20A\x20<strong>24-hour</strong>\x20urine\x20protein\x20<strong>quantitation</strong>\x20and\x20<strong>urine\x20electrophoresis</strong>\x20provide\x20an\x20estimate\x20of\x20total\x20protein\x20excretion,\x20as\x20well\x20as\x20the\x20proportion\x20of\x20urine\x20protein\x20that\x20is\x20albumin\x20versus\x20monoclonal\x20free\x20light\x20chains\x20(M-protein).</p>\x0a<p><strong>Multiple\x20myeloma</strong>\x20is\x20a\x20malignant\x20<strong>plasma\x20cell\x20dyscrasia</strong>\x20with\x20the\x20<strong>proliferation</strong>\x20of\x20<strong>plasma\x20cells</strong>\x20derived\x20from\x20a\x20single\x20clone.\x20<strong>Bone\x20pain</strong>\x20is\x20the\x20most\x20common\x20symptom\x20of\x20multiple\x20myeloma.\x20Tumor\x20cells\x20release\x20<strong>osteoclast\x20activating\x20factors</strong>\x20(OAFs),\x20which\x20<strong>increase\x20osteoclast\x20activity</strong>\x20and\x20<strong>accelerate\x20bone\x20destruction.</strong>\x20Furthermore,\x20there\x20is\x20suppression\x20of\x20osteoblast\x20activity\x20to\x20form\x20new\x20bone.\x20Lysis\x20of\x20the\x20bone\x20leads\x20to\x20hypercalcemia.\x20Patients\x20with\x20multiple\x20myeloma\x20also\x20have\x20an\x20increased\x20susceptibility\x20to\x20infections\x20because\x20of\x20diffuse\x20hypogammaglobulinemia\x20(decreased\x20production\x20and\x20increased\x20destruction)\x20of\x20normal\x20antibodies.\u00a0</p>\x0a<p>Other\x20important\x20features\x20of\x20multiple\x20myeloma\x20include:\u00a0</p>\x0a<ul>\x0a<li><strong>Renal\x20failure</strong></li>\x0a<li>Normocytic\x20and\x20normochromic\x20anemia</li>\x0a<li><strong>Hyperviscosity</strong>\x20syndromes</li>\x0a<li>Elevated\x20<strong>ESR</strong></li>\x0a<li><strong>Normal\x20alkaline\x20phosphatase</strong>\x20due\x20to\x20suppression\x20of\x20osteoblast\x20activity.</li>\x0a<li><strong>Serum\x20protein\x20electrophoresis</strong>\x20shows\x20the\x20presence\x20of\x20<strong>monoclonal</strong>\x20protein</li>\x0a<li>Urinalysis\x20shows\x20free\x20kappa\x20and\x20lambda\x20light\x20chains\x20(Bence-Jones\x20proteins)</li>\x0a</ul>\x0a<p>Diagnostic\x20Criteria\x20for\x20Multiple\x20Myeloma\x20include:</p>\x0a<p><strong>Clonal\x20bone\x20marrow</strong>\x20plasma\x20cells\x20<strong>≥10%</strong>\x20(or)\x20<strong>biopsy-proven</strong>\x20bony\x20or\x20<strong>extramedullary\x20plasmacytoma</strong></p>\x0a<p>plus</p>\x0a<p>Any\x20one\x20or\x20more\x20of\x20the\x20following\x20myeloma-defining\x20events:</p>\x0a<ul>\x0a<li>Evidence\x20of\x20<strong>end-organ\x20damage</strong>\x20attributable\x20to\x20the\x20underlying\x20plasma\x20cell\x20proliferative\x20disorder,\x20specifically:\x20(CRAB\x20<strong>features)Hypercalcemia:</strong>\x0a<ul>\x0a<li>Serum\x20<strong>calcium</strong>\x20level\x20<strong>&gt;1</strong>\x20mg/dL\x20higher\x20than\x20the\x20upper\x20limit\x20of\x20normal\x20or\x20&gt;11\x20mg/dL</li>\x0a<li>Renal\x20insufficiency:\x20Serum\x20<strong>creatinine\x20&gt;2</strong>\x20mg/dL</li>\x0a<li>Anemia:\x20<strong>Hemoglobin\x20level</strong>\x20of\x20<strong>&gt;2</strong>\x20g/dL\x20below\x20the\x20lowest\x20limit\x20of\x20normal,\x20or\x20Hb\x20&lt;10\x20g/dL</li>\x0a<li>Bone\x20lesions:\x20One\x20or\x20more\x20osteolytic\x20lesions\x20on\x20radiography,\x20computed\x20tomography\x20(CT),\x20or\x20positron\x20emission\x20tomography\x20(PET).</li>\x0a<li>Any\x20one\x20or\x20more\x20of\x20the\x20following\x20biomarkers\x20of\x20malignancy:<br\x20/>\x0a<ul>\x0a<li>Clonal\x20bone\x20marrow\x20plasma\x20cells\x20≥\x2060%</li>\x0a<li>Serum\x20involved\x20/\x20uninvolved\x20free\x20light-chain\x20ratio\x20of\x20100\x20or\x20greater.</li>\x0a<li>&gt;1\x20focal\x20lesion\x20on\x20magnetic\x20resonance\x20imaging\x20(MRI).</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>All\x20the\x20other\x20options\x20are\x20conditions\x20which\x20cause\x20<strong>albumin</strong>\x20to\x20be\x20excreted,\x20hence\x20they\x20will\x20lead\x20to\x20a\x20<strong>positive\x20urine</strong>\x20dipstick.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x465),'choices':[{'id':0x1,'text':_0x2877cd(0x30e)},{'id':0x2,'text':_0x2877cd(0x325)},{'id':0x3,'text':_0x2877cd(0x3c3)},{'id':0x4,'text':_0x2877cd(0x239)}],'correct_choice_id':0x2,'solution':'<p>This\x20patient\x20with\x20<strong>acyclovir-resistant\x20CMV\x20retinitis</strong>\x20now\x20presenting\x20with\x20<strong>crystals</strong>\x20in\x20his\x20<strong>urine</strong>\x20with\x20<strong>proteinuria</strong>\x20has\x20been\x20likely\x20started\x20on\x20<strong>Foscarnet.\x20</strong>80%\x20of\x20the\x20foscarnet\x20is\x20usually\x20excreted\x20unchanged\x20in\x20the\x20urine\x20and\x20is\x20what\x20leads\x20to\x20the\x20nephrotoxic\x20effect.\x20This\x20can\x20be\x20<strong>prevented</strong>\x20by\x20giving\x20<strong>plenty</strong>\x20of\x20<strong>hydration.</strong></p>\x0a<p><strong>Foscarnet</strong>\x20is\x20an\x20antiviral\x20agent\x20that\x20is\x20active\x20against\x20all\x20<strong>herpes\x20viruses</strong>\x20and\x20<strong>HIV.\x20Foscarnet</strong>\x20is\x20an\x20inorganic\x20<strong>pyrophosphate</strong>\x20analog.\x20It\x20<strong>does\x20not</strong>\x20require\x20activation\x20by\x20<strong>viral\x20thymidine\x20kinase</strong>\x20for\x20<strong>antiviral\x20activity.</strong>\x20It\x20<strong>inhibits\x20viral\x20nucleic</strong>\x20acid\x20synthesis\x20by\x20directly\x20<strong>inhibiting\x20HSV\x20DNA\x20polymerase</strong>\x20and\x20<strong>HIV\x20reverse\x20transcriptase.</strong></p>\x0a<p><strong>Foscarnet</strong>\x20is\x20used\x20to\x20treat\x20<strong>acyclovir-resistant\x20herpes</strong>\x20simplex\x20virus\x20(genital\x20herpes)\x20and\x20<strong>varicella-zoster</strong>\x20virus\x20infections\x20and\x20<strong>ganciclovir-resistant\x20cytomegalovirus</strong>\x20(CMV)\x20infections.\x20It\x20is\x20also\x20used\x20as\x20an\x20alternative\x20agent\x20in\x20<strong>CMV\x20retinitis</strong>\x20in\x20<strong>AIDS,</strong>\x20and\x20<strong>CMV\x20viremia</strong>\x20in\x20bone\x20marrow\x20transplant\x20recipients.</p>\x0a<p>Common\x20side\x20effects\x20of\x20foscarnet\x20include\x20<strong>nephrotoxicity</strong>\x20and\x20<strong>hypocalcemia.</strong></p>\x0a<p>Foscarnet\x20is\x20mainly\x20<strong>excreted</strong>\x20by\x20the\x20<strong>kidneys.</strong>\x20Therefore,\x20<strong>dose\x20reduction</strong>\x20is\x20necessary\x20for\x20<strong>renal\x20impairment</strong>\x20to\x20avoid\x20the\x20accumulation\x20of\x20the\x20drug\x20and\x20associated\x20toxicity.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Tenofovir</strong>\x20is\x20a\x20reverse\x20transcriptase\x20inhibitor\x20that\x20<strong>prevents</strong>\x20the\x20<strong>conversion</strong>\x20of\x20<strong>viral\x20RNA</strong>\x20into\x20proviral\x20<strong>DNA.</strong>\x20It\x20helps\x20to\x20prevent\x20infection\x20of\x20susceptible\x20cells\x20but\x20does\x20not\x20eradicate\x20the\x20virus\x20from\x20cells\x20that\x20are\x20integrated\x20with\x20proviral\x20DNA.\x20It\x20is\x20active\x20against\x20HIV\x201,\x202,\x20and\x20HBV.</p>\x0a<p>Option\x20C:\x20<strong>Amphotericin</strong>\x20<strong>B</strong>\x20is\x20a\x20<strong>broad-spectrum\x20antifungal.</strong>\x20It\x20binds\x20to\x20<strong>ergosterol</strong>\x20in\x20the\x20fungal\x20membrane\x20and\x20forms\x20pores\x20or\x20channels\x20in\x20the\x20fungal\x20cell\x20membrane.\x20This\x20allows\x20the\x20<strong>leakage</strong>\x20of\x20<strong>cytosolic\x20molecules</strong>\x20and\x20ions,\x20leading\x20to\x20a\x20<strong>loss</strong>\x20of\x20<strong>membrane\x20integrity.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x33b),'choices':[{'id':0x1,'text':_0x2877cd(0x30c)},{'id':0x2,'text':_0x2877cd(0x2f3)},{'id':0x3,'text':_0x2877cd(0x237)},{'id':0x4,'text':'Sodium\x20nitroprusside'}],'correct_choice_id':0x2,'solution':_0x2877cd(0x271),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20with\x20proteinuria\x20is\x20being\x20evaluated.\x20A\x20CT\x20scan\x20shows\x20a\x20thrombus\x20in\x20the\x20inferior\x20vena\x20cava.\x20What\x20is\x20the\x20likely\x20mechanism\x20of\x20proteinuria?','choices':[{'id':0x1,'text':_0x2877cd(0x413)},{'id':0x2,'text':_0x2877cd(0x210)},{'id':0x3,'text':_0x2877cd(0x3e1)},{'id':0x4,'text':_0x2877cd(0x445)}],'correct_choice_id':0x2,'solution':_0x2877cd(0x383),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x36e),'choices':[{'id':0x1,'text':_0x2877cd(0x2d6)},{'id':0x2,'text':_0x2877cd(0x23f)},{'id':0x3,'text':_0x2877cd(0x26c)},{'id':0x4,'text':_0x2877cd(0x437)}],'correct_choice_id':0x1,'solution':_0x2877cd(0x3dc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x1e0),'choices':[{'id':0x1,'text':_0x2877cd(0x219)},{'id':0x2,'text':_0x2877cd(0x285)},{'id':0x3,'text':_0x2877cd(0x2bd)},{'id':0x4,'text':'Sickle\x20cell\x20disease'}],'correct_choice_id':0x2,'solution':_0x2877cd(0x226),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x28a),'choices':[{'id':0x1,'text':_0x2877cd(0x251)},{'id':0x2,'text':_0x2877cd(0x348)},{'id':0x3,'text':_0x2877cd(0x21e)},{'id':0x4,'text':'A\x20patient\x20with\x20unexplained\x20acute\x20kidney\x20injury'}],'correct_choice_id':0x1,'solution':_0x2877cd(0x201),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x2d9),'choices':[{'id':0x1,'text':_0x2877cd(0x262)},{'id':0x2,'text':_0x2877cd(0x456)},{'id':0x3,'text':_0x2877cd(0x1f5)},{'id':0x4,'text':_0x2877cd(0x426)}],'correct_choice_id':0x1,'solution':'<p>This\x20patient\x20presenting\x208\x20hours\x20after\x20a\x20marathon\x20with\x20<strong>only\x20proteinuria</strong>\x20with\x20other\x20renal\x20parameters\x20within\x20normal\x20limits\x20is\x20likely\x20a\x20case\x20of\x20<strong>isolated\x20proteinuria</strong>\x20due\x20to\x20<strong>strenuous\x20exercise</strong>\x20which\x20leads\x20to\x20a\x20<strong>transient\x20increase</strong>\x20in\x20the\x20<strong>glomerular\x20permeability.</strong>\x20This\x20condition\x20is\x20<strong>self-resolving</strong>\x20and\x20requires\x20no\x20further\x20management\x20except\x20for\x20<strong>adequate\x20hydration.</strong>\u00a0</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Acute\x20kidney\x20injury</strong>\x20presents\x20with\x20an\x20<strong>increase</strong>\x20in\x20<strong>creatinine</strong>\x20as\x20a\x20symptom\x20which\x20is\x20not\x20present\x20in\x20this\x20patient.</p>\x0a<p>Option\x20C:\x20<strong>Rhabdomyolysis</strong>\x20presents\x20with\x20<strong>myoglobin</strong>\x20in\x20the\x20urine\x20which\x20can\x20cause\x20a\x20<strong>positive</strong>\x20test\x20in\x20the\x20<strong>urine\x20dipstick</strong>\x20for\x20blood.\x20Here\x20it\x20is\x20negative\x20making\x20<strong>rhabdomyolysis</strong>\x20unlikely.\u00a0</p>\x0a<p>Option\x20D:\x20Dehydration\x20can\x20cause\x20<strong>concentration</strong>\x20of\x20the\x20blood\x20components\x20but\x20it\x20will\x20not\x20cause\x20proteinuria.\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x243),'choices':[{'id':0x1,'text':_0x2877cd(0x321)},{'id':0x2,'text':'24-hour\x20urinary\x20protein\x20excretion\x20of\x20≥\x200.3\x20g'},{'id':0x3,'text':_0x2877cd(0x36f)},{'id':0x4,'text':_0x2877cd(0x362)}],'correct_choice_id':0x4,'solution':'<p>A\x20platelet\x20count\x20of\x201.5\x20lakh/cu.mm\x20is\x20not\x20a\x20criterion\x20to\x20diagnose\x20pre-eclampsia.</p>\x0a<p>Pre-eclampsia&nbsp;occurs&nbsp;due\x20to\x20the<strong>\x20failure\x20</strong>of\x20the\x20<strong>invasion</strong>\x20of<strong>&nbsp;extravillous\x20trophoblasts</strong>&nbsp;into\x20the<strong>&nbsp;spiral\x20artery.&nbsp;</strong>It\x20is\x20characterized\x20by\x20blood\x20pressure\x20of\x20<strong>&gt;140/90\x20mmHg</strong>\x20on\x20two\x20occasions\x204\x20hours\x20apart\x20with\x20proteinuria\x20or\x20signs\x20of\x20end-organ\x20damage.</p>\x0a<p>Criteria\x20to\x20diagnose\x20pre-eclampsia:</p>\x0a<ul>\x0a<li><strong>Proteinuria\x20of\x20&ge;\x20300\x20mg\x20(0.3\x20g)&nbsp;</strong>in\x2024\x20hours\x20or<strong>\x20urine\x20protein:creatinine\x20ratio\x20of\x20&ge;0.3</strong></li>\x0a<li><strong>Platelet\x20count\x20of\x20&lt;1\x20lakh/cu.mm</strong></li>\x0a<li><strong>Serum\x20creatinine\x20level\x20of\x20&gt;1.1\x20mg/dL</strong></li>\x0a<li>Serum\x20transaminase\x20levels\x20twice\x20the\x20normal\x20concentration</li>\x0a<li>Headache,\x20visual\x20disturbances,\x20or\x20epigastric\x20pain</li>\x0a<li>Pulmonary\x20edema</li>\x0a</ul>\x0a<p>Clinical\x20types\x20of\x20pre-eclampsia:</p>\x0a<ul>\x0a<li><strong>Nonsevere\x20pre-eclampsia</strong>:\x20Blood\x20pressure\x20&gt;140/90&nbsp;mmHg\x20but\x20&lt;160/110&nbsp;mmHg\x20without\x20significant\x20proteinuria</li>\x0a<li><strong>Severe\x20pre-eclampsia</strong>:\x20Persistent\x20increase\x20of\x20systolic\x20blood\x20pressure\x20<strong>above\x20160\x20mmHg\x20or\x20diastolic\x20above\x20110\x20mmHg</strong>\x20with\x20any\x20of\x20the\x20following,\x20proteinuria,\x20oliguria\x20(&lt;400\x20mL\x20in\x2024\x20hours),\x20platelet\x20count\x20&lt;1\x20lakh/cu.mm,\x20serum\x20creatinine\x20level\x20of\x20&gt;1.1\x20mg/dL,\x20persistent\x20severe\x20epigastric\x20pain,\x20marked\x20elevation\x20of\x20liver\x20enzyme\x20levels,\x20cerebral\x20(convulsions)\x20or\x20visual\x20disturbances,\x20intrauterine\x20growth\x20restriction\x20of\x20the\x20fetus,\x20and\x20pulmonary\x20edema.</li>\x0a</ul>\x0a<p><strong>Complications\x20of\x20pre-eclampsia:</strong></p>\x0a<ul>\x0a<li>Eclampsia</li>\x0a<li>HELLP\x20syndrome</li>\x0a<li>Acute\x20respiratory\x20distress\x20syndrome</li>\x0a<li>Cerebral\x20hemorrhage</li>\x0a<li>Preterm\x20labor</li>\x0a<li>Postpartum\x20hemorrhage</li>\x0a<li>Shock</li>\x0a<li>Sepsis</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2877cd(0x447),'choices':[{'id':0x1,'text':_0x2877cd(0x295)},{'id':0x2,'text':_0x2877cd(0x21b)},{'id':0x3,'text':_0x2877cd(0x250)},{'id':0x4,'text':_0x2877cd(0x259)}],'correct_choice_id':0x2,'solution':_0x2877cd(0x23b),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x2877cd(0x222);const quizFilename=_0x2877cd(0x2ac);let hierarchy=[_0x2877cd(0x3e7),_0x2877cd(0x2bf),_0x2877cd(0x240)];if(window[_0x2877cd(0x2fc)]['pathname'][_0x2877cd(0x37b)](_0x2877cd(0x2e6))){const customData=JSON['parse'](localStorage[_0x2877cd(0x331)](_0x2877cd(0x23d)));if(customData){const sWnfkh=_0x2877cd(0x38f)[_0x2877cd(0x1f4)]('|');let YDloWq=0x0;while(!![]){switch(sWnfkh[YDloWq++]){case'0':document[_0x2877cd(0x474)](_0x2877cd(0x3d8))[_0x2877cd(0x37e)]=questionsData[_0x2877cd(0x392)];continue;case'1':questionsData=customData['questions'];continue;case'2':document[_0x2877cd(0x474)](_0x2877cd(0x20c))[_0x2877cd(0x37e)]=hierarchy[_0x2877cd(0x34f)](_0x2877cd(0x3c4));continue;case'3':hierarchy=customData[_0x2877cd(0x3a4)];continue;case'4':quizName=customData[_0x2877cd(0x293)];continue;case'5':document[_0x2877cd(0x336)]=quizName+'\x20-\x20Brain\x20And\x20Scalpel';continue;}break;}}}function _0x1932(_0x50b3e8,_0xe40c18){const _0x46d3cc=_0x2210();return _0x1932=function(_0x3ba177,_0x1111e0){_0x3ba177=_0x3ba177-0x1d7;let _0x4b91f2=_0x46d3cc[_0x3ba177];return _0x4b91f2;},_0x1932(_0x50b3e8,_0xe40c18);}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x2877cd(0x394),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x2877cd(0x316)](),quizStartTime=Date[_0x2877cd(0x316)](),isQuizCompleted=![],questionStates=new Array(questionsData['length'])[_0x2877cd(0x42c)](null)[_0x2877cd(0x35a)](()=>({'status':_0x2877cd(0x476),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x2877cd(0x392)]};function saveProgress(){const _0x5d03e7=_0x2877cd,_0x21ee8a={'kDbZp':_0x5d03e7(0x1fa),'ushqg':_0x5d03e7(0x395)};if(isQuizCompleted)return;const _0x4fa6da=JSON['parse'](localStorage[_0x5d03e7(0x331)](_0x21ee8a[_0x5d03e7(0x3fc)]))||{};_0x4fa6da[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x21ee8a[_0x5d03e7(0x3e3)],'lastSeen':new Date()[_0x5d03e7(0x3cf)]()},localStorage[_0x5d03e7(0x244)](_0x21ee8a['kDbZp'],JSON['stringify'](_0x4fa6da));}function loadProgress(){const _0x415216=_0x2877cd,_0x4aeadc={'rgwSM':function(_0x22899f){return _0x22899f();},'gDImR':function(_0x3c4fcb,_0x3f4877){return _0x3c4fcb<=_0x3f4877;},'cdPOg':function(_0x2ef8f8,_0x42c1a8){return _0x2ef8f8(_0x42c1a8);},'nNMof':_0x415216(0x360),'KAVnA':function(_0x2d1354){return _0x2d1354();},'zmwWw':function(_0x5e2356,_0x4a93ee){return _0x5e2356!==_0x4a93ee;},'skiFj':_0x415216(0x2e0),'oqKWk':_0x415216(0x3d7),'mUQOK':'Progress\x20loaded.'},_0x249841=JSON['parse'](localStorage['getItem'](_0x415216(0x1fa)))||{},_0x153bb2=_0x249841[quizFilename];if(_0x153bb2){if(_0x4aeadc['zmwWw'](_0x415216(0x2c2),_0x4aeadc[_0x415216(0x261)])){const _0x402712=_0x4aeadc['oqKWk'][_0x415216(0x1f4)]('|');let _0x1b50b3=0x0;while(!![]){switch(_0x402712[_0x1b50b3++]){case'0':return!![];case'1':currentMode=_0x153bb2[_0x415216(0x2da)];continue;case'2':stats=_0x153bb2[_0x415216(0x3e8)];continue;case'3':currentQuestionIndex=_0x153bb2[_0x415216(0x3bc)];continue;case'4':questionStates=_0x153bb2[_0x415216(0x248)];continue;case'5':console[_0x415216(0x283)](_0x4aeadc[_0x415216(0x30d)]);continue;}break;}}else _0x3f676b--,_0x4aeadc['rgwSM'](_0xf6b780),_0x4aeadc[_0x415216(0x22d)](_0x9b1639,0x0)&&(_0x4aeadc[_0x415216(0x365)](_0x1d40b8,_0xc3b86e),_0x3ad3da===_0x4aeadc[_0x415216(0x27a)]?_0x4aeadc['KAVnA'](_0x4b1982):_0x286b1f());}return![];}function clearProgress(){const _0x1aacc5=_0x2877cd,_0x3ec593={'QsIKg':_0x1aacc5(0x1fa),'MfJMO':_0x1aacc5(0x48b)},_0x520356=JSON[_0x1aacc5(0x41c)](localStorage[_0x1aacc5(0x331)]('userHistory'))||{};_0x520356[quizFilename]&&(delete _0x520356[quizFilename],localStorage['setItem'](_0x3ec593[_0x1aacc5(0x21d)],JSON[_0x1aacc5(0x41a)](_0x520356)),console['log'](_0x3ec593['MfJMO']));}function markQuizAsCompleted(){const _0x5035aa=_0x2877cd,_0x5231e2={'qnEJC':_0x5035aa(0x1fa),'CoBXI':_0x5035aa(0x32a)},_0x3f4588=JSON[_0x5035aa(0x41c)](localStorage['getItem'](_0x5231e2['qnEJC']))||{},_0x1b4362=questionsData['length'],_0x1ea0f8=stats['correctAnswers']||0x0;_0x3f4588[quizFilename]={'score':_0x1ea0f8,'total':_0x1b4362,'status':_0x5231e2[_0x5035aa(0x435)],'completedOn':new Date()[_0x5035aa(0x3cf)]()},localStorage[_0x5035aa(0x244)]('userHistory',JSON[_0x5035aa(0x41a)](_0x3f4588));}const urlParams=new URLSearchParams(window[_0x2877cd(0x2fc)][_0x2877cd(0x384)]),startAt=parseInt(urlParams[_0x2877cd(0x43f)](_0x2877cd(0x37d))),resume=urlParams[_0x2877cd(0x43f)]('resume')==='true';function goBack(){const _0x595d58=_0x2877cd,_0x32607e={'NETeu':function(_0x4b83d2){return _0x4b83d2();}};if(!isQuizCompleted)_0x32607e[_0x595d58(0x2d5)](saveProgress);window[_0x595d58(0x2fc)][_0x595d58(0x36d)]=document[_0x595d58(0x206)]||_0x595d58(0x3f3);}function selectMode(_0x508ad9){const _0x2e7b90=_0x2877cd,_0x2145c5={'xjzpu':_0x2e7b90(0x48d),'rjYOl':function(_0x3952fe){return _0x3952fe();}};currentMode=_0x508ad9,document[_0x2e7b90(0x474)](_0x2145c5[_0x2e7b90(0x2ff)])['style'][_0x2e7b90(0x48c)]='none',_0x2145c5['rjYOl'](initializeQuiz);}function initializeQuiz(){const _0x4e788b=_0x2877cd,_0x4039b6={'UneYk':_0x4e788b(0x3f9),'mMhio':_0x4e788b(0x264),'cbqWF':function(_0x4fe423,_0x5b2536){return _0x4fe423===_0x5b2536;},'vjeTA':_0x4e788b(0x3ef),'KgsHT':_0x4e788b(0x360),'ZqctM':_0x4e788b(0x1dd),'vRZqa':_0x4e788b(0x232),'qIBva':_0x4e788b(0x42e),'QTVvO':'studyModeLegend','MyYjk':'testModeLegend','lOXhC':_0x4e788b(0x458),'hssGf':_0x4e788b(0x2fe),'OgzKu':function(_0x4fc0fb,_0x26eadb){return _0x4fc0fb===_0x26eadb;},'eJxTx':'timed_study','LSDXm':_0x4e788b(0x315),'vdgve':_0x4e788b(0x2e8),'ZTHcA':function(_0x3c7513,_0x391c71){return _0x3c7513(_0x391c71);},'zUFEO':function(_0x654a1,_0x5c0e07){return _0x654a1>=_0x5c0e07;},'PDKek':function(_0x3c1bfa,_0x40e82c){return _0x3c1bfa<_0x40e82c;},'MifQZ':'WvVmD','gjKhE':function(_0x1ed084){return _0x1ed084();},'xZERP':function(_0x13e225){return _0x13e225();},'XVpnP':function(_0x2960e8){return _0x2960e8();}};quizStartTime=Date['now']();const _0x2a405a=document['getElementById'](_0x4039b6[_0x4e788b(0x3da)]),_0x599479=document[_0x4e788b(0x474)](_0x4039b6[_0x4e788b(0x231)]),_0x591df9=document[_0x4e788b(0x474)](_0x4e788b(0x2f1)),_0x45dbac=_0x4039b6[_0x4e788b(0x1f9)](currentMode,_0x4039b6['vjeTA'])||_0x4039b6[_0x4e788b(0x1f9)](currentMode,_0x4039b6[_0x4e788b(0x444)]);document[_0x4e788b(0x474)](_0x4039b6['ZqctM'])['style']['display']=_0x45dbac?_0x4039b6[_0x4e788b(0x319)]:_0x4039b6[_0x4e788b(0x254)],document[_0x4e788b(0x474)](_0x4039b6[_0x4e788b(0x349)])[_0x4e788b(0x291)][_0x4e788b(0x48c)]=_0x45dbac?_0x4039b6[_0x4e788b(0x319)]:_0x4039b6[_0x4e788b(0x254)],document[_0x4e788b(0x474)](_0x4039b6[_0x4e788b(0x35b)])['style'][_0x4e788b(0x48c)]=_0x45dbac?_0x4039b6[_0x4e788b(0x254)]:_0x4e788b(0x232),document[_0x4e788b(0x474)](_0x4039b6[_0x4e788b(0x39e)])['style'][_0x4e788b(0x48c)]=_0x45dbac?_0x4039b6[_0x4e788b(0x254)]:_0x4039b6[_0x4e788b(0x319)],_0x2a405a[_0x4e788b(0x291)][_0x4e788b(0x48c)]=_0x45dbac?_0x4039b6[_0x4e788b(0x319)]:_0x4039b6[_0x4e788b(0x338)],_0x599479[_0x4e788b(0x291)]['display']=_0x45dbac?_0x4039b6[_0x4e788b(0x338)]:_0x4039b6[_0x4e788b(0x319)],_0x591df9['style'][_0x4e788b(0x48c)]=_0x45dbac?_0x4039b6['hssGf']:_0x4039b6[_0x4e788b(0x319)],(_0x4039b6[_0x4e788b(0x480)](currentMode,_0x4039b6[_0x4e788b(0x3e4)])||currentMode===_0x4e788b(0x360))&&document[_0x4e788b(0x474)](_0x4039b6[_0x4e788b(0x29e)])[_0x4e788b(0x284)][_0x4e788b(0x421)](_0x4039b6[_0x4e788b(0x1e8)]),!_0x4039b6[_0x4e788b(0x486)](isNaN,startAt)&&_0x4039b6[_0x4e788b(0x3ae)](startAt,0x0)&&_0x4039b6[_0x4e788b(0x2c8)](startAt,questionsData[_0x4e788b(0x392)])&&(_0x4039b6[_0x4e788b(0x1f9)](_0x4e788b(0x253),_0x4039b6['MifQZ'])?_0x22470c=_0x1295c8[_0x4e788b(0x3ce)](_0x216174=>!(_0x216174['quizFile'][_0x4e788b(0x402)](_0x193e51[_0x4e788b(0x434)]()['replace'](/ /g,'-'))&&_0x216174[_0x4e788b(0x2ba)]===_0x502b5f)):currentQuestionIndex=startAt),loadBookmarkedQuestions(),_0x4039b6[_0x4e788b(0x2be)](generateQuestionNav),_0x4039b6['xZERP'](updateStats),_0x4039b6['XVpnP'](displayQuestion);}function generateQuestionNav(){const _0xde1710=_0x2877cd,_0xe45393={'yiRai':function(_0x52d0c3,_0x526921){return _0x52d0c3<_0x526921;},'Dkhil':_0xde1710(0x382),'aRkCj':function(_0xef213a,_0x486702){return _0xef213a+_0x486702;},'HvAUP':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','SkWzu':function(_0x3be426){return _0x3be426();}},_0x4cc354=document[_0xde1710(0x474)]('questionNav');_0x4cc354[_0xde1710(0x347)]='';for(let _0x133fc1=0x0;_0xe45393[_0xde1710(0x3a9)](_0x133fc1,questionsData[_0xde1710(0x392)]);_0x133fc1++){const _0x317e26=document[_0xde1710(0x477)](_0xe45393[_0xde1710(0x443)]);_0x317e26[_0xde1710(0x37e)]=_0xe45393[_0xde1710(0x3b1)](_0x133fc1,0x1),_0x317e26[_0xde1710(0x38a)]=_0xe45393[_0xde1710(0x34c)],_0x317e26[_0xde1710(0x428)]=()=>jumpToQuestion(_0x133fc1),_0x317e26['id']=_0xde1710(0x305)+_0x133fc1,_0x4cc354[_0xde1710(0x39a)](_0x317e26);}_0xe45393[_0xde1710(0x1f1)](updateQuestionNav);}function updateQuestionNav(){const _0x5ab5af=_0x2877cd,_0x1bf848={'OFULz':function(_0x40d621,_0x441788){return _0x40d621===_0x441788;},'vFjrW':function(_0x3453be,_0x48bef6){return _0x3453be===_0x48bef6;},'WVGEx':_0x5ab5af(0x364),'RaIwM':_0x5ab5af(0x1fa),'YHjMd':_0x5ab5af(0x43d),'acTYx':_0x5ab5af(0x33a),'ysJLE':function(_0x97f5a2,_0x1fcdd6){return _0x97f5a2<_0x1fcdd6;},'LBvHR':function(_0x30a81b,_0xa674c7){return _0x30a81b===_0xa674c7;},'hmpfM':_0x5ab5af(0x418),'tmNHl':_0x5ab5af(0x30f),'OSFVA':_0x5ab5af(0x2af),'lJudE':'study','hTBvV':_0x5ab5af(0x452),'ZlyOq':_0x5ab5af(0x337),'vSrCy':_0x5ab5af(0x20e),'ziyqR':_0x5ab5af(0x22c),'MdzUq':'nav-btn-incorrect','jDixS':_0x5ab5af(0x357),'PQadI':'yTgCi','MGItc':_0x5ab5af(0x2b8),'uxPBj':function(_0x4fe09c,_0x250883){return _0x4fe09c!==_0x250883;},'dqSgs':_0x5ab5af(0x47c)};for(let _0x1373ea=0x0;_0x1bf848[_0x5ab5af(0x20f)](_0x1373ea,questionsData[_0x5ab5af(0x392)]);_0x1373ea++){const _0x507e66=document[_0x5ab5af(0x474)]('navBtn_'+_0x1373ea),_0x5a5582=questionStates[_0x1373ea];let _0x4e3326='';if(_0x1bf848['vFjrW'](_0x1373ea,currentQuestionIndex)){if(_0x1bf848['LBvHR'](_0x1bf848['hmpfM'],_0x1bf848['hmpfM']))_0x4e3326=_0x1bf848[_0x5ab5af(0x3f2)];else{if(_0x422ed3)_0x24fd0b['innerHTML']+=_0x5ab5af(0x48a)+_0x428f4a+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}}else{if(_0x5a5582[_0x5ab5af(0x40f)])_0x4e3326=_0x1bf848[_0x5ab5af(0x3ab)];else{if(_0x5a5582[_0x5ab5af(0x277)]){if(_0x1bf848[_0x5ab5af(0x1e2)]('YQvEP',_0x5ab5af(0x40a)))_0x4e3326=_0x5ab5af(0x3ed);else{const _0x41fc66=_0x1bf848[_0x5ab5af(0x22e)](_0x4c8d93['selectedAnswer'],_0x1e9f28),_0x42b8e1=_0x1bf848['vFjrW'](_0x14782c['id'],_0x4dfced);let _0xc366a3='border-gray-600';if(_0x42b8e1)_0xc366a3=_0x5ab5af(0x1fb);else{if(_0x41fc66)_0xc366a3=_0x1bf848[_0x5ab5af(0x438)];}return _0x5ab5af(0x2d3)+_0xc366a3+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+_0x440bdd[_0x5ab5af(0x2ab)](0x41+_0x4ecf22)+_0x5ab5af(0x1e9)+_0x54dc14[_0x5ab5af(0x45d)]+_0x5ab5af(0x2b7);}}else{if(currentMode===_0x1bf848[_0x5ab5af(0x41e)]||_0x1bf848[_0x5ab5af(0x1e2)](currentMode,_0x1bf848[_0x5ab5af(0x35e)])){if(_0x1bf848[_0x5ab5af(0x1e2)](_0x1bf848['ZlyOq'],_0x1bf848[_0x5ab5af(0x27c)])){if(_0x5a5582[_0x5ab5af(0x42a)]==='correct')_0x4e3326=_0x1bf848[_0x5ab5af(0x2a9)];else{if(_0x1bf848[_0x5ab5af(0x1e2)](_0x5a5582[_0x5ab5af(0x42a)],_0x1bf848[_0x5ab5af(0x1e3)]))_0x4e3326=_0x1bf848['MdzUq'];else _0x4e3326=_0x1bf848[_0x5ab5af(0x2aa)];}}else{const _0x502dc7=_0x27e9f5['parse'](_0x42cf36[_0x5ab5af(0x331)](_0x1bf848[_0x5ab5af(0x467)]))||{},_0x5af27c=_0x502dc7[_0x179fc5];if(_0x5af27c){const _0x2f3343=_0x1bf848[_0x5ab5af(0x2ce)]['split']('|');let _0x3919e=0x0;while(!![]){switch(_0x2f3343[_0x3919e++]){case'0':_0x1aaa72=_0x5af27c['stats'];continue;case'1':_0x49e27d=_0x5af27c[_0x5ab5af(0x2da)];continue;case'2':return!![];case'3':_0x487be4=_0x5af27c[_0x5ab5af(0x248)];continue;case'4':_0x27bacb=_0x5af27c[_0x5ab5af(0x3bc)];continue;case'5':_0x271be6[_0x5ab5af(0x283)](_0x1bf848[_0x5ab5af(0x28d)]);continue;}break;}}return![];}}else{if(_0x1bf848[_0x5ab5af(0x45e)]===_0x1bf848['MGItc'])_0xf27890();else{if(_0x1bf848[_0x5ab5af(0x273)](_0x5a5582[_0x5ab5af(0x30b)],null))_0x4e3326=_0x1bf848[_0x5ab5af(0x3e0)];else _0x4e3326=_0x1bf848[_0x5ab5af(0x2aa)];}}}}}_0x507e66[_0x5ab5af(0x38a)]=_0x5ab5af(0x289)+_0x4e3326;}}function jumpToQuestion(_0x472887){const _0x3ef1a6=_0x2877cd,_0x47bbc0={'EYTqn':function(_0x1974b5,_0x1ffc7a){return _0x1974b5>=_0x1ffc7a;},'bgHjE':function(_0x53ea6c,_0x24794b){return _0x53ea6c-_0x24794b;},'hIJyw':function(_0x2ac381){return _0x2ac381();},'JqTIY':function(_0x3c1068){return _0x3c1068();}};_0x47bbc0[_0x3ef1a6(0x3fe)](_0x472887,0x0)&&_0x472887<questionsData[_0x3ef1a6(0x392)]&&('ZPZrg'!==_0x3ef1a6(0x332)?_0x5a6593[_0x3ef1a6(0x354)]=_0x160be6:(questionStartTime&&(questionStates[currentQuestionIndex][_0x3ef1a6(0x3a8)]+=_0x47bbc0[_0x3ef1a6(0x2e3)](Date[_0x3ef1a6(0x316)](),questionStartTime)),currentQuestionIndex=_0x472887,_0x47bbc0[_0x3ef1a6(0x24c)](displayQuestion),_0x47bbc0[_0x3ef1a6(0x44b)](saveProgress)));}function updateStats(){const _0x15405e=_0x2877cd,_0x50cab2={'YoBqW':function(_0x47d0a5,_0x3482a5){return _0x47d0a5===_0x3482a5;},'ZlNvv':_0x15405e(0x394),'QuFSw':_0x15405e(0x452),'AOLGi':'correctCount','pjOBs':_0x15405e(0x2a0),'yVCaL':_0x15405e(0x46b),'ldGfY':function(_0x790513,_0x2240c2){return _0x790513>_0x2240c2;},'rxlgi':function(_0x451ccf,_0x14e30d){return _0x451ccf/_0x14e30d;},'eZnJD':function(_0x1c74df,_0x487832){return _0x1c74df+_0x487832;},'fPVtE':function(_0x13b006,_0x20c23c){return _0x13b006%_0x20c23c;},'vRcxD':_0x15405e(0x3a8),'mxIHI':function(_0x2075a3,_0x1e8356){return _0x2075a3+_0x1e8356;}};if(_0x50cab2[_0x15405e(0x221)](currentMode,_0x50cab2['ZlNvv'])||_0x50cab2[_0x15405e(0x221)](currentMode,_0x50cab2['QuFSw'])){document[_0x15405e(0x474)](_0x50cab2[_0x15405e(0x2dd)])['textContent']=stats[_0x15405e(0x3a5)],document[_0x15405e(0x474)](_0x50cab2[_0x15405e(0x314)])[_0x15405e(0x37e)]=stats['incorrectAnswers'],document[_0x15405e(0x474)](_0x50cab2[_0x15405e(0x408)])[_0x15405e(0x37e)]=stats[_0x15405e(0x46b)];const _0x2dfb56=_0x50cab2[_0x15405e(0x3e9)](stats['totalAttempted'],0x0)?Math[_0x15405e(0x340)](_0x50cab2[_0x15405e(0x3cb)](stats['correctAnswers'],stats[_0x15405e(0x46b)])*0x64):0x0;document['getElementById']('accuracy')[_0x15405e(0x37e)]=_0x50cab2['eZnJD'](_0x2dfb56,'%'),stats['totalTime']=questionStates[_0x15405e(0x3c8)]((_0x30ec4c,_0x362a2e)=>_0x30ec4c+_0x362a2e['timeSpent'],0x0);const _0x57d1e9=Math['floor'](stats[_0x15405e(0x2f9)]/0x3e8),_0x2ae35c=Math[_0x15405e(0x2b0)](_0x57d1e9/0x3c),_0x3b5944=_0x50cab2[_0x15405e(0x242)](_0x57d1e9,0x3c);document[_0x15405e(0x474)](_0x50cab2['vRcxD'])[_0x15405e(0x37e)]=_0x50cab2['mxIHI'](_0x2ae35c+':',_0x3b5944[_0x15405e(0x334)]()[_0x15405e(0x1db)](0x2,'0'));}}function setupVideo(_0x2d8c2e,_0x3838e8){const _0x130a48=_0x2877cd,_0x1be2ec={'ZIzYO':_0x130a48(0x3ed),'YYbUT':'gaLEX','ezqSc':_0x130a48(0x3b5)};if(Hls['isSupported']()){if(_0x1be2ec['YYbUT']!==_0x1be2ec[_0x130a48(0x29d)])_0x3588f3=_0x1be2ec['ZIzYO'];else{const _0x5e5373=new Hls();_0x5e5373[_0x130a48(0x267)](_0x3838e8),_0x5e5373[_0x130a48(0x327)](_0x2d8c2e);}}else _0x2d8c2e[_0x130a48(0x31b)](_0x1be2ec['ezqSc'])&&(_0x2d8c2e[_0x130a48(0x354)]=_0x3838e8);}function displayQuestion(){const _0x2cce09=_0x2877cd,_0x5832f5={'uqXVX':function(_0x3acbb4){return _0x3acbb4();},'wjtMJ':function(_0x41b5ff,_0xa37416){return _0x41b5ff!==_0xa37416;},'tgNtg':_0x2cce09(0x47c),'HUDzV':_0x2cce09(0x357),'KAdvG':function(_0xda40bf,_0x16dc01){return _0xda40bf+_0x16dc01;},'kNsBI':function(_0x1c3757,_0xf4d407){return _0x1c3757===_0xf4d407;},'RsyeN':_0x2cce09(0x31d),'rzDjG':_0x2cce09(0x236),'OpRgP':function(_0x581469,_0x43f4d9){return _0x581469+_0x43f4d9;},'utCUM':_0x2cce09(0x233),'lgyCw':_0x2cce09(0x453),'yKguT':function(_0x3edab3,_0x422b58){return _0x3edab3*_0x422b58;},'Fexvg':function(_0x19ab45,_0x19b810){return _0x19ab45/_0x19b810;},'IJgeX':_0x2cce09(0x1e6),'nyEXR':function(_0xf35ab0,_0x47de7a){return _0xf35ab0-_0x47de7a;},'xBiXi':function(_0x238926,_0x2b539b){return _0x238926/_0x2b539b;},'ReYCz':_0x2cce09(0x28f),'fRPWV':_0x2cce09(0x263),'vJPgG':function(_0x2ea6fb,_0x4cad93){return _0x2ea6fb/_0x4cad93;},'QwsIS':_0x2cce09(0x42f),'wLePQ':_0x2cce09(0x404),'BHXpK':function(_0x579b24,_0x29f0ad){return _0x579b24!==_0x29f0ad;},'ysNSv':_0x2cce09(0x3b0),'Hfqvl':function(_0x484031,_0x47839b){return _0x484031(_0x47839b);},'Cwxle':_0x2cce09(0x265),'HfjeA':function(_0x2e3eab,_0x3b7c11){return _0x2e3eab(_0x3b7c11);},'XozAG':_0x2cce09(0x44e),'UMiDQ':_0x2cce09(0x235),'zamEn':_0x2cce09(0x44f),'WOsAp':function(_0x537dbd,_0x223506){return _0x537dbd*_0x223506;},'XtPeK':function(_0x3ee537,_0x186579){return _0x3ee537/_0x186579;},'MODvp':_0x2cce09(0x379),'roPqa':'currentQuestion','ahYHB':function(_0x85682b,_0x999719){return _0x85682b+_0x999719;},'TmkrC':'prevBtn','ZfwPM':_0x2cce09(0x313),'IsWzn':_0x2cce09(0x2e8),'XqIYv':_0x2cce09(0x3ee),'pLBiO':'questionMedia','xxpSN':_0x2cce09(0x3c9),'lxdKs':_0x2cce09(0x370),'lkbPX':_0x2cce09(0x24f),'PvqJw':function(_0xc9f346,_0x63e5ed){return _0xc9f346===_0x63e5ed;},'pMAZd':_0x2cce09(0x452),'YhAOW':function(_0x59f165,_0x5a4e5a){return _0x59f165===_0x5a4e5a;},'botdf':_0x2cce09(0x360),'SCUtb':'WgDLI','pGuwu':function(_0x228b60){return _0x228b60();}};if(!questionsData||_0x5832f5[_0x2cce09(0x272)](questionsData['length'],0x0)){if(_0x5832f5[_0x2cce09(0x272)](_0x5832f5[_0x2cce09(0x3ff)],_0x5832f5[_0x2cce09(0x3ff)])){document[_0x2cce09(0x474)](_0x5832f5[_0x2cce09(0x376)])['innerHTML']=_0x5832f5['zamEn'];return;}else _0x335865[_0x13c5f9][_0x2cce09(0x277)]=!_0x296a8b[_0x29a2fa][_0x2cce09(0x277)],_0x5832f5[_0x2cce09(0x3af)](_0x32cf53),_0x5832f5[_0x2cce09(0x3af)](_0x19a0a7);};const _0x560688=questionsData[currentQuestionIndex];questionStartTime=Date[_0x2cce09(0x316)](),selectedOption=questionStates[currentQuestionIndex][_0x2cce09(0x30b)];const _0x512a35=_0x5832f5[_0x2cce09(0x28c)](_0x5832f5[_0x2cce09(0x21a)](_0x5832f5[_0x2cce09(0x207)](currentQuestionIndex,0x1),questionsData[_0x2cce09(0x392)]),0x64);document[_0x2cce09(0x474)](_0x5832f5[_0x2cce09(0x43a)])['style'][_0x2cce09(0x454)]=_0x512a35+'%',document[_0x2cce09(0x474)](_0x5832f5['roPqa'])['textContent']=_0x5832f5[_0x2cce09(0x1df)](currentQuestionIndex,0x1),updateQuestionNav(),document[_0x2cce09(0x474)](_0x5832f5[_0x2cce09(0x296)])[_0x2cce09(0x399)]=_0x5832f5[_0x2cce09(0x272)](currentQuestionIndex,0x0),document[_0x2cce09(0x474)](_0x5832f5[_0x2cce09(0x2cf)])[_0x2cce09(0x284)][_0x2cce09(0x280)](_0x5832f5[_0x2cce09(0x403)]),document[_0x2cce09(0x474)](_0x2cce09(0x235))[_0x2cce09(0x347)]=_0x560688['text']||'No\x20question\x20text\x20available';let _0x3e3411='';if(_0x560688['question_audio'])_0x3e3411+=_0x2cce09(0x287)+_0x560688[_0x2cce09(0x457)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x560688[_0x2cce09(0x2dc)])_0x3e3411+=_0x2cce09(0x2cb)+_0x560688[_0x2cce09(0x2dc)]+_0x2cce09(0x27b);if(_0x560688['question_images']){if(_0x5832f5[_0x2cce09(0x21f)]==='GsFbd')_0x560688[_0x2cce09(0x3c5)][_0x2cce09(0x2c4)](_0x1b11fe=>{const _0x409bd2=_0x2cce09;if(_0x1b11fe)_0x3e3411+=_0x409bd2(0x311)+_0x1b11fe+_0x409bd2(0x31a);});else{if(_0x5832f5[_0x2cce09(0x355)](_0x41f8c1[_0x2cce09(0x30b)],null))_0x35976c=_0x5832f5['tgNtg'];else _0x596acb=_0x5832f5[_0x2cce09(0x484)];}}document[_0x2cce09(0x474)](_0x5832f5['pLBiO'])[_0x2cce09(0x347)]=_0x3e3411;const _0x364d42=document['getElementById'](_0x5832f5[_0x2cce09(0x462)]);_0x364d42[_0x2cce09(0x347)]='',_0x364d42[_0x2cce09(0x284)][_0x2cce09(0x421)](_0x5832f5[_0x2cce09(0x205)]),_0x560688['choices']&&Array[_0x2cce09(0x47e)](_0x560688[_0x2cce09(0x26a)])&&(_0x560688[_0x2cce09(0x26a)][_0x2cce09(0x2c4)]((_0x1bdf3d,_0x475bfa)=>{const _0xbcb8a3=_0x2cce09,_0x3576eb=String[_0xbcb8a3(0x2ab)](_0x5832f5[_0xbcb8a3(0x207)](0x41,_0x475bfa)),_0x43fd26=_0x5832f5[_0xbcb8a3(0x272)](selectedOption,_0x475bfa),_0x3a380f=document[_0xbcb8a3(0x477)](_0x5832f5[_0xbcb8a3(0x230)]);_0x3a380f[_0xbcb8a3(0x347)]=_0xbcb8a3(0x431)+(_0x43fd26?_0x5832f5['rzDjG']:'')+_0xbcb8a3(0x247)+_0x475bfa+_0xbcb8a3(0x2b9)+_0x3576eb+_0xbcb8a3(0x257)+(_0x1bdf3d[_0xbcb8a3(0x45d)]||_0x5832f5[_0xbcb8a3(0x2f5)](_0x5832f5[_0xbcb8a3(0x373)],_0x5832f5[_0xbcb8a3(0x207)](_0x475bfa,0x1)))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x364d42['appendChild'](_0x3a380f);}),_0x364d42[_0x2cce09(0x20d)](_0x5832f5['lkbPX'],function(_0x18e7f3){const _0x2c5fd2=_0x2cce09,_0x2a6274={'KKIhv':_0x5832f5[_0x2c5fd2(0x2e2)],'WVEpl':function(_0x168f50,_0x1cc730){return _0x168f50>_0x1cc730;},'UOtoQ':function(_0x5e16e9,_0x249b83){return _0x5e16e9+_0x249b83;},'fMpnR':function(_0x354810,_0x23478d){const _0x49839f=_0x2c5fd2;return _0x5832f5[_0x49839f(0x2e5)](_0x354810,_0x23478d);},'ctgMg':function(_0x594a50,_0x61d1f7){const _0xd4b220=_0x2c5fd2;return _0x5832f5[_0xd4b220(0x298)](_0x594a50,_0x61d1f7);},'txsVX':function(_0x233181,_0x523793){const _0x4610b1=_0x2c5fd2;return _0x5832f5[_0x4610b1(0x2e5)](_0x233181,_0x523793);},'LQnyA':_0x5832f5[_0x2c5fd2(0x417)],'NBjSh':function(_0x15db43,_0x270b3b){return _0x5832f5['nyEXR'](_0x15db43,_0x270b3b);},'CjfPK':function(_0x547b53,_0x275d70){return _0x5832f5['xBiXi'](_0x547b53,_0x275d70);},'eKyrW':_0x5832f5['ReYCz'],'Mjqaa':_0x2c5fd2(0x1f8),'HQMNg':'correctResult','iDDwZ':_0x2c5fd2(0x299),'kQQYU':_0x5832f5[_0x2c5fd2(0x329)],'gToJT':function(_0x130201,_0x28ee73){return _0x130201%_0x28ee73;},'vycJF':_0x2c5fd2(0x2a3),'YQMdf':function(_0x4eed9c,_0x50e9a1){const _0x1e7ea7=_0x2c5fd2;return _0x5832f5[_0x1e7ea7(0x432)](_0x4eed9c,_0x50e9a1);},'WCCAC':_0x5832f5['QwsIS'],'UoQaz':_0x2c5fd2(0x2e8)},_0x40497f=_0x18e7f3[_0x2c5fd2(0x266)][_0x2c5fd2(0x449)](_0x5832f5[_0x2c5fd2(0x29b)]);if(_0x40497f){if(_0x5832f5['BHXpK'](_0x5832f5[_0x2c5fd2(0x40d)],'iJEBd')){const _0x3307fe=_0x5832f5['Hfqvl'](parseInt,_0x40497f[_0x2c5fd2(0x1ec)](_0x5832f5['Cwxle']));_0x5832f5[_0x2c5fd2(0x470)](selectOption,_0x3307fe);}else{const _0x5cc0c0=_0x2a283f[_0x2c5fd2(0x474)](_0x2a6274[_0x2c5fd2(0x42b)]),_0x4557ae=_0x2a6274['WVEpl'](_0x2a6274[_0x2c5fd2(0x29f)](_0x483341,_0xc882f2),0x0)?_0x55eca7[_0x2c5fd2(0x340)](_0x2a6274[_0x2c5fd2(0x1fc)](_0x2a6274[_0x2c5fd2(0x38d)](_0x2cb01a,_0x5b7e60+_0x3a9fcf),0x64)):0x0,_0x5d919e=_0x2a6274[_0x2c5fd2(0x246)](_0x2a6274[_0x2c5fd2(0x246)](0x2,_0xe67e34['PI']),0x41),_0x2d2fc8=_0x51757a[_0x2c5fd2(0x474)](_0x2a6274[_0x2c5fd2(0x3a1)]);_0x2d2fc8[_0x2c5fd2(0x291)][_0x2c5fd2(0x353)]=_0x5d919e+'\x20'+_0x5d919e,_0x2d2fc8[_0x2c5fd2(0x291)][_0x2c5fd2(0x2f6)]=_0x2a6274[_0x2c5fd2(0x39b)](_0x5d919e,_0x2a6274[_0x2c5fd2(0x246)](_0x2a6274[_0x2c5fd2(0x2de)](_0x4557ae,0x64),_0x5d919e)),_0x89e6[_0x2c5fd2(0x474)](_0x2a6274['eKyrW'])[_0x2c5fd2(0x37e)]=_0x4557ae+'%',_0x260ca5['getElementById'](_0x2a6274[_0x2c5fd2(0x2ef)])[_0x2c5fd2(0x37e)]=_0x309cbf[_0x2c5fd2(0x392)],_0x2c310d[_0x2c5fd2(0x474)](_0x2a6274[_0x2c5fd2(0x33e)])['textContent']=_0x593b2f,_0x546d33[_0x2c5fd2(0x474)](_0x2a6274['iDDwZ'])['textContent']=_0x55db4a,_0x1b0168['getElementById'](_0x2a6274[_0x2c5fd2(0x433)])['textContent']=_0x509f4e;const _0x2c8739=_0x13b7c7[_0x2c5fd2(0x2b0)](_0x2a6274[_0x2c5fd2(0x2de)](_0x5d52e1,0xea60)),_0x3cc02e=_0x7ea372['floor'](_0x2a6274[_0x2c5fd2(0x2de)](_0x2a6274[_0x2c5fd2(0x416)](_0x13f08c,0xea60),0x3e8));_0x396005[_0x2c5fd2(0x474)](_0x2a6274[_0x2c5fd2(0x3a3)])['textContent']=_0x2c8739+':'+_0x3cc02e['toString']()[_0x2c5fd2(0x1db)](0x2,'0');const _0x38a180=_0x2a6274[_0x2c5fd2(0x2de)](_0x5cd9f4,_0x58c0c9[_0x2c5fd2(0x392)]),_0x369e00=_0x64c7db['floor'](_0x2a6274[_0x2c5fd2(0x2de)](_0x38a180,0xea60)),_0x17c585=_0x4d0c94[_0x2c5fd2(0x2b0)](_0x2a6274['YQMdf'](_0x2a6274[_0x2c5fd2(0x416)](_0x38a180,0xea60),0x3e8));_0x7941cf['getElementById'](_0x2a6274[_0x2c5fd2(0x47a)])['textContent']=_0x369e00+':'+_0x17c585[_0x2c5fd2(0x334)]()[_0x2c5fd2(0x1db)](0x2,'0'),_0x5cc0c0[_0x2c5fd2(0x284)][_0x2c5fd2(0x421)](_0x2a6274[_0x2c5fd2(0x215)]);}}})),_0x5832f5[_0x2cce09(0x3af)](updateBookmarkButton),_0x5832f5['uqXVX'](updateMarkReviewButton),(_0x5832f5[_0x2cce09(0x32d)](currentMode,_0x5832f5['pMAZd'])||_0x5832f5[_0x2cce09(0x1e5)](currentMode,_0x5832f5[_0x2cce09(0x3b6)]))&&!isQuizCompleted&&(_0x5832f5[_0x2cce09(0x1e5)](_0x5832f5[_0x2cce09(0x393)],_0x2cce09(0x32b))?(_0xdf39fc[_0x1117e2]['timeSpent']+=_0x1e9947['now']()-_0x1829d8,_0x26158f=_0x58380a['now']()):_0x5832f5['pGuwu'](startTimer));}function selectOption(_0x42fa64){const _0x2be312=_0x2877cd,_0xd1f43d={'tBNOl':_0x2be312(0x2a6),'gTlLO':'Correct','CVxpm':'incorrect','zVtUG':_0x2be312(0x43c),'gJJgx':'mMjvs','sVWSL':'selected','VLWOt':function(_0x3cd2cd,_0x29f54d){return _0x3cd2cd===_0x29f54d;},'biuhX':function(_0x348d1a){return _0x348d1a();},'lDxiQ':_0x2be312(0x23d),'RpzGV':_0x2be312(0x3d7),'Yaebh':_0x2be312(0x20c),'pfYGQ':_0x2be312(0x3c4),'PqaIW':function(_0x5d15d5,_0x560cca){return _0x5d15d5+_0x560cca;},'LJWKN':'\x20-\x20Brain\x20And\x20Scalpel','HwhUU':'answered','ZGgGD':'.option-button','zLouL':_0x2be312(0x394),'Uclvy':function(_0x69c98d,_0x4e6532){return _0x69c98d===_0x4e6532;},'dMAog':_0x2be312(0x452),'tCqPE':_0x2be312(0x2a2),'acPDW':function(_0x35a680){return _0x35a680();},'nZPTW':'not_attempted','dvWGn':_0x2be312(0x1fe),'ZAdKB':function(_0x36edb1){return _0x36edb1();}},_0xa5e22=document[_0x2be312(0x474)](_0x2be312(0x3c9));if(_0xa5e22[_0x2be312(0x284)][_0x2be312(0x45b)](_0xd1f43d[_0x2be312(0x3cc)]))return;questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=Date['now']()-questionStartTime,questionStartTime=Date['now']());selectedOption=_0x42fa64,questionStates[currentQuestionIndex][_0x2be312(0x30b)]=_0x42fa64,document[_0x2be312(0x37a)](_0xd1f43d['ZGgGD'])[_0x2be312(0x2c4)]((_0x207f2e,_0x26b376)=>{const _0x20c165=_0x2be312;if(_0x20c165(0x482)!==_0xd1f43d[_0x20c165(0x2cd)])_0x207f2e[_0x20c165(0x284)][_0x20c165(0x27e)](_0xd1f43d[_0x20c165(0x218)],_0xd1f43d[_0x20c165(0x211)](_0x26b376,_0x42fa64));else{const _0x2b4caf=_0x54d135[_0x20c165(0x26a)][_0x262b87[_0x20c165(0x30b)]];_0x2b4caf['id']===_0x153dc0?(_0x4bec77=_0xd1f43d[_0x20c165(0x1ef)],_0x10b42b=_0xd1f43d['gTlLO']):(_0x2af387=_0xd1f43d[_0x20c165(0x2cc)],_0x4d5c68=_0xd1f43d[_0x20c165(0x322)]);}});if(currentMode===_0xd1f43d[_0x2be312(0x3b2)]||_0xd1f43d[_0x2be312(0x46a)](currentMode,_0xd1f43d[_0x2be312(0x320)]))_0xd1f43d['tCqPE']!=='oJfDB'?_0xd1f43d[_0x2be312(0x369)](processAnswer):_0xd1f43d[_0x2be312(0x47d)](_0x344662);else{if(_0xd1f43d[_0x2be312(0x46a)](questionStates[currentQuestionIndex]['status'],_0xd1f43d[_0x2be312(0x32e)])){if(_0xd1f43d[_0x2be312(0x46a)]('xzjRq',_0xd1f43d[_0x2be312(0x2db)])){const _0x42225c=_0x21b30c[_0x2be312(0x41c)](_0x84dbc9[_0x2be312(0x331)](_0xd1f43d[_0x2be312(0x38e)]));if(_0x42225c){const _0x1ff572=_0xd1f43d[_0x2be312(0x335)][_0x2be312(0x1f4)]('|');let _0x432849=0x0;while(!![]){switch(_0x1ff572[_0x432849++]){case'0':_0x20775f['getElementById'](_0xd1f43d[_0x2be312(0x463)])[_0x2be312(0x37e)]=_0x14ad9a[_0x2be312(0x34f)](_0xd1f43d[_0x2be312(0x422)]);continue;case'1':_0x5cc3e0[_0x2be312(0x336)]=_0xd1f43d[_0x2be312(0x37f)](_0x5b5aea,_0xd1f43d[_0x2be312(0x41d)]);continue;case'2':_0xd2c1a2=_0x42225c['name'];continue;case'3':_0x5187f2=_0x42225c[_0x2be312(0x3a4)];continue;case'4':_0x5c6499=_0x42225c['questions'];continue;case'5':_0x4a489a['getElementById'](_0x2be312(0x3d8))[_0x2be312(0x37e)]=_0x3b4c42[_0x2be312(0x392)];continue;}break;}}}else questionStates[currentQuestionIndex][_0x2be312(0x42a)]=_0x2be312(0x370),stats['totalAttempted']++,stats[_0x2be312(0x269)]--;}_0xd1f43d[_0x2be312(0x47d)](updateQuestionNav);}_0xd1f43d[_0x2be312(0x3f4)](saveProgress);}function processAnswer(){const _0x1533c4=_0x2877cd,_0x32ae5e={'DwNzl':function(_0x77c473,_0x43e36b){return _0x77c473===_0x43e36b;},'ocjDo':function(_0x567ee3,_0x1fff5e){return _0x567ee3===_0x1fff5e;},'nMLQR':_0x1533c4(0x476),'RMeSY':_0x1533c4(0x2a6),'eJkiE':_0x1533c4(0x22c),'TUKBL':function(_0x38bd45){return _0x38bd45();},'COSQk':function(_0x133a8a,_0x404b15){return _0x133a8a(_0x404b15);}},_0x3ee61a=questionsData[currentQuestionIndex],_0x55e87c=_0x3ee61a[_0x1533c4(0x419)];if(_0x32ae5e[_0x1533c4(0x24a)](selectedOption,null))return;const _0x37e7bd=_0x3ee61a[_0x1533c4(0x26a)][selectedOption],_0x397006=_0x32ae5e['DwNzl'](_0x37e7bd['id'],_0x55e87c);if(_0x32ae5e[_0x1533c4(0x204)](questionStates[currentQuestionIndex]['status'],_0x32ae5e[_0x1533c4(0x34e)])){stats[_0x1533c4(0x46b)]++,stats['notAttempted']--;if(_0x397006)stats[_0x1533c4(0x3a5)]++;else stats[_0x1533c4(0x3be)]++;}questionStates[currentQuestionIndex][_0x1533c4(0x42a)]=_0x397006?_0x32ae5e['RMeSY']:_0x32ae5e[_0x1533c4(0x333)],_0x32ae5e[_0x1533c4(0x3c6)](updateStats),_0x32ae5e['COSQk'](showInlineFeedback,_0x397006),_0x32ae5e[_0x1533c4(0x3c6)](updateQuestionNav);}function showInlineFeedback(_0x38ae7d){const _0x2efd5a=_0x2877cd,_0x5284b7={'BvlSK':_0x2efd5a(0x236),'DGOAk':_0x2efd5a(0x22c),'ZyTFs':function(_0x25d619,_0x3d974e){return _0x25d619!==_0x3d974e;},'Mopin':_0x2efd5a(0x394),'RZWkl':_0x2efd5a(0x452),'yOHfT':_0x2efd5a(0x3c9),'cwHVr':_0x2efd5a(0x404)};if(_0x5284b7[_0x2efd5a(0x47b)](currentMode,_0x5284b7[_0x2efd5a(0x29c)])&&_0x5284b7[_0x2efd5a(0x47b)](currentMode,_0x5284b7[_0x2efd5a(0x3eb)]))return;const _0x2678bc=document['getElementById'](_0x5284b7[_0x2efd5a(0x20a)]),_0x40b5e0=_0x2678bc[_0x2efd5a(0x37a)](_0x5284b7['cwHVr']),_0x1bf8b2=questionsData[currentQuestionIndex],_0x3f9adf=_0x1bf8b2['correct_choice_id'];let _0x135eee=_0x1bf8b2['choices']['findIndex'](_0x1bb3c2=>_0x1bb3c2['id']===_0x3f9adf);_0x2678bc['classList'][_0x2efd5a(0x280)](_0x2efd5a(0x370)),_0x40b5e0['forEach']((_0x962c0b,_0x1ee798)=>{const _0xf9dd85=_0x2efd5a;_0x962c0b[_0xf9dd85(0x284)][_0xf9dd85(0x421)](_0x5284b7[_0xf9dd85(0x366)]);if(_0x1ee798===_0x135eee)_0x962c0b[_0xf9dd85(0x284)]['add'](_0xf9dd85(0x2a6));else{if(_0x1ee798===selectedOption&&!_0x38ae7d)_0x962c0b['classList'][_0xf9dd85(0x280)](_0x5284b7[_0xf9dd85(0x203)]);}}),showSolution();}function showSolution(){const _0x34ba9a=_0x2877cd,_0x387d7f={'gOIxV':function(_0x35840a,_0x4a54ec){return _0x35840a(_0x4a54ec);},'PklvU':_0x34ba9a(0x412),'FTJyo':_0x34ba9a(0x450),'bKYkb':function(_0x43f8e1,_0x1ac780){return _0x43f8e1!==_0x1ac780;},'gzBIx':_0x34ba9a(0x394),'aNZHZ':_0x34ba9a(0x452),'qkXyc':_0x34ba9a(0x411),'KDbjC':'solutionVideo','BmGWw':_0x34ba9a(0x1ea),'IQrgy':_0x34ba9a(0x2e8),'lCgNp':_0x34ba9a(0x1f6),'ARARG':function(_0x365cff,_0x4b62ce,_0x3ec0ff){return _0x365cff(_0x4b62ce,_0x3ec0ff);},'rPEsi':'cJQbR','lpcZC':'OylaE','Sziny':_0x34ba9a(0x380),'cjuSU':function(_0x1a4eb3,_0x3177a9){return _0x1a4eb3!==_0x3177a9;},'eGwBb':_0x34ba9a(0x32c),'Ewdcx':_0x34ba9a(0x24e),'awwbY':function(_0x395943,_0x102502){return _0x395943===_0x102502;},'fefEa':_0x34ba9a(0x473),'kWaMw':_0x34ba9a(0x2bb),'YsJEa':_0x34ba9a(0x313)};if(_0x387d7f[_0x34ba9a(0x25b)](currentMode,_0x387d7f['gzBIx'])&&_0x387d7f['bKYkb'](currentMode,_0x387d7f[_0x34ba9a(0x217)]))return;const _0x3df520=questionsData[currentQuestionIndex];document[_0x34ba9a(0x474)](_0x387d7f[_0x34ba9a(0x3f0)])[_0x34ba9a(0x347)]=_0x3df520[_0x34ba9a(0x3fd)]||_0x34ba9a(0x29a);const _0x521ad1=document[_0x34ba9a(0x474)](_0x387d7f[_0x34ba9a(0x21c)]),_0x49d1f8=document['getElementById'](_0x387d7f[_0x34ba9a(0x481)]),_0x15d81d=_0x3df520[_0x34ba9a(0x2f8)];if(_0x15d81d){_0x521ad1[_0x34ba9a(0x284)][_0x34ba9a(0x421)](_0x387d7f['IQrgy']);if(_0x15d81d['includes'](_0x387d7f[_0x34ba9a(0x423)]))_0x387d7f[_0x34ba9a(0x475)](setupVideo,_0x49d1f8,_0x15d81d);else _0x49d1f8[_0x34ba9a(0x354)]=_0x15d81d;}else{if(_0x387d7f[_0x34ba9a(0x288)]===_0x387d7f[_0x34ba9a(0x1f7)]){const _0x1d48ff=_0x825504[_0x34ba9a(0x459)](_0x2aafd2,arguments);return _0x2e43ad=null,_0x1d48ff;}else _0x521ad1[_0x34ba9a(0x284)][_0x34ba9a(0x280)](_0x387d7f[_0x34ba9a(0x25a)]);}const _0x5e1032=document[_0x34ba9a(0x474)](_0x387d7f[_0x34ba9a(0x341)]);_0x5e1032[_0x34ba9a(0x347)]='';_0x3df520[_0x34ba9a(0x258)]&&(_0x387d7f[_0x34ba9a(0x466)](_0x387d7f[_0x34ba9a(0x3d2)],_0x387d7f['Ewdcx'])?_0x5e1032[_0x34ba9a(0x347)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x3df520[_0x34ba9a(0x258)]+_0x34ba9a(0x36c):_0x554d7f['innerHTML']+=_0x34ba9a(0x2fa)+_0x187521['explanation_audio_hin']+_0x34ba9a(0x36c));_0x3df520[_0x34ba9a(0x44a)]&&(_0x387d7f[_0x34ba9a(0x471)](_0x387d7f[_0x34ba9a(0x1d7)],_0x34ba9a(0x3db))?_0x23b9a7=GEJama[_0x34ba9a(0x1f0)](_0x1cb6a3,GEJama[_0x34ba9a(0x229)]+GEJama[_0x34ba9a(0x3ea)]+');')():_0x5e1032['innerHTML']+=_0x34ba9a(0x2fa)+_0x3df520[_0x34ba9a(0x44a)]+_0x34ba9a(0x36c));const _0x5b805e=document[_0x34ba9a(0x474)](_0x387d7f['kWaMw']);_0x5b805e[_0x34ba9a(0x347)]='',_0x3df520[_0x34ba9a(0x209)]&&_0x3df520[_0x34ba9a(0x209)][_0x34ba9a(0x2c4)](_0x318957=>{const _0x3bdb0a=_0x34ba9a;if(_0x318957)_0x5b805e['innerHTML']+=_0x3bdb0a(0x48a)+_0x318957+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}),document[_0x34ba9a(0x474)](_0x387d7f[_0x34ba9a(0x390)])[_0x34ba9a(0x284)][_0x34ba9a(0x421)](_0x387d7f[_0x34ba9a(0x25a)]);}function submitQuiz(){const _0x26a953=_0x2877cd,_0xf71cdb={'cHRGG':_0x26a953(0x346),'XoXOZ':function(_0x98592b,_0x251811){return _0x98592b===_0x251811;},'QmASg':function(_0x2a270a,_0x3d35ce){return _0x2a270a===_0x3d35ce;},'IquWA':'upFen','OiwjD':_0x26a953(0x378),'UTWul':'correct','YFDFg':function(_0x6ea02c,_0x25c5fd){return _0x6ea02c(_0x25c5fd);},'DlzAU':_0x26a953(0x488),'juFXQ':function(_0x4b9dc1,_0x376312){return _0x4b9dc1-_0x376312;},'hjbKV':function(_0x4be875,_0x4e624a){return _0x4be875-_0x4e624a;},'hYIyU':function(_0x16b39a,_0x2cc3cc){return _0x16b39a+_0x2cc3cc;},'wJiFF':_0x26a953(0x227),'nTUdx':function(_0x22e975,_0x2b891d,_0x164849,_0x205ef7,_0x52c2dd){return _0x22e975(_0x2b891d,_0x164849,_0x205ef7,_0x52c2dd);}};if(timer)clearInterval(timer);if(!_0xf71cdb[_0x26a953(0x2b6)](confirm,_0xf71cdb[_0x26a953(0x2ed)]))return;isQuizCompleted=!![];let _0x4ae72c=0x0,_0x18bda0=0x0;const _0x4736d9=_0xf71cdb[_0x26a953(0x35f)](Date[_0x26a953(0x316)](),quizStartTime);questionsData[_0x26a953(0x2c4)]((_0x136625,_0x3bcdd3)=>{const _0x3bf5a6=_0x26a953,_0x133c34={'SQEWR':_0xf71cdb[_0x3bf5a6(0x34b)]},_0x2d2f1e=questionStates[_0x3bcdd3];if(_0x2d2f1e[_0x3bf5a6(0x30b)]!==null){if(_0xf71cdb['XoXOZ'](_0x136625['choices'][_0x2d2f1e[_0x3bf5a6(0x30b)]]['id'],_0x136625[_0x3bf5a6(0x419)])){if(_0xf71cdb[_0x3bf5a6(0x2d2)](_0xf71cdb['IquWA'],_0xf71cdb['OiwjD']))return _0x4dcb93[_0x3bf5a6(0x334)]()[_0x3bf5a6(0x384)](ZAfiEB[_0x3bf5a6(0x328)])['toString']()[_0x3bf5a6(0x212)](_0x412730)[_0x3bf5a6(0x384)](ZAfiEB[_0x3bf5a6(0x328)]);else _0x4ae72c++,_0x2d2f1e[_0x3bf5a6(0x42a)]=_0xf71cdb[_0x3bf5a6(0x44d)];}else _0x18bda0++,_0x2d2f1e['status']='incorrect';}});const _0x565a4e=JSON[_0x26a953(0x41c)](localStorage[_0x26a953(0x331)](_0x26a953(0x227)))||[];_0x565a4e[_0x26a953(0x200)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x26a953(0x316)](),'totalTime':_0x4736d9,'stats':{'correct':_0x4ae72c,'incorrect':_0x18bda0,'notAttempted':_0xf71cdb[_0x26a953(0x224)](questionsData[_0x26a953(0x392)],_0xf71cdb[_0x26a953(0x3b3)](_0x4ae72c,_0x18bda0))}}),localStorage[_0x26a953(0x244)](_0xf71cdb['wJiFF'],JSON[_0x26a953(0x41a)](_0x565a4e)),stats['correctAnswers']=_0x4ae72c,stats[_0x26a953(0x3be)]=_0x18bda0,markQuizAsCompleted(),_0xf71cdb[_0x26a953(0x472)](showPerformanceAnalysis,_0x4ae72c,_0x18bda0,_0xf71cdb['juFXQ'](questionsData[_0x26a953(0x392)],_0x4ae72c+_0x18bda0),_0x4736d9);}function showPerformanceAnalysis(_0x9b45ab,_0x11641d,_0x2b1ea6,_0x3dcb31){const _0x1ff846=_0x2877cd,_0x441b6b={'qAFNK':_0x1ff846(0x453),'glymp':function(_0x1c81a1,_0x47c6ac){return _0x1c81a1>_0x47c6ac;},'JvWxX':function(_0x2c2164,_0x58b186){return _0x2c2164+_0x58b186;},'SwkQl':function(_0x5ec334,_0x3ede26){return _0x5ec334*_0x3ede26;},'aPhsh':function(_0x4dade6,_0x115a11){return _0x4dade6/_0x115a11;},'ymHmt':function(_0x24c3b9,_0x133d2a){return _0x24c3b9*_0x133d2a;},'XegQX':'accuracyScore','mfpFS':_0x1ff846(0x1f8),'uBqIB':_0x1ff846(0x2a4),'WETpq':_0x1ff846(0x299),'cXjzg':_0x1ff846(0x263),'OIksZ':function(_0x4da26e,_0x2ae959){return _0x4da26e/_0x2ae959;},'IhhcZ':function(_0x4fec4e,_0x28639f){return _0x4fec4e%_0x28639f;},'MoKKc':'totalTimeResult','eYGOA':function(_0x4b415a,_0x2d30f2){return _0x4b415a/_0x2d30f2;},'PpoRh':function(_0x35874f,_0x4e6932){return _0x35874f/_0x4e6932;},'iSgGz':_0x1ff846(0x42f)},_0x11bc7e=document[_0x1ff846(0x474)](_0x441b6b[_0x1ff846(0x356)]),_0xeaca59=_0x441b6b['glymp'](_0x441b6b[_0x1ff846(0x238)](_0x9b45ab,_0x11641d),0x0)?Math['round'](_0x441b6b[_0x1ff846(0x2f4)](_0x441b6b['aPhsh'](_0x9b45ab,_0x441b6b[_0x1ff846(0x238)](_0x9b45ab,_0x11641d)),0x64)):0x0,_0xe599a5=_0x441b6b[_0x1ff846(0x2f4)](_0x441b6b[_0x1ff846(0x2f4)](0x2,Math['PI']),0x41),_0x4e0e96=document[_0x1ff846(0x474)](_0x1ff846(0x1e6));_0x4e0e96[_0x1ff846(0x291)][_0x1ff846(0x353)]=_0xe599a5+'\x20'+_0xe599a5,_0x4e0e96['style']['strokeDashoffset']=_0xe599a5-_0x441b6b[_0x1ff846(0x3d5)](_0x441b6b[_0x1ff846(0x38b)](_0xeaca59,0x64),_0xe599a5),document[_0x1ff846(0x474)](_0x441b6b[_0x1ff846(0x3c1)])[_0x1ff846(0x37e)]=_0xeaca59+'%',document[_0x1ff846(0x474)](_0x441b6b[_0x1ff846(0x23c)])[_0x1ff846(0x37e)]=questionsData[_0x1ff846(0x392)],document[_0x1ff846(0x474)](_0x441b6b['uBqIB'])[_0x1ff846(0x37e)]=_0x9b45ab,document[_0x1ff846(0x474)](_0x441b6b[_0x1ff846(0x274)])['textContent']=_0x11641d,document[_0x1ff846(0x474)](_0x441b6b[_0x1ff846(0x3d1)])['textContent']=_0x2b1ea6;const _0x1cc9ba=Math[_0x1ff846(0x2b0)](_0x3dcb31/0xea60),_0x5acbdf=Math['floor'](_0x441b6b['OIksZ'](_0x441b6b[_0x1ff846(0x2a5)](_0x3dcb31,0xea60),0x3e8));document[_0x1ff846(0x474)](_0x441b6b[_0x1ff846(0x3a6)])[_0x1ff846(0x37e)]=_0x1cc9ba+':'+_0x5acbdf[_0x1ff846(0x334)]()[_0x1ff846(0x1db)](0x2,'0');const _0x28cb76=_0x441b6b[_0x1ff846(0x2c3)](_0x3dcb31,questionsData[_0x1ff846(0x392)]),_0x5751a4=Math[_0x1ff846(0x2b0)](_0x441b6b[_0x1ff846(0x2c3)](_0x28cb76,0xea60)),_0x4489d2=Math[_0x1ff846(0x2b0)](_0x441b6b[_0x1ff846(0x47f)](_0x441b6b[_0x1ff846(0x2a5)](_0x28cb76,0xea60),0x3e8));document[_0x1ff846(0x474)](_0x441b6b[_0x1ff846(0x35d)])[_0x1ff846(0x37e)]=_0x5751a4+':'+_0x4489d2[_0x1ff846(0x334)]()['padStart'](0x2,'0'),_0x11bc7e[_0x1ff846(0x284)]['remove'](_0x1ff846(0x2e8));}function closePerformanceModal(){const _0x27ee5c=_0x2877cd,_0x769b62={'sSeNh':_0x27ee5c(0x453),'xBZPT':_0x27ee5c(0x2e8)};document[_0x27ee5c(0x474)](_0x769b62['sSeNh'])[_0x27ee5c(0x284)][_0x27ee5c(0x280)](_0x769b62[_0x27ee5c(0x410)]);}function reviewQuestions(){const _0x2c67b7=_0x2877cd,_0x3dd8b1={'jSccI':function(_0x99be93,_0x28b176){return _0x99be93===_0x28b176;},'uJmHp':_0x2c67b7(0x202),'hzTeo':'border-red-500','UWikD':_0x2c67b7(0x446),'WUJKu':_0x2c67b7(0x3b4),'gYpRH':function(_0x42a405,_0x4fbd95){return _0x42a405!==_0x4fbd95;},'mbNso':_0x2c67b7(0x2a6),'bUGDO':_0x2c67b7(0x2f0),'RWhbY':function(_0x5c8f8d,_0xae275f){return _0x5c8f8d===_0xae275f;},'FlTyw':'JQejt','tKKvS':_0x2c67b7(0x22c),'bIcLH':_0x2c67b7(0x43c),'QtixX':_0x2c67b7(0x31d),'QXReL':_0x2c67b7(0x490),'OuhlM':function(_0x42450a,_0x12b4d9){return _0x42450a===_0x12b4d9;},'aOSUq':_0x2c67b7(0x3a2),'jIdXn':_0x2c67b7(0x3d6),'GQcpW':_0x2c67b7(0x3e2),'FKVUX':_0x2c67b7(0x420),'iBFME':_0x2c67b7(0x23a),'MXBTx':function(_0x313bcb){return _0x313bcb();}};document[_0x2c67b7(0x474)](_0x3dd8b1['FKVUX'])['classList'][_0x2c67b7(0x421)](_0x2c67b7(0x2e8));const _0x2101f4=document[_0x2c67b7(0x474)](_0x3dd8b1[_0x2c67b7(0x455)]);_0x2101f4[_0x2c67b7(0x347)]='',questionsData['forEach']((_0x1769cc,_0x279430)=>{const _0x4ced83=_0x2c67b7,_0x5acae2={'CURRd':function(_0x7f6bfa,_0x9a844e){const _0x4b04ac=_0x1932;return _0x3dd8b1[_0x4b04ac(0x286)](_0x7f6bfa,_0x9a844e);},'RXoex':_0x3dd8b1[_0x4ced83(0x2b3)],'MZTLx':_0x4ced83(0x1fb),'Hnlie':_0x3dd8b1['hzTeo']},_0x7e859b=questionStates[_0x279430],_0x1b99ce=_0x1769cc[_0x4ced83(0x419)];let _0x546e20=_0x3dd8b1['UWikD'],_0x40a199=_0x3dd8b1[_0x4ced83(0x318)];if(_0x3dd8b1[_0x4ced83(0x3dd)](_0x7e859b[_0x4ced83(0x30b)],null)){const _0x569175=_0x1769cc['choices'][_0x7e859b['selectedAnswer']];_0x3dd8b1[_0x4ced83(0x286)](_0x569175['id'],_0x1b99ce)?(_0x546e20=_0x3dd8b1[_0x4ced83(0x2b5)],_0x40a199=_0x3dd8b1['bUGDO']):_0x3dd8b1['RWhbY'](_0x3dd8b1[_0x4ced83(0x39c)],_0x4ced83(0x397))?_0x3746ee[_0x4ced83(0x354)]=_0x9fc57a:(_0x546e20=_0x3dd8b1[_0x4ced83(0x2a7)],_0x40a199=_0x3dd8b1[_0x4ced83(0x377)]);}const _0x2e2fcf=document[_0x4ced83(0x477)](_0x3dd8b1[_0x4ced83(0x415)]);_0x2e2fcf[_0x4ced83(0x38a)]='review-question\x20'+_0x546e20;let _0x7865cd=(_0x1769cc['choices']||[])[_0x4ced83(0x35a)]((_0x5c61ce,_0x177c92)=>{const _0x41a105=_0x4ced83;if(_0x5acae2[_0x41a105(0x241)](_0x41a105(0x24b),_0x41a105(0x276)))_0x3f0e3f();else{const _0x1d684b=_0x5acae2[_0x41a105(0x241)](_0x7e859b[_0x41a105(0x30b)],_0x177c92),_0x4c4d72=_0x5acae2[_0x41a105(0x241)](_0x5c61ce['id'],_0x1b99ce);let _0x92ec22=_0x5acae2[_0x41a105(0x323)];if(_0x4c4d72)_0x92ec22=_0x5acae2['MZTLx'];else{if(_0x1d684b)_0x92ec22=_0x5acae2[_0x41a105(0x386)];}return _0x41a105(0x2d3)+_0x92ec22+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+String['fromCharCode'](0x41+_0x177c92)+_0x41a105(0x1e9)+_0x5c61ce['text']+_0x41a105(0x2b7);}})[_0x4ced83(0x34f)]('');const _0x47baa9=_0x1769cc[_0x4ced83(0x2f8)]?_0x4ced83(0x213)+_0x279430+_0x4ced83(0x25f)+_0x1769cc[_0x4ced83(0x2f8)]+_0x4ced83(0x3f6):'';let _0x44fa01='';if(_0x1769cc['explanation_audio_eng'])_0x44fa01+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22'+_0x1769cc[_0x4ced83(0x258)]+_0x4ced83(0x36c);if(_0x1769cc['explanation_audio_hin'])_0x44fa01+=_0x4ced83(0x2d7)+_0x1769cc[_0x4ced83(0x44a)]+_0x4ced83(0x36c);let _0x4e46c2=(_0x1769cc[_0x4ced83(0x209)]||[])[_0x4ced83(0x35a)](_0x596fb7=>_0x596fb7?_0x4ced83(0x48a)+_0x596fb7+_0x4ced83(0x483):'')[_0x4ced83(0x34f)]('');_0x2e2fcf[_0x4ced83(0x347)]=_0x4ced83(0x350)+(_0x279430+0x1)+_0x4ced83(0x469)+(_0x546e20==='correct'?_0x3dd8b1[_0x4ced83(0x1ee)]:_0x3dd8b1['OuhlM'](_0x546e20,_0x3dd8b1[_0x4ced83(0x2a7)])?_0x3dd8b1['aOSUq']:_0x3dd8b1[_0x4ced83(0x485)])+_0x4ced83(0x3fb)+_0x40a199+_0x4ced83(0x3bb)+_0x1769cc[_0x4ced83(0x45d)]+_0x4ced83(0x468)+_0x7865cd+_0x4ced83(0x3a7)+(_0x1769cc[_0x4ced83(0x3fd)]||_0x3dd8b1[_0x4ced83(0x436)])+_0x4ced83(0x2d4)+_0x47baa9+_0x4ced83(0x1eb)+_0x44fa01+_0x4ced83(0x1eb)+_0x4e46c2+_0x4ced83(0x3ac),_0x2101f4[_0x4ced83(0x39a)](_0x2e2fcf);}),_0x3dd8b1['MXBTx'](initializeReviewVideos);}function initializeReviewVideos(){const _0xfdd43f=_0x2877cd,_0x32dc03={'wknqx':function(_0x463bd8,_0x19eecb){return _0x463bd8+_0x19eecb;},'eroPL':_0xfdd43f(0x31d),'ZEJwS':_0xfdd43f(0x236),'tQhvy':function(_0x359442,_0xfd58ae){return _0x359442===_0xfd58ae;},'oIWni':_0xfdd43f(0x46e),'QmOHC':_0xfdd43f(0x1f6),'ilIql':_0xfdd43f(0x34d)};document['querySelectorAll'](_0x32dc03[_0xfdd43f(0x46d)])[_0xfdd43f(0x2c4)](_0x54458a=>{const _0x34b18f=_0xfdd43f,_0x6a25cf={'flFfp':function(_0x5831b4,_0x5793b9){const _0x1b7729=_0x1932;return _0x32dc03[_0x1b7729(0x2f7)](_0x5831b4,_0x5793b9);},'TCXDf':function(_0x4341a4,_0x495d45){return _0x4341a4===_0x495d45;},'MAuyN':_0x32dc03[_0x34b18f(0x228)],'srCli':_0x32dc03[_0x34b18f(0x2df)],'WpFoA':function(_0x4a6426,_0xfcd0e2){return _0x4a6426+_0xfcd0e2;}};if(_0x32dc03[_0x34b18f(0x388)](_0x32dc03['oIWni'],_0x32dc03['oIWni'])){const _0x5b5a79=_0x54458a['dataset'][_0x34b18f(0x354)];if(_0x5b5a79&&_0x5b5a79[_0x34b18f(0x402)](_0x32dc03['QmOHC']))setupVideo(_0x54458a,_0x5b5a79);else _0x5b5a79&&(_0x54458a[_0x34b18f(0x354)]=_0x5b5a79);}else{const _0x12cd18=_0x14001b[_0x34b18f(0x2ab)](_0x6a25cf[_0x34b18f(0x39d)](0x41,_0x278ca6)),_0x25dfb3=_0x6a25cf[_0x34b18f(0x1e1)](_0xed6acb,_0x135141),_0xe46c5=_0x162a98['createElement'](_0x6a25cf[_0x34b18f(0x491)]);_0xe46c5[_0x34b18f(0x347)]=_0x34b18f(0x431)+(_0x25dfb3?_0x6a25cf[_0x34b18f(0x2a8)]:'')+'\x22\x20data-option-index=\x22'+_0x50d654+_0x34b18f(0x2b9)+_0x12cd18+_0x34b18f(0x257)+(_0x2e1ee1[_0x34b18f(0x45d)]||_0x6a25cf['flFfp'](_0x34b18f(0x233),_0x6a25cf['WpFoA'](_0x15caec,0x1)))+_0x34b18f(0x1de),_0x47702b['appendChild'](_0xe46c5);}});}function retakeQuiz(){const _0xe7f83d=_0x2877cd,_0x525068={'NaqYh':function(_0x52148f,_0x19e766){return _0x52148f-_0x19e766;},'nMPAt':function(_0xfed61b){return _0xfed61b();},'iUYQM':'bookmarkedQuestions','boIwC':function(_0x43e8f9,_0x2abfcf){return _0x43e8f9(_0x2abfcf);},'DdYCO':_0xe7f83d(0x2e9),'UhOax':function(_0x122b63,_0x359301){return _0x122b63!==_0x359301;},'NPvyJ':_0xe7f83d(0x41f),'KoZgO':'VZyXF','dsiOt':_0xe7f83d(0x2e6),'knvcO':function(_0x2fcb4f,_0x33132b){return _0x2fcb4f!==_0x33132b;},'VcaIH':'JVtYB','xXSsw':function(_0x40320d){return _0x40320d();}};if(_0x525068['boIwC'](confirm,_0x525068[_0xe7f83d(0x359)])){if(_0x525068[_0xe7f83d(0x372)](_0x525068[_0xe7f83d(0x1f2)],_0x525068['KoZgO']))window['location'][_0xe7f83d(0x389)]['endsWith'](_0x525068[_0xe7f83d(0x2c5)])&&(_0x525068[_0xe7f83d(0x3df)](_0x525068['VcaIH'],_0x525068['VcaIH'])?(_0x1841b5&&(_0x9f5aa1[_0x1151f5]['timeSpent']+=_0x525068['NaqYh'](_0x5516e6['now'](),_0x2acf0d)),_0x387775--,_0x35b7c5(),_0x525068[_0xe7f83d(0x252)](_0x30655f)):localStorage[_0xe7f83d(0x46f)](_0xe7f83d(0x23d))),_0x525068[_0xe7f83d(0x414)](clearProgress),location['reload']();else{const _0xb62746=!_0x288d71[_0x5f1fe7][_0xe7f83d(0x40f)];_0x1422b1[_0x4487f0][_0xe7f83d(0x40f)]=_0xb62746;let _0x55aedc=_0x2f8777[_0xe7f83d(0x41c)](_0x21d588['getItem'](_0x525068[_0xe7f83d(0x424)]))||[];if(_0xb62746){const _0x4b8093={'quizName':_0xa41192,'quizFile':_0x33e3b1['location'][_0xe7f83d(0x389)][_0xe7f83d(0x1f4)]('/')[_0xe7f83d(0x1d9)](),'questionIndex':_0x312ea1,'question':_0x59fe37[_0x1eb9f7],'hierarchy':_0xabf383,'timestamp':_0x3dbfe3[_0xe7f83d(0x316)]()};_0x55aedc[_0xe7f83d(0x200)](_0x4b8093);}else _0x55aedc=_0x55aedc['filter'](_0x1232cf=>!(_0x1232cf[_0xe7f83d(0x26b)][_0xe7f83d(0x402)](_0x1aa2fb[_0xe7f83d(0x434)]()['replace'](/ /g,'-'))&&_0x1232cf[_0xe7f83d(0x2ba)]===_0x57bbeb));_0x45ac47[_0xe7f83d(0x244)](_0xe7f83d(0x344),_0x231f61[_0xe7f83d(0x41a)](_0x55aedc)),_0x196616(),_0x525068[_0xe7f83d(0x252)](_0x4f1134);}}}function loadBookmarkedQuestions(){const _0x1c6afa=_0x2877cd,_0x1ee628={'pZNaP':function(_0x16f1d3,_0x183d6f){return _0x16f1d3<_0x183d6f;},'gAmQV':function(_0x3b74f0,_0x4f4009){return _0x3b74f0===_0x4f4009;},'pdfQV':_0x1c6afa(0x1ed)},_0x129231=JSON[_0x1c6afa(0x41c)](localStorage['getItem'](_0x1c6afa(0x344)))||[];_0x129231[_0x1c6afa(0x2c4)](_0x3f16bb=>{const _0x285565=_0x1c6afa;if(_0x3f16bb[_0x285565(0x26b)][_0x285565(0x402)](quizName[_0x285565(0x434)]()[_0x285565(0x3ad)](/ /g,'-'))){if(_0x1ee628[_0x285565(0x40b)](_0x3f16bb[_0x285565(0x2ba)],questionsData[_0x285565(0x392)])){if(_0x1ee628[_0x285565(0x214)](_0x1ee628[_0x285565(0x297)],_0x1ee628['pdfQV']))questionStates[_0x3f16bb[_0x285565(0x2ba)]][_0x285565(0x40f)]=!![];else{_0x4e38a7[_0x285565(0x46b)]++,_0x209d09[_0x285565(0x269)]--;if(_0x2a338)_0x2ed5f3['correctAnswers']++;else _0x477a5e[_0x285565(0x3be)]++;}}}});}function _0x2210(){const _0x3150d9=['24\x20hour\x20urine\x20collection','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','CVxpm','gJJgx','YHjMd','ZfwPM','bINVt','Sustained\x20proteinuria','QmASg','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','NETeu','Mycophenolate\x20mofetil','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','5ODQXvJ','A\x20marathon\x20runner\x20is\x20brought\x20in\x20because\x20of\x20reduced\x20urination\x208\x20hours\x20after\x20a\x2030\x20km\x20marathon\x20on\x20a\x20sunny\x20day.\x20Urine\x20analysis\x20shows\x20a\x20dark\x20yellow\x20color,\x20creatinine\x200.8\x20mg/dl,\x20urine\x20protein\x20++,\x20and\x20blood\x20negative.\x20His\x20BP\x20is\x20100/60\x20mmHg.\x20What\x20is\x20the\x20cause\x20of\x20his\x20urinary\x20protein\x20findings?','currentMode','dvWGn','question_video','AOLGi','CjfPK','ZEJwS','aIEkF','qVxgg','lgyCw','bgHjE','Urine\x20albumin\x20to\x20creatinine\x20ratio','yKguT','custom_quiz.html','<p><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>This\x20patient\x20with\x20a\x20history\x20of\x20<strong>massive\x20proteinuria</strong>\x20now\x20presenting\x20with\x20a\x20thrombus\x20in\x20his\x20<strong>renal\x20vein</strong>\x20has\x20developed\x20<strong>renal\x20vein\x20thrombosis.</strong>\x20The\x20history\x20of\x20massive\x20proteinuria\x20suggests\x20a\x20nephrotic\x20syndrome.\x20Membranous\x20nephropathy\x20is\x20the\x20most\x20commonly\x20associated\x20nephrotic\x20syndrome\x20associated\x20with\x20RVT.\x20<strong>AntiPLA2R\x20antibodies</strong>\x20are\x20associated\x20with\x20membranous\x20nephropathy.</span></p>\x0a<p><strong\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>Membranous\x20nephropathy</strong><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>\x20is\x20one\x20of\x20the\x20most\x20common\x20causes\x20of\x20nephrotic\x20syndrome\x20in\x20older\x20adults,\x20with\x20a\x20peak\x20incidence\x20in\x2030–50\x20years\x20and\x20a\x20male:\x20female\x20ratio\x20of\x202:1.\x20It\x20is\x20a\x20form\x20of\x20chronic\x20</span><strong\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>immune-complex-mediated</strong><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>\x20disease.\x20It\x20can\x20be\x20</span><strong\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>primary</strong><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>\x20(75%\x20of\x20cases)\x20or\x20</span><strong\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>secondary.\x20Factors</strong><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>\x20that\x20can\x20lead\x20to</span><strong\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>\x20secondary\x20membranous\x20nephropathy</strong><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>\x20include:</span></p>\x0a<ul>\x0a<li><strong>Solid\x20malignancies\u00a0</strong>-\x20<strong>colon</strong>,\x20breast,\x20lung.</li>\x0a<li>Infection\x20-\x20<strong>Hepatitis\x20B</strong>,\x20Syphilis,\x20Malaria,\x20Schistosomiasis</li>\x0a<li>Rheumatological\x20disorders\x20-\x20Lupus,\x20IgG4-related\x20disease.</li>\x0a</ul>\x0a<p>Light\x20microscopy\x20shows\x20<strong>diffuse\x20thickening\x20of</strong>\x20the\x20<strong>glomerular\x20capillary\x20wall,\x20</strong>due\x20to\x20deposition\x20of\x20immune\x20complexes\x20between\x20the\x20basement\x20membrane\x20and\x20the\x20overlying\x20epithelial\x20cells.\x20<strong>Irregular\x20spikes</strong>\x20of\x20basement\x20membrane\x20between\x20these\x20deposits\x20are\x20best\x20<strong>seen\x20with\x20silver\x20stains</strong>.\x20<strong>Immunofluorescence\x20microscopy</strong>\x20shows\x20<strong>diffuse</strong>\x20<strong>granular</strong>\x20<strong>deposits</strong>\x20containing\x20<strong>IgG</strong>\x20and\x20<strong>C3.\x20</strong><strong>Electron\x20microscopy\x20</strong>shows\x20electron-dense\x20<strong>subepithelial\x20deposits</strong>\x20(<strong>epimembranous\x20spikes</strong>)\x20and\x20effacement\x20of\x20foot\x20processes\x20of\x20podocytes.</p>\x0a<p>This\x20patient\x27s\x20clinical\x20features\x20are\x20suggestive\x20of\x20a\x20diagnosis\x20of\x20<strong>nephrotic\x20syndrome</strong>\x20complicated\x20with\x20renal\x20vein\x20thrombosis.\x20<strong>Thrombo-embolic\x20complications</strong>\x20in\x20nephrotic\x20syndrome\x20are\x20due\x20to\x20the\x20<strong>loss\x20of\x20endogenous\x20anticoagulants\x20</strong>such\x20as\x20<strong>antithrombin\x20III</strong>\u00a0in\x20the\x20urine.</p>\x0a<p>Other\x20options:<br\x20/>Option\x20B:\x20Elevated\x20complement\x20levels\x20are\x20not\x20associated\x20with\x20any\x20nephrotic\x20syndrome\x20reduced\x20C3\x20levels\x20are\x20seen\x20in\x20post\x20streptococcal\x20glomerulonephritis.</p>\x0a<p>Option\x20C:\x20Splitting\x20of\x20the\x20glomerular\x20basement\x20membrane\x20is\x20seen\x20in\x20Alport\x20syndrome.</p>\x0a<p>Option\x20D:\x20Immune\x20complexes\x20comprised\x20of\x20vitamin\x20D\x20is\x20seen\x20in\x20IgA\x20nephropathy.\x20However,\x20all\x20these\x20conditions\x20are\x20not\x20commonly\x20associated\x20with\x20RVT.\u00a0</p>','hidden','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','zfShH','vwFsY','xrZsF','DlzAU','bookmarkText','Mjqaa','Correct','testModeReviewLegend','Splitting\x20of\x20the\x20glomerular\x20basement\x20membranes','Captopril','SwkQl','OpRgP','strokeDashoffset','wknqx','explanation_video','totalTime','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','wMetM','location','UkzTn','flex','xjzpu','You\x20are\x20managing\x20a\x20patient\x20with\x20microalbuminuria.\x20\x20He\x20has\x20a\x20past\x20history\x20of\x20diabetes\x20and\x20hypertension.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20as\x20a\x20part\x20of\x20his\x20drug\x20regimen\x20?','iQeYa','preventDefault','Elevated\x20complement\x20levels','Pembrolizumab','navBtn_','JEVRy','<p>This\x20child\x20with\x20a\x20history\x20of\x20<strong>frothy\x20urine</strong>\x20for\x203\x20weeks\x20now\x20presenting\x20with\x20<strong>ascites</strong>\x20has\x20a\x20culture\x20positive\x20for\x20<strong>Streptococcus\x20pneumonia.</strong>\x20This\x20indicates\x20<strong>peritonitis.</strong>\x20The\x20presence\x20of\x20<strong>hypercholesterolemia</strong>\x20in\x20combination\x20with\x20<strong>frothy\x20urine</strong>\x20raises\x20suspicion\x20of\x20<strong>nephrotic\x20syndrome.</strong>This\x20leads\x20to\x20a\x20loss\x20of\x20<strong>immunoglobulins</strong>\x20in\x20the\x20<strong>urine</strong>\x20which\x20renders\x20the\x20<strong>child</strong>\x20unable\x20to\x20mount\x20an\x20<strong>immune\x20response</strong>\x20making\x20him\x20<strong>susceptible</strong>\x20to\x20<strong>infections.</strong>\u00a0</p>\x0a<p><strong>Nephrotic\x20syndrome</strong>\x20in\x20children\x20is\x20primarily\x20<strong>idiopathic,</strong>\x20with\x20<strong>minimal\x20change\x20disease</strong>\x20being\x20the\x20most\x20common\x20<strong>glomerular\x20lesion.</strong>\x20Podocyte\x20injury\x20or\x20genetic\x20mutations\x20in\x20podocyte\x20proteins\x20can\x20lead\x20to\x20<strong>nephrotic-range</strong>\x20proteinuria.</p>\x0a<p><strong>Edema</strong>\x20is\x20the\x20most\x20common\x20presenting\x20symptom.\x20They\x20have\x20elevated\x20levels\x20of\x20<strong>cholesterol,\x20triglycerides,\x20low-density\x20lipoproteins</strong>\x20(LDL),\x20and\x20<strong>very\x20low-density</strong>\x20lipoproteins\x20(VLDL).\x20It\x20is\x20caused\x20by\x20both\x20increased\x20<strong>lipid\x20synthesis</strong>\x20and\x20<strong>decreased\x20lipid\x20catabolism.</strong>\u00a0</p>\x0a<p>They\x20are\x20prone\x20to\x20infections\x20especially\x20by\x20<strong>encapsulated\x20bacteria</strong>\x20due\x20to\x20factors\x20such\x20as\x20<strong>urinary\x20losses</strong>\x20of\x20<strong>immunoglobulin</strong>\x20G\x20(IgG)\x20and\x20complement\x20factors\x20(C3,\x20C5,\x20factors\x20B\x20and\x20D).\x20<strong>Nephrotic</strong>\x20syndrome\x20is\x20a\x20<strong>hypercoagulable</strong>\x20state\x20due\x20to\x20<strong>vascular</strong>\x20stasis,\x20<strong>increased</strong>\x20platelet,\x20increased\x20<strong>hepatic\x20production</strong>\x20of\x20fibrinogen,\x20and\x20<strong>urinary\x20losses</strong>\x20of\x20<strong>antithrombotic</strong>\x20factors\x20such\x20as\x20antithrombin\x20III\x20and\x20protein\x20S.\u00a0</p>\x0a<p>The\x20<strong>diagnosis</strong>\x20is\x20confirmed\x20by\x20performing\x20a\x20urinalysis\x20and\x20<strong>urine\x20protein:\x20creatinine</strong>\x20ratio.\x20The\x20recommended\x20initial\x20treatment\x20for\x20nephrotic\x20syndrome\x20is\x20a\x20daily\x20dose\x20of\x20<strong>2mg/kg</strong>\x20(max\x2060mg)\x20of\x20<strong>prednisolone</strong>\x20for\x206\x20weeks\x20followed\x20by\x20an\x20<strong>alternate</strong>\x20dose\x20of\x20<strong>1.5mg/kg\x20(max\x2040mg)</strong>\x20for\x20the\x20next\x20<strong>6-8</strong>\x20weeks.\u00a0</p>\x0a<p>Definitions\x20regarding\x20the\x20course\x20of\x20nephrotic\x20syndrome:\u00a0</p>\x0a<p><strong>Remission</strong>\x20is\x20characterized\x20by\x20a\x20urine\x20protein:\x20creatinine\x20ratio\x20of\x20&lt;0.2\x20or\x20&lt;1+\x20protein\x20on\x20urine\x20dipstick\x20testing\x20for\x203\x20consecutive\x20days<br\x20/><strong>Response</strong>\x20in\x20nephrotic\x20syndrome\x20is\x20defined\x20as\x20achieving\x20remission\x20within\x20the\x20initial\x204\x20weeks\x20of\x20corticosteroid\x20therapy<br\x20/><strong>Relapse</strong>\x20is\x20indicated\x20by\x20an\x20increase\x20in\x20urine\x20protein:\x20creatinine\x20ratio\x20&gt;0.2\x20or\x20a\x20reading\x20of\x202+\x20and\x20higher\x20for\x203\x20consecutive\x20days.<br\x20/><strong>Frequently</strong>\x20relapsing:\x20≥2\x20relapses\x20in\x206\x20months\x20or\x204\x20relapses\x20in\x2012\x20months.<br\x20/><strong>Steroid-dependent</strong>\x20nephrotic\x20syndrome:\x20Relapse\x20during\x20steroid\x20tapering\x20or\x20within\x202\x20weeks\x20of\x20discontinuation.<br\x20/><strong>Steroid\x20resistance:</strong>\x20Failure\x20to\x20achieve\x20remission\x20despite\x20therapy\x20with\x20daily\x20prednisolone\x20for\x204\x20weeks\x20and\x20alternate\x20days\x20for\x20the\x20next\x204\x20weeks.</p>','A\x2043-year-old\x20male\x20patient\x20comes\x20with\x20complaints\x20of\x20frothy\x20urine\x20and\x20facial\x20swelling\x20since\x203\x20weeks\x20.\x20He\x20has\x20had\x20an\x20on-and-off\x20history\x20of\x20back\x20and\x20flank\x20pain\x20over\x20the\x20past\x20year.\x20Vitals\x20are\x20pulse\x2070bpm,\x20BP\x20160/96\x20mmHg.\x20An\x20abdominal\x20ultrasound\x20is\x20ordered.\x20What\x20is\x20likely\x20to\x20be\x20seen\x20on\x20USG?','Sunitinib','Nephrolithiasis','selectedAnswer','Labetalol','mUQOK','Tenofovir','nav-btn-current','table','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','KlzWX','solutionContainer','pjOBs','timerContainer','now','480033KJlQIF','WUJKu','vRZqa','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','canPlayType','A\x20patient\x20diagnosed\x20with\x20renal\x20cell\x20carcinoma\x20was\x20started\x20on\x20a\x20tyrosine\x20kinase\x20inhibitor\x20that\x20acts\x20by\x20inhibiting\x20VEGF.\x20He\x20is\x20now\x20being\x20evaluated\x20for\x20increasing\x20protein\x20excretion\x20in\x20his\x20urine.\x20Which\x20of\x20the\x20following\x20drugs\x20was\x20prescribed\x20to\x20the\x20patient?','div','ZPnvq','Spudx','dMAog','Urine\x20protein\x20creatinine\x20ratio\x20of\x20≥\x200.3','zVtUG','RXoex','NgvVe','Foscarnet','yYjUX','attachMedia','SQEWR','fRPWV','completed','eHmdI','XMolL','PvqJw','nZPTW','<p><strong>24-hour\x20urine</strong>\x20collection\x20is\x20the\x20<strong>gold\x20standard</strong>\x20for\x20<strong>quantification</strong>\x20of\x20<strong>protein</strong>\x20excreted\x20in\x20the\x20<strong>urine.</strong></p>\x0a<p>In\x20this\x20test,\x20after\x20the\x20first\x20voided\x20morning\x20sample\x20is\x20discarded,\x20subsequent\x20urine\x20samples\x20are\x20collected\x20in\x20a\x20container.\x20Usually,\x20a\x20<strong>preservative</strong>\x20is\x20added\x20to\x20allow\x20for\x20later\x20testing.\x20This\x20<strong>24\x20hour</strong>\x20sample\x20is\x20then\x20evaluated\x20to\x20calculate\x20the\x20amount\x20of\x20protein\x20excreted.\x20Although\x20<strong>spot\x20urine\x20protein</strong>\x20to\x20<strong>creatinine</strong>\x20ratios\x20are\x20done\x20in\x20clinical\x20practice,\x20they\x20have\x20the\x20disadvantage\x20of\x20being\x20<strong>dependent</strong>\x20on\x20<strong>creatinine\x20excretion</strong>\x20which\x20can\x20vary.\x20Hence,\x2024-hour\x20urine\x20protein\x20studies\x20are\x20done\x20in\x20doubtful\x20cases\x20to\x20quantify\x20urine\x20protein.</p>','WQVUL','getItem','ZPZrg','eJkiE','toString','RpzGV','title','nCoKq','hssGf','Intravascular\x20hemolysis','Progress\x20loaded.','A\x2045-year-old\x20female\x20patient\x20presents\x20to\x20the\x20casualty\x20due\x20to\x20reduced\x20urination.\x20A\x20Foley\x20catheter\x20is\x20placed.\x20The\x20urine\x20analysis\x20reveals\x20proteinuria.\x20Her\x20BP\x20was\x20found\x20to\x20be\x20200/100\x20mmHg.\x20She\x20has\x20a\x20history\x20of\x20scleroderma.\x20Which\x20of\x20the\x20following\x20drugs\x20will\x20be\x20the\x20mainstay\x20in\x20her\x20management?','fJCdm','oKIlI','HQMNg','zbcjz','round','Sziny','ETSsp','<p>This\x20patient\x20presenting\x20with\x20<strong>nephrotic\x20range\x20proteinuria</strong>\x20with\x20complaints\x20of\x20fatigue\x20most\x20likely\x20has\x20developed\x20<strong>anemia</strong>\x20secondary\x20to\x20<strong>urinary\x20protein\x20losses.</strong>\x20There\x20is\x20an\x20increase\x20in\x20excretion\x20of\x20transferrin,\x20(a\x20protein\x20responsible\x20for\x20carrying\x20iron),\x20<strong>iron,</strong>\x20and\x20other\x20ions\x20which\x20lead\x20to\x20these\x20patients\x20being\x20susceptible\x20to\x20<strong>iron\x20deficiency</strong>\x20anemia.\u00a0</p>\x0a<p><strong>Nephrotic\x20syndrome</strong>\x20in\x20children\x20is\x20primarily\x20idiopathic,\x20with\x20<strong>minimal\x20change</strong>\x20disease\x20being\x20the\x20most\x20<strong>common\x20glomerular</strong>\x20lesion.\x20Podobcyte\x20<strong>injury</strong>\x20or\x20genetic\x20mutations\x20in\x20podocyte\x20proteins\x20can\x20lead\x20to\x20nephrotic-range\x20proteinuria.</p>\x0a<p><strong>Edema</strong>\x20is\x20the\x20most\x20common\x20presenting\x20symptom.\x20They\x20have\x20elevated\x20levels\x20of\x20<strong>cholesterol,\x20triglycerides,\x20low-density</strong>\x20lipoproteins\x20(LDL),\x20and\x20<strong>very\x20low-density</strong>\x20lipoproteins\x20(VLDL).\x20It\x20is\x20caused\x20by\x20both\x20increased\x20<strong>lipid\x20synthesis</strong>\x20and\x20decreased\x20<strong>lipid\x20catabolism.</strong>\u00a0</p>\x0a<p>They\x20are\x20<strong>prone</strong>\x20to\x20<strong>infections</strong>\x20especially\x20by\x20<strong>encapsulated\x20bacteria</strong>\x20due\x20to\x20factors\x20such\x20as\x20<strong>urinary\x20losses</strong>\x20of\x20<strong>immunoglobulin</strong>\x20G\x20(IgG)\x20and\x20complement\x20factors\x20(C3,\x20C5,\x20factors\x20B\x20and\x20D).\x20Nephrotic\x20syndrome\x20is\x20a\x20<strong>hypercoagulable</strong>\x20state\x20due\x20to\x20<strong>vascular\x20stasis,</strong>\x20increased\x20platelet,\x20increased\x20<strong>hepatic</strong>\x20production\x20of\x20<strong>fibrinogen,</strong>\x20and\x20urinary\x20losses\x20of\x20antithrombotic\x20factors\x20such\x20as\x20antithrombin\x20III\x20and\x20protein\x20S.\x20<strong>Iron\x20deficiency</strong>\x20anemia\x20is\x20a\x20<strong>rare</strong>\x20sequelae\x20and\x20is\x20associated\x20with\x20the\x20<strong>steroid-resistant</strong>\x20variant\x20of\x20nephrotic\x20syndrome.\x20Still,\x20it\x20can\x20be\x20present\x20in\x20children\x20who\x20have\x20gone\x20untreated\x20for\x20a\x20long\x20time.\u00a0</p>\x0a<p>The\x20diagnosis\x20is\x20confirmed\x20by\x20performing\x20a\x20<strong>urinalysis</strong>\x20and\x20<strong>urine\x20protein:\x20creatinine</strong>\x20ratio.\x20The\x20recommended\x20initial\x20treatment\x20for\x20nephrotic\x20syndrome\x20is\x20a\x20daily\x20dose\x20of\x202mg/kg\x20(max\x2060mg)\x20of\x20prednisolone\x20for\x206\x20weeks\x20followed\x20by\x20an\x20alternate\x20dose\x20of\x201.5mg/kg\x20(max\x2040mg)\x20for\x20the\x20next\x206-8\x20weeks.\u00a0</p>\x0a<p>Definitions\x20regarding\x20the\x20course\x20of\x20nephrotic\x20syndrome:\u00a0</p>\x0a<p><strong>Remission</strong>\x20is\x20characterized\x20by\x20a\x20urine\x20protein:\x20creatinine\x20ratio\x20of\x20&lt;0.2\x20or\x20&lt;1+\x20protein\x20on\x20urine\x20dipstick\x20testing\x20for\x203\x20consecutive\x20days<br\x20/><strong>Response</strong>\x20in\x20nephrotic\x20syndrome\x20is\x20defined\x20as\x20achieving\x20remission\x20within\x20the\x20initial\x204\x20weeks\x20of\x20corticosteroid\x20therapy<br\x20/><strong>Relapse</strong>\x20is\x20indicated\x20by\x20an\x20increase\x20in\x20urine\x20protein:\x20creatinine\x20ratio\x20&gt;0.2\x20or\x20a\x20reading\x20of\x202+\x20and\x20higher\x20for\x203\x20consecutive\x20days.<br\x20/><strong>Frequently</strong>\x20relapsing:\x20≥2\x20relapses\x20in\x206\x20months\x20or\x204\x20relapses\x20in\x2012\x20months.<br\x20/><strong>Steroid-dependent</strong>\x20nephrotic\x20syndrome:\x20Relapse\x20during\x20steroid\x20tapering\x20or\x20within\x202\x20weeks\x20of\x20discontinuation.<br\x20/><strong>Steroid\x20resistance:</strong>\x20Failure\x20to\x20achieve\x20remission\x20despite\x20therapy\x20with\x20daily\x20prednisolone\x20for\x204\x20weeks\x20and\x20alternate\x20days\x20for\x20the\x20next\x204\x20weeks.</p>','bookmarkedQuestions','ArrowRight','(((.+)+)+)+$','innerHTML','A\x20patient\x20with\x20hematuria\x20and\x20proteinuria','QTVvO','rNQMH','cHRGG','HvAUP','video[data-src]','nMLQR','join','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','UCHWI','QOXbp','strokeDasharray','src','wjtMJ','qAFNK','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','TfYKw','DdYCO','map','MyYjk','An\x2018-year-old\x20waiter\x20comes\x20for\x20a\x20follow-up\x20of\x20proteinuria.\x20He\x20also\x20complains\x20of\x20swelling\x20in\x20his\x20feet\x20after\x20standing\x20all\x20day.\x20Urinalysis\x20showed\x20500\x20mg\x20of\x20protein.\x20However,\x20a\x20repeat\x20sample\x20taken\x20on\x20the\x20next\x20morning\x20had\x20no\x20protein.\x20What\x20is\x20the\x20likely\x20diagnosis?','iSgGz','hTBvV','juFXQ','timed_exam','EdzeC','Platelet\x20count\x20of\x201.5\x20lakh/cu.mm','oMXez','border-red-500','cdPOg','BvlSK','DOMContentLoaded','gdAJS','acPDW','ghHge','CAuma','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','href','A\x20patient\x20post\x20hepatic\x20transplant\x20requires\x20immunosuppression.\x20He\x20has\x20proteinuria\x20on\x20the\x20urine\x20dipstick.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20safe\x20to\x20use\x20in\x20his\x20case?','Serum\x20creatinine\x20level\x20of\x201.8\x20mg/dL','answered','BXrXd','UhOax','utCUM','xjghs','Hemolysis','UMiDQ','bIcLH','vhzEn','progressBar','querySelectorAll','endsWith','Marked','startAt','textContent','PqaIW','solutionAudio','nLWzr','button','<p>This\x20patient\x20with\x20a\x20finding\x20of\x20<strong>proteinuria</strong>\x20is\x20found\x20to\x20have\x20a\x20<strong>thrombus</strong>\x20in\x20the\x20<strong>inferior\x20vena\x20cava.</strong>\x20This\x20leads\x20to\x20an\x20<strong>increased\x20capillary\x20hydrostatic\x20pressure\x20downstream</strong>\x20from\x20the\x20<strong>renal\x20vein</strong>\x20which\x20leads\x20to\x20<strong>hyperfiltration</strong>\x20and\x20thus\x20<strong>proteinuria.</strong>\u00a0</p>\x0a<p><strong>Starling\x27s</strong>\x20forces\x20are\x20what\x20determine\x20the\x20rate\x20of\x20filtration\x20along\x20a\x20capillary.\x20These\x20forces\x20are\x20represented\x20as:</p>\x0a<p><strong>Fluid\x20movement\x20=\x20k\x20[(Pc−\x20Pi)\x20−\x20(πc−\x20πi)]</strong></p>\x0a<p>where,\x20k\x20=\x20capillary\x20filtration\x20coefficient</p>\x0a<p>Pc\x20=\x20capillary\x20hydrostatic\x20pressure</p>\x0a<p>Pi\x20=\x20interstitial\x20hydrostatic\x20pressure</p>\x0a<p>πc\x20=\x20capillary\x20colloid\x20osmotic\x20pressure</p>\x0a<p>πi\x20=\x20interstitial\x20colloid\x20osmotic\x20pressure</p>\x0a<p>In\x20this\x20scenario,\x20this\x20patient\x20with\x20a\x20<strong>thrombus</strong>\x20in\x20the\x20<strong>IVC</strong>\x20has\x20increased\x20<strong>Pc</strong>\x20which\x20leads\x20to\x20<strong>increased\x20fluid\x20movements</strong>\x20into\x20the\x20<strong>kidney\x20tubules.</strong>\x20This\x20hyperfiltration\x20can\x20lead\x20to\x20proteinuria\x20if\x20the\x20force\x20is\x20large\x20enough\x20to\x20cause\x20injury\x20to\x20the\x20tubular\x20cells.\x20Similar\x20findings\x20are\x20seen\x20in\x20a\x20<strong>patient</strong>\x20with\x20<strong>hypertension</strong>\x20who\x20will\x20also\x20have\x20<strong>hyperfiltration\x20injury</strong>\x20leading\x20to\x20<strong>proteinuria.</strong>\u00a0</p>','search','fTmKH','Hnlie','Urinary\x20protein\x20losses','tQhvy','pathname','className','aPhsh','<p><strong>Sunitinib</strong>\x20is\x20a\x20small\x20molecule,\x20<strong>multi-targeted\x20kinase\x20antagonist/inhibitor</strong>\x20and\x20has\x20been\x20shown\x20to\x20have\x20<strong>anti-tumor\x20activity\x20</strong>in\x20<strong>renal\x20cell\x20carcinoma\x20(RCC)</strong>,\x20<strong>gastrointestinal\x20stromal\x20tumor</strong>\x20(GIST)\x20and\x20<strong>pancreatic\x20neuroendocrine\x20tumors</strong>\x20(pNETs).\x20<strong>Proteinuria</strong>\x20is\x20a\x20common\x20adverse\x20effect\x20of\x20the\x20drug.\u00a0</p>\x0a<p><strong>Pharmacology</strong>\x20of\x20sunitinib:</p>\x0a<ul>\x0a<li>Molecular\x20targets\x20of\x20sunitinib\x20are\x20<strong>c-Kit,\x20VEGFR-2,\x20PDGFR-β</strong>\x20and\x20<strong>Flt-3.</strong></li>\x0a<li>Sunitinib\x20targets\x20mutations\x20in\x20the\x20RET\x20gene.</li>\x0a<li>The\x20<strong>mechanisms</strong>\x20of\x20<strong>sunitinib’s\x20action</strong>\x20are:Inhibition\x20of\x20activated\x20c-Kit\x20and\x20PDGFR\x20in\x20GIST</li>\x0a<li>Inhibition\x20of\x20VEGFR\x20in\x20advanced\x20RCC</li>\x0a</ul>\x0a<p><strong>Adverse\x20effects:</strong></p>\x0a<ul>\x0a<li><strong>Its</strong>\x20specific\x20adverse\x20effects\x20include\x20<strong>neutropenia,\x20diarrhea</strong>\x20and\x20<strong>fatigue.</strong></li>\x0a<li>Generally,\x20the\x20other\x20common\x20side\x20effects\x20of\x20agents\x20having\x20anti-VEGFR\x20activity\x20are\x20<strong>hypertension</strong>\x20and\x20<strong>proteinuria.</strong></li>\x0a<li>Rarely,\x20they\x20cause\x20<strong>bleeding</strong>\x20and\x20<strong>clotting\x20disorders,</strong>\x20and\x20<strong>perforation</strong>\x20of\x20<strong>scarred\x20gastrointestinal\x20lesions.</strong></li>\x0a<li>Hand-foot\x20syndrome\x20has\x20also\x20been\x20noted\x20in\x20the\x20use\x20of\x20these\x20agents,\x20with\x20erythema\x20and\x20desquamation\x20of\x20distal\x20extremities.</li>\x0a</ul>\x0a<p><strong>Administration:</strong>\x20In\x20advanced\x20RCC\x20and\x20in\x20adjuvant\x20therapy,\x20sunitinib\x20is\x20given\x20<strong>orally,</strong>\x20at\x20a\x20dose\x20of\x20<strong>50mg\x20per\x20day,</strong>\x20once\x20daily,\x20with\x20or\x20without\x20food,\x20for\x20<strong>4\x20weeks</strong>\x20out\x20of\x206\x20(nine\x206-week\x20cycles\x20in\x20adjuvant\x20therapy).</p>\x0a<p>Uses:</p>\x0a<ul>\x0a<li>In\x20<strong>metastatic\x20GIST,</strong>\x20the\x20main\x20chemotherapeutic\x20agent\x20used\x20is\x20imatinib,\x20which\x20is\x20a\x20selective\x20inhibitor\x20of\x20the\x20c-kit\x20tyrosine\x20kinase.\x20Patients\x20whose\x20tumors\x20have\x20become\x20refractory\x20to\x20imatinib\x20benefit\x20from\x20agents\x20like\x20sunitinib,\x20which\x20also\x20inhibits\x20c-kit\x20tyrosine\x20kinase.</li>\x0a<li>It\x20is\x20now\x20undergoing\x20studies\x20for\x20efficacy\x20in\x20hepatocellular\x20carcinoma.</li>\x0a</ul>\x0a<p>Update:</p>\x0a<ul>\x0a<li>The\x20drug\x20was\x20previously\x20approved\x20for\x20use\x20by\x20various\x20regulatory\x20bodies\x20in\x202006,\x20for\x20conditions\x20like\x20GIST\x20and\x20advanced\x20RCC.</li>\x0a<li>In\x202017,\x20<strong>sunitinib\x20maleate</strong>\x20was\x20approved\x20by\x20the\x20FDA\x20for\x20use\x20as\x20<strong>adjuvant\x20therapy</strong>\x20for\x20patients\x20at\x20risk\x20for\x20<strong>recurrence</strong>\x20of\x20<strong>RCC</strong>\x20after\x20a\x20kidney\x20has\x20been\x20removed\x20<strong>(nephrectomy).</strong></li>\x0a<li>This\x20was\x20based\x20on\x20a\x20multi-center,\x20international,\x20double-blinded,\x20placebo-controlled\x20trial\x20among\x20615\x20patients\x20with\x20high\x20risk\x20of\x20recurrent\x20RCC\x20following\x20nephrectomy.</li>\x0a</ul>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Option\x20A:\x20<strong>Ramucirumab</strong>\x20is\x20a\x20human\x20IgG1\x20monoclonal\x20antibody\x20that\x20targets\x20<strong>VEGFR2,</strong>\x20preventing\x20<strong>VEGFR</strong>\x20ligand\x20binding\x20and\x20thereby\x20reducing\x20ligand-induced\x20activity\x20in\x20endothelial\x20cells.\x20It\x20is\x20used\x20in\x20combination\x20with\x20docetaxel\x20to\x20treat\x20patients\x20with\x20metastatic\x20non-small\x20cell\x20lung\x20cancer\x20(NSCLC).\x20Adverse\x20effects\x20include\x20<strong>hypertension</strong>\x20and\x20<strong>diarrhea.</strong></p>\x0a<p>Option\x20C:\x20<strong>Aflibercept</strong>\x20is\x20a\x20recombinant\x20fusion\x20protein\x20that\x20functions\x20as\x20a\x20VEGF\x20trap\x20by\x20sequestering\x20VEGF\x20using\x20the\x20VEGFR1-binding\x20domain.\x20It\x20is\x20used\x20in\x20treating\x20metastatic\x20colorectal\x20cancer</p>\x0a<p>Option\x20D:\x20<strong>Pembrolizumab</strong>\x20is\x20a\x20humanized\x20monoclonal\x20IgG4κ\x20isotype\x20antibody\x20that\x20prevents\x20the\x20interaction\x20between\x20programmed\x20cell\x20death\x20protein\x201\x20(PD-1)\x20and\x20its\x20ligands.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20non-small\x20cell\x20lung\x20cancer,\x20either\x20before\x20or\x20after\x20chemotherapy\x20with\x20platinum.\x20It\x20is\x20also\x20used\x20in\x20the\x20treatment\x20of\x20melanoma,\x20urothelial\x20cancer,\x20Merkel\x20cell\x20carcinoma\x20and\x20Hodgkin\x20lymphoma.\x20Serious\x20adverse\x20events\x20include\x20<strong>pneumonitis,\x20colitis</strong>\x20and\x20<strong>hepatitis.</strong></p>','ctgMg','lDxiQ','1|4|3|5|0|2','YsJEa','trGwy','length','SCUtb','study','incomplete','bind','wTfcL','ViAfB','disabled','appendChild','NBjSh','FlTyw','flFfp','lOXhC','QaTOi','aOADH','LQnyA','red','vycJF','hierarchy','correctAnswers','MoKKc','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','timeSpent','yiRai','FXUaF','OSFVA','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','replace','zUFEO','uqXVX','nWaMq','aRkCj','zLouL','hYIyU','Not\x20Attempted','application/vnd.apple.mpegurl','botdf','680671SxOkwI','IVWmX','yhHoE','Dfzcm','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','currentQuestionIndex','bYspk','incorrectAnswers','yEZno','Transient\x20proteinuria','XegQX','trace','Amphotericin\x20B','\x20>\x20','question_images','TUKBL','timeDisplay','reduce','optionsContainer','2,3,4,5','rxlgi','HwhUU','<p>This\x20patient\x20complains\x20of\x20<strong>swelling</strong>\x20in\x20his\x20<strong>face</strong>\x20accompanied\x20by\x20<strong>frothy\x20urine</strong>\x20which\x20likely\x20indicates\x20<strong>proteinuria.</strong>\x20This\x20combined\x20with\x20findings\x20of\x20<strong>on</strong>\x20and\x20<strong>off\x20back</strong>\x20and\x20<strong>flank\x20pain</strong>\x20with\x20<strong>high\x20blood\x20pressure</strong>\x20raises\x20suspicions\x20of\x20<strong>Autosomal\x20dominant\x20polycystic\x20kidney\x20disease.</strong>\x20That\x20would\x20manifest\x20as\x20<strong>cystic\x20lesions</strong>\x20in\x20the\x20<strong>kidneys</strong>\x20on\x20<strong>USG</strong>\x20of\x20the\x20abdomen\x20and\x20pelvis.</p>\x0a<div\x20class=\x22ng-scope\x22>\x0a<div\x20class=\x22ng-scope\x22>\x0a<p>ADPKD\x20is\x20inherited\x20as\x20an<strong>\u00a0autosomal\x20dominant</strong>\u00a0trait\x20with\x20mutations\x20in\x20the\u00a0<strong>PKD1</strong>(chromosome\x2016)\x20and\u00a0<strong>PKD2</strong>\u00a0genes\x20(chromosome\x204).\u00a0</p>\x0a<p>The\x20disease\x20does\x20not\x20usually\x20manifest<strong>\u00a0before</strong>\u00a0<strong>30\x20years\u00a0</strong>of\x20age,\x20and\x20in\x20some\x20patients,\x20it\x20is\x20never\x20diagnosed.\u00a0The\x20progression\x20of\x20the\x20disease\x20is\x20faster\x20in\x20males.\u00a0</p>\x0a<p><strong>Hypertension\u00a0</strong>is\x20the\x20most\x20common\x20presentation.\u00a0<strong>Renal\u00a0</strong>manifestations\u00a0of\x20ADPKD\u00a0include:</p>\x0a<ul>\x0a<li>Flank/loin\x20pain\x20-\u00a0\u00a0either\x20due\x20to\x20haemorrhage\x20inside\x20cysts\x20or\x20due\x20to\x20renal\x20stones\x20(most\x20commonly\u00a0<strong>uric\x20acid\x20stones</strong>)</li>\x0a<li>Irregular\x20upper\x20quadrant\x20renal\x20mass</li>\x0a<li>Proteinuria</li>\x0a<li>Hematuria</li>\x0a<li>Uremia</li>\x0a<li><strong>Renal\x20failure\u00a0</strong>(seen\x20in\x2010-15%\x20of\x20the\x20patients\x20who\x20receive\x20hemodialysis)</li>\x0a</ul>\x0a<p>Proteinuria\x20is\x20seen\x20in\x20patients\x20with\x20<strong>progressive\x20disease</strong>\x20and\x20it\x20is\x20usually\x20<strong>nephrotic</strong>\x20range.\x20Biopsies\x20have\x20shown\x20the\x20etiology\x20to\x20be\x20<strong>focal\x20segmental\x20glomerulosclerosis</strong>\x20and\x20<strong>membranous\x20nephropathy.</strong></p>\x0a<div\x20class=\x22ng-scope\x22>\x0a<div\x20class=\x22ng-scope\x22>\x0a<p>The\x20most\x20common\x20extrarenal\x20manifestation\x20is\u00a0<strong>hepatic\x20cysts</strong>\u00a0which\x20are\u00a0<strong>derived\x20from\x20the\x20biliary\x20epithelium</strong>.<strong>\u00a0</strong>Other\x20extra-renal\x20manifestations\x20of\x20ADPKD:</p>\x0a<ul>\x0a<li>Pancreatic\x20cysts</li>\x0a<li>Berry\x20aneurysms\x20(Rupture\x20of\x20cerebral\x20aneurysms\x20is\x20an\x20important\x20cause\x20of\x20morbidity\x20and\x20The\x20prevalence\x20of\x20intracranial\x20aneurysms\x20in\x20patients\x20with\x20PKD\x20is\x2040%.)</li>\x0a<li>Colonic\x20diverticula</li>\x0a<li>Abdominal\x20hernias</li>\x0a<li>Mitral\x20valve\x20prolapse\u00a0</li>\x0a</ul>\x0a<p>\u00a0Screening\x20cerebral\x20angiography\x20is\x20strongly\x20considered\x20in\x20all\x20patients\x20with\x20PKD\x20and\x20a\x20family\x20history\x20of\x20cerebral\x20aneurysm\x20or\x20subarachnoid\x20haemorrhage.</p>\x0a</div>\x0a</div>\x0a<p><strong>Intravenous\x20pyelography</strong>\u00a0shows\x20characteristic\u00a0<strong>spider\x20leg\x20sign</strong>,\x20as\x20a\x20result\x20of\x20stretched\x20calyces\x20due\x20to\x20multiple\x20cysts.\x20Nephrogram\x20shows\x20a\u00a0<strong>swiss\x20cheese</strong>\u00a0appearance.\x20On\u00a0<strong>prenatal\x20USG</strong>,\x20the\x20presence\x20of\x20either\u00a0<strong>&gt;\x203\x20cysts\u00a0</strong>in\u00a0<strong>unilateral\x20kidneys</strong>\u00a0or<strong>\u00a0&gt;\x202\x20cysts</strong>\u00a0in\u00a0<strong>each\x20kidney</strong>\u00a0is\x20suggestive\x20of\x20PKD.\u00a0</p>\x0a<p>Treatment\u00a0includes</p>\x0a<ul>\x0a<li><strong>Surgical\x20decompression</strong>\u00a0is\u00a0<strong>not</strong>\u00a0a\u00a0<strong>routine</strong>\u00a0procedure\x20performed\x20in\x20these\x20patients.\x20It\x20may\x20be\x20required\x20only\x20in\x20cases\x20of\x20very\x20large\x20cysts\x20causing\x20persistent\x20pain\x20and\x20infected\x20cysts.</li>\x0a<li>Analgesics</li>\x0a<li><strong>Increased</strong>\u00a0<strong>fluid</strong>\u00a0intake\u00a0\x0a<ul>\x0a<li>Prevents\x20renal\x20stone\x20formation</li>\x0a<li>Reduces\x20growth\x20of\x20cysts\x20by\x20suppressing\x20ADH\x20release</li>\x0a</ul>\x0a</li>\x0a<li><strong>ACE\x20inhibitors\u00a0</strong>and\x20ARBs\x0a<ul>\x0a<li>Blood\x20pressure\x20control\u00a0</li>\x0a<li>Slowing\x20of\x20cyst\x20growth</li>\x0a</ul>\x0a</li>\x0a<li><strong>Tolvaptan\u00a0</strong>(V2\x20receptor\x20antagonist)\x0a<ul>\x0a<li>Reduce\x20pain\x20and\u00a0<strong>slow\u00a0</strong>the<strong>\u00a0decline\u00a0</strong>in<strong>\u00a0renal\x20function</strong></li>\x0a</ul>\x0a</li>\x0a<li>Long-term\x20dialysis</li>\x0a<li><strong>Renal\x20transplant</strong>\x0a<ul>\x0a<li>Definitive\x20management</li>\x0a<li>Pre-transplant\x20nephrectomy\x20may\x20be\x20required\x20in\x20patients\x20with\x20very\x20large\x20polycystic\x20kidneys</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<div\x20class=\x22ng-scope\x22>\x0a<div\x20class=\x22ng-scope\x22>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Option\x20A:\x20<strong>Fluid</strong>\x20in\x20the\x20<strong>peritoneal\x20cavity</strong>\x20can\x20occur\x20in\x20case\x20of\x20<strong>ascites.</strong>\x20However,\x20ascites\x20is\x20a\x20late\x20manifestation\x20of\x20prolonged\x20<strong>proteinuria.</strong>\x20This\x20patient\x27s\x20<strong>flank\x20pain</strong>\x20with\x20<strong>hypertension</strong>\x20should\x20raise\x20<strong>suspicions</strong>\x20of\x20<strong>ADPKD</strong><strong>.</strong></p>\x0a<p>Option\x20B:\x20<strong>Radiopaque\x20masses</strong>\x20in\x20<strong>kidneys</strong>\x20can\x20be\x20seen\x20in\x20<strong>nephrolithiasis.</strong>\x20This\x20presents\x20with\x20<strong>flank</strong>\x20<strong>pain</strong>\x20but\x20it\x20is\x20colicky\x20in\x20nature\x20and\x20usually\x20does\x20not\x20cause\x20<strong>proteinuria\x20enough</strong>\x20to\x20cause\x20<strong>facial\x20swelling.\x20Hypertension</strong>\x20is\x20also\x20not\x20associated\x20with\x20nephrolithiasis.</p>\x0a<p>Option\x20D:\x20<strong>Shrinkage</strong>\x20of\x20a\x20<strong>kidney</strong>\x20can\x20occur\x20in\x20case\x20of\x20a\x20<strong>unilateral\x20renal\x20artery</strong>\x20stenosis\x20which\x20leads\x20to\x20reduced\x20perfusion\x20and\x20reduction\x20in\x20the\x20size.\x20However,\x20this\x20isn\x27t\x20associated\x20with\x20proteinuria\x20and\x20flank\x20pain.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','filter','toISOString','adrJd','cXjzg','eGwBb','Ramucirumab','Ewbvw','ymHmt','gray','4|2|3|1|5|0','totalQuestions','warn','UneYk','kktzx','<p>This\x20patient\x20with\x20a\x20history\x20of\x20<strong>hepatic\x20transplantation</strong>\x20requires\x20<strong>immunosuppression.</strong>\x20Since\x20he\x20is\x20a\x20known\x20case\x20of\x20<strong>renal\x20disease</strong>\x20with\x20<strong>proteinuria,</strong>\x20he\x20requires\x20a\x20<strong>drug</strong>\x20that\x20has\x20a\x20<strong>low\x20incidence</strong>\x20of\x20<strong>nephrotoxicity.\x20Mycophenolate\x20mofetil</strong>\x20is\x20the\x20drug\x20of\x20choice\x20for\x20him.</p>\x0a<p><strong>Mycophenolate\x20mofetil</strong>\x20is\x20a\x20prodrug\x20that\x20is\x20rapidly\x20converted\x20to\x20<strong>mycophenolic</strong>\x20acid.</p>\x0a<p>It\x20is\x20a\x20<strong>selective,\x20non-competitive,\x20reversible</strong>\x20inhibitor\x20of\x20<strong>inosine\x20monophosphate\x20dehydrogenase</strong>\x20(IMPDH),\x20an\x20important\x20enzyme\x20in\x20the\x20de\x20novo\x20pathway\x20of\x20guanine\x20nucleotide\x20synthesis.</p>\x0a<p>It\x20is\x20a\x20useful\x20immunosuppressive\x20in\x20cases\x20where\x20<strong>cyclosporine</strong>\x20or\x20<strong>tacrolimus</strong>\x20are\x20not\x20tolerated.\x20It\x20is\x20used\x20for\x20the\x20<strong>prevention</strong>\x20of\x20<strong>organ\x20transplant</strong>\x20rejection.</p>\x0a<p>Other\x20options:</p>\x0a<p><strong>Sirolimus</strong>\x20can\x20cause\x20worsening\x20proteinuria\x20in\x20existing\x20kidney\x20disease\x20and\x20is\x20hence\x20contraindicated\x20in\x20this\x20patient.\u00a0</p>\x0a<p><strong>Cyclosporin</strong>\x20and\x20<strong>tacrolimus</strong>\x20are\x20both\x20<strong>nephrotoxic</strong>\x20and\x20are\x20not\x20indicated\x20for\x20a\x20known\x20case\x20of\x20kidney\x20dysfuntion.</p>','gYpRH','LOmEU','knvcO','dqSgs','Increased\x20\x20colloid\x20osmotic\x20pressure','No\x20solution\x20available.','ushqg','eJxTx','Multiple\x20myeloma','Anti\x20PLA2R\x20antibodies','Marrow','stats','ldGfY','FTJyo','RZWkl','Urinary\x20loss\x20of\x20protein','nav-btn-marked-review','GsFbd','test','qkXyc','zfPXJ','tmNHl','index.html','ZAdKB','Wttsa','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','ypypK','ZcMeG','bookmarkBtn','key','-600\x20text-white\x22>','kDbZp','solution','EYTqn','XozAG','1,2,5','60244WAgYKX','includes','IsWzn','.option-button','ILkOI','aFscg','Aflibercept','yVCaL','gBKiv','YQvEP','pZNaP','6112MvXgdN','ysNSv','exception','bookmarked','xBZPT','solutionText','return\x20(function()\x20','Increased\x20capillary\x20osmotic\x20pressure','xXSsw','QtixX','gToJT','IJgeX','mDiYZ','correct_choice_id','stringify','reload','parse','LJWKN','lJudE','WMjFa','questionReviewSection','remove','pfYGQ','lCgNp','iUYQM','xNCEs','Dehydration','385070JAkxzO','onclick','Chronic\x20low\x20protein\x20diet','status','KKIhv','fill','GgqUu','block','avgTimeResult','YuZge','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','vJPgG','kQQYU','toLowerCase','CoBXI','GQcpW','Tacrolimus','WVGEx','RtneO','MODvp','CMVEL','Incorrect','3|0|4|1|5|2','5722360agkcGG','get','You\x20are\x20analyzing\x20urine\x20samples\x20for\x20the\x20presence\x20of\x20proteins.\x20Which\x20of\x20the\x20following\x20conditions\x20is\x20associated\x20with\x20a\x20high\x20false\x20negative\x20rate\x20on\x20the\x20urinary\x20dipstick\x20for\x20the\x20presence\x20of\x20protein?','LXxjv','fbovq','Dkhil','KgsHT','Increased\x20interstitial\x20osmotic\x20pressure','not-attempted','A\x205-year-old\x20child\x20presented\x20with\x20edema,\x20oliguria,\x20and\x20frothy\x20urine.\x20He\x20has\x20no\x20history\x20of\x20similar\x20complaints.\x20His\x20urine\x20was\x20positive\x20for\x203+\x20proteinuria,\x20no\x20RBCs/WBCs,\x20and\x20no\x20casts.\x20His\x20serum\x20albumin\x20was\x202.4\x20gm/dL\x20and\x20serum\x20creatinine\x20was\x200.5\x20mg/dL.\x20What\x20is\x20the\x20most\x20likely\x20diagnosis?','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','closest','explanation_audio_hin','JqTIY','Lupus\x20nephritis','UTWul','oTZGv','No\x20questions\x20available\x20for\x20this\x20quiz.','{}.constructor(\x22return\x20this\x22)(\x20)','GzEKj','timed_study','performanceModal','width','iBFME','Acute\x20kidney\x20injury','question_audio','submitSection','apply','info','contains','quizSidebar','text','PQadI','IuLmZ','prototype','__proto__','xxpSN','Yaebh','FzKve','A\x20patient\x20with\x20acyclovir\x20resistant\x20CMV\x20retinitis\x20on\x20treatment\x20with\x20an\x20IV\x20drug\x20is\x20being\x20evaluated\x20for\x20a\x20positive\x20diptick\x20protein\x20test.\x20There\x20are\x20also\x20crystals\x20seen\x20in\x20his\x20urine\x20on\x20microscopy.\x20What\x20is\x20the\x20likely\x20drug\x20he\x20was\x20started\x20on?','cjuSU','RaIwM','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','Uclvy','totalAttempted','JQixf','ilIql','NOIsl','removeItem','HfjeA','awwbY','nTUdx','uaffr','getElementById','ARARG','not_attempted','createElement','PYRZr','A\x2012-year-old\x20boy\x20comes\x20with\x20complaints\x20of\x20fatigue\x20and\x20tiredness\x20for\x202\x20weeks.\x20He\x20consumes\x20a\x20balanced\x20diet.\x20He\x20also\x20has\x20been\x20having\x20frothy\x20urine\x20for\x20a\x20few\x20months.\x20Further\x20evaluation\x20shows\x207.2\x20mg/dl\x20hemoglobin,\x20normal\x20serum\x20eosinophil\x20count,\x20and\x203.5\x20g\x20of\x20protein\x20in\x20the\x20urine.\x20Which\x20of\x20the\x20following\x20explains\x20his\x20anemia?','WCCAC','ZyTFs','nav-btn-answered','biuhX','isArray','PpoRh','OgzKu','BmGWw','DVkyA','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','HUDzV','jIdXn','ZTHcA','VJUzt','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','<p>This\x20patient\x20presenting\x20with\x20<strong>proteinuria</strong>\x20in\x20a\x20urine\x20sample\x20with\x20a\x20<strong>clean\x20sample</strong>\x20in\x20the\x20<strong>morning</strong>\x20most\x20likely\x20has\x20<strong>orthostatic\x20proteinuria,</strong>\x20which\x20occurs\x20due\x20to\x20his\x20<strong>upright\x20posture</strong>\x20all\x20day.\u00a0</p>\x0a<p>Orthostatic\x20proteinuria\x20is\x20the\x20<strong>most\x20common</strong>\x20cause\x20of\x20<strong>isolated\x20proteinuria</strong>\x20in\x20<strong>teenagers</strong>\x20and\x20<strong>children.</strong>\x20It\x20is\x20believed\x20to\x20occur\x20due\x20to\x20either\x20a\x20<strong>left\x20renal\x20vein\x20entrapment</strong>\x20or\x20an\x20<strong>exaggerated\x20vascular\x20response</strong>\x20leading\x20to\x20<strong>increased\x20filtration\x20pressure</strong>\x20in\x20the\x20kidneys.\x20Family\x20history\x20should\x20be\x20obtained\x20to\x20rule\x20out\x20any\x20familial\x20conditions\x20associated\x20with\x20proteinuria.\u00a0</p>\x0a<p><strong>Diagnosis</strong>\x20and\x20<strong>Management:</strong>\x20Diagnosis\x20is\x20confirmed\x20by\x20obtaining\x20a\x20<strong>Urine\x20protein</strong>\x20to\x20<strong>creatinine\x20ratio</strong>\x20in\x20the\x20<strong>standing</strong>\x20and\x20<strong>recumbent\x20position</strong>\x20and\x20noting\x20a\x20difference\x20between\x20the\x20two.\u00a0</p>\x0a<p>Usually,\x20asymptomatic\x20patients\x20need\x20no\x20further\x20management.\x20<strong>Annual\x20followups</strong>\x20are\x20required\x20to\x20monitor\x20for\x20further\x20worsening\x20of\x20the\x20proteinuria.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Minimal\x20change\x20disease</strong>\x20is\x20associated\x20with\x20<strong>&gt;3g</strong>\x20of\x20<strong>protein\x20excretion</strong>\x20per\x20day\x20with\x20<strong>edema</strong>\x20and\x20<strong>hypercholesterolemia.</strong>\x20This\x20patient\x20does\x20not\x20meet\x20the\x20criteria\x20for\x20a\x20diagnosis\x20of\x20MCD.</p>\x0a<p>Option\x20C:\x20<strong>Sustained</strong>\x20proteinuria\x20is\x20a\x20term\x20used\x20to\x20describe\x20<strong>&gt;1-2g/day</strong>\x20of\x20<strong>proteinuria</strong>\x20and\x20is\x20associated\x20with\x20<strong>glomerular</strong>\x20disease.</p>\x0a<p>Option\x20D:\x20<strong>Transient</strong>\x20proteinuria\x20is\x20seen\x20in\x20conditions\x20like\x20<strong>fever,\x20exercise</strong>\x20and\x20emotional\x20<strong>stress</strong>\x20and\x20has\x20a\x20benign\x20prognosis.</p>','<div\x20class=\x22mt-4\x22><img\x20src=\x22','Previous\x20progress\x20cleared.','display','modeModal','usqLv','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','green','MAuyN','Which\x20of\x20the\x20following\x20tests\x20are\x20done\x20to\x20evaluate\x20protein\x20in\x20urine?','fefEa','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','pop','YwIxg','padStart','ZKdhI','statsBar','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','ahYHB','A\x20patient\x20with\x20rheumatic\x20heart\x20disease\x20comes\x20with\x20complaints\x20of\x20reduced\x20urination.\x20Urine\x20analysis\x20reveals\x20proteinuria\x20and\x20hematuria.\x20A\x20renal\x20biopsy\x20shows\x20crescent\x20formation,\x20with\x20a\x20few\x20embolic\x20and\x20septic\x20abscesses.\x20Which\x20of\x20the\x20following\x20primary\x20conditions\x20could\x20have\x20led\x20to\x20his\x20renal\x20findings?','TCXDf','LBvHR','ziyqR','All\x20of\x20the\x20following\x20conditions\x20cause\x20overflow\x20proteinuria\x20except:','YhAOW','scoreCircle','2046522DYkuyJ','vdgve','</span><span>','explanationVideoPlayer','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','getAttribute','BHcDw','QXReL','tBNOl','gOIxV','SkWzu','NPvyJ','EaPBA','split','Rhabdomyolysis','.m3u8','lpcZC','totalQuestionsResult','cbqWF','userHistory','border-green-500','fMpnR','kjVdE','uCdQT','aXMGz','push','<p>Isolated\x20<strong>proteinuria</strong>\x20of\x20<strong>less\x20than\x20500\x20mg/day</strong>\x20is\x20a\x20<strong>contraindication</strong>\x20to\x20renal\x20biopsy\x20since\x20the\x20<strong>risks\x20outweigh</strong>\x20the\x20<strong>benefits.\u00a0</strong>This\x20range\x20of\x20proteinuria\x20is\x20usually\x20a\x20mild\x20disease\x20or\x20can\x20be\x20a\x20consequence\x20of\x20normal\x20aging.\u00a0</p>\x0a<p>Indications\x20of\x20kidney\x20biopsy:</p>\x0a<ol>\x0a<li>Nephrotic\x20syndrome\x20with\x20no\x20apparent\x20cause</li>\x0a<li>Nephritic\x20syndrome\x20to\x20identify\x20the\x20cause\x20to\x20guide\x20further\x20management</li>\x0a<li>Unexplained\x20acute\x20kidney\x20injury</li>\x0a</ol>\x0a<p>Contraindications\x20of\x20kidney\x20biopsy:</p>\x0a<ol>\x0a<li><strong>Non-nephrotic</strong>\x20range\x20proteinuria(&lt;500mg/day)\x20with\x20no\x20hematuria\x20as\x20their\x20prognosis\x20is\x20good\x20and\x20usually\x20have\x20no\x20specialised\x20treatment</li>\x0a<li><strong>Single\x20kidney</strong>\x20is\x20a\x20a\x20relative\x20contraindication</li>\x0a<li><strong>Bleeding\x20diathesis</strong></li>\x0a<li>Hydronephrosis</li>\x0a<li>Solitary\x20native\x20kidney</li>\x0a</ol>\x0a<p>Pregnancy\x20as\x20such\x20is\x20not\x20a\x20contraindication\x20for\x20renal\x20biopsy\x20and\x20is\x20decided\x20on\x20a\x20case\x20to\x20case\x20basis.\u00a0</p>','border-gray-600','DGOAk','ocjDo','lxdKs','referrer','KAdvG','AotMc','explanation_images','yOHfT','Alport\x20syndrome','quizHierarchy','addEventListener','nav-btn-correct','ysJLE','Increased\x20capillary\x20hydrostatic\x20pressure','VLWOt','constructor','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','gAmQV','UoQaz','rtOty','aNZHZ','sVWSL','Henoch-Schonlein\x20purpura','XtPeK','Minimal\x20change\x20disease','KDbjC','QsIKg','A\x20pregnant\x20woman','XqIYv','AgLmz','YoBqW','Proteinuria\x20Mini\x20Test\x20-\x20-Tmt','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','hjbKV','Mark\x20for\x20Review','<p>This\x20patient\x20with\x20<strong>rheumatic\x20heart\x20disease</strong>\x20(indicating\x20a\x20damaged\x20heart\x20valve)\x20now\x20presents\x20with\x20<strong>oliguria,</strong>\u00a0<strong>proteinuria,</strong>\x20and\x20<strong>hematuria</strong>.\x20The\x20biopsy\x20findings\x20of\x20crescents\x20and\x20<strong>abscesses</strong>\x20make\x20<strong>septic\x20emboli</strong>\x20the\x20likely\x20cause.\x20<strong>Subacute\x20bacterial\x20endocarditis</strong>\x20is\x20most\x20likely\x20associated\x20with\x20<strong>endocarditis-associated\x20glomerulonephritis.</strong>\u00a0</p>\x0a<p><strong>Endocarditis-associated\x20glomerulonephritis</strong>\x20is\x20mostly\x20associated\x20with\x20<strong>subacute\x20bacterial\x20endocarditis</strong>\x20that\x20has\x20gone\x20<strong>untreated</strong>\x20for\x20a\x20long\x20time\x20as\x20it\x20allows\x20for\x20the\x20formation\x20of\x20<strong>antigen-antibody\x20complexes.\x20Acute\x20bacterial\x20endocarditis</strong>\x20on\x20the\x20other\x20hand\x20is\x20picked\x20up\x20clinically\x20and\x20is\x20usually\x20<strong>treated\x20aggressively</strong>\x20thus\x20<strong>not\x20allowing</strong>\x20for\x20the\x20<strong>kidney\x20disease</strong>\x20to\x20<strong>progress.</strong>\u00a0</p>\x0a<p>Patients\x20commonly\x20present\x20with\x20oliguria,\x20acute\x20kidney\x20injury\x20or\x20rapidly\x20progressive\x20glomerulonephritis.\x20Grossly,\x20the\x20kidney\x20will\x20show\x20a\x20<strong>flea-bitten\x20appearance</strong>\x20with\x20<strong>multiple\x20abscesses.</strong>\x20Biopsy\x20shows\x20crescents.\x20Immunofluorescence\x20shows\x20IgM,\x20IgG,\x20and\x20C3.</p>\x0a<p>Treatment\x20is\x20treating\x20the\x20underlying\x20endocarditis,\x20and\x20monitoring\x20the\x20patient\x20for\x20improvement\x20in\x20kidney\x20function.\u00a0</p>\x0a<p>Other\x20Options:<br\x20/><br\x20/>Option\x20A:\x20<strong>Henoch-schonlein\x20purpura</strong>\x20usually\x20has\x20an\x20accompanying\x20palpable\x20purpura\x20with\x20glomerulonephritis.\x20It\x20is\x20also\x20not\x20associated\x20with\x20rapidly\x20progressive\x20glomerulonephritis.</p>\x0a<p>Option\x20C:\x20<strong>Microangiopathic\x20hemolytic\x20anemia</strong>\x20can\x20occur\x20in\x20cases\x20of\x20valve\x20replacements\x20where\x20the\x20valve\x20malfunctions\x20leading\x20to\x20shearing\x20and\x20rupture\x20of\x20RBCs.\x20This\x20can\x20present\x20with\x20findings\x20of\x20proteinuria\x20and\x20hematuria\x20but\x20the\x20presence\x20of\x20crescents\x20on\x20biopsy\x20and\x20a\x20lack\x20of\x20history\x20of\x20valve\x20replacement\x20makes\x20endocrditis\x20likely.</p>\x0a<p>Option\x20D:\u00a0\x20<strong>Sickle\x20cell\x20disease</strong>\x20causes\x20renal\x20papillary\x20necrosis\x20which\x20presents\x20with\x20frank\x20hematuria\x20and\x20progressively\x20declining\x20renal\x20function.\x20The\x20additional\x20finding\x20of\x20septic\x20emboli\x20makes\x20an\x20infective\x20cause\x20more\x20likely.\u00a0</p>','quizPerformanceData','eroPL','PklvU','QaGzj','Hepatic\x20fibrosis','incorrect','gDImR','OFULz','console','RsyeN','mMhio','none','Option\x20','wICUZ','questionText','selected','Clonidine','JvWxX','Cidofovir','reviewQuestionsContainer','<p>The\x20above\x20clinical\x20vignette\x20is\x20suggestive\x20of\x20<strong>minimal\x20change\x20disease.</strong></p>\x0a<p>It\x20most\x20frequently\x20manifests\x20between\x20the\x20ages\x20of\x202\x20and\x206\x20years.\x20Edema\x20is\x20typically\x20seen\x20in\x20children\x20and\x20is\x20first\x20noticed\x20in\x20the\x20lower\x20extremities\x20and\x20around\x20the\x20eyes.\x20The\x20<strong>absence\x20of\x20hypertension</strong>\x20and\x20<strong>extensive\x20hematuria</strong>\x20are\x20key\x20indicators\x20of\x20minimal\x20change\x20disease.</p>\x0a<p>A\x20urinalysis\x20reveals<strong>\x203+\x20or\x204+\x20proteinuria</strong>.\x20A\x20protein:\x20creatinine\x20ratio\x20of\x20&gt;\x202.0\x20is\x20required\x20in\x20spot\x20urine.\x20The\x20level\x20of\x20serum\x20creatinine\x20is\x20typically\x20normal,\x20but\x20it\x20may\x20be\x20unusually\x20elevated\x20if\x20the\x20intravascular\x20volume\x20contracts\x20and\x20reduces\x20renal\x20perfusion.\x20The\x20serum\x20albumin\x20concentration\x20is\x20<strong>less\x20than\x202.5</strong>\x20g/dL,\x20and\x20the\x20levels\x20of\x20triglycerides\x20and\x20cholesterol\x20are\x20high.\x20The\x20levels\x20of\x20s<strong>erum\x20complement\x20are\x20normal</strong>.\x20If\x20the\x20patient\x20meets\x20the\x20typical\x20clinical\x20profile\x20of\x20MCNS,\x20a\x20kidney\x20biopsy\x20is\x20not\x20generally\x20carried\x20out.</p>','mfpFS','customQuizData','eSdtE','Sirolimus','2023-24','CURRd','fPVtE','A\x20young\x20primigravida\x20at\x2034\x20weeks\x20of\x20gestation\x20was\x20admitted\x20since\x20her\x20BP\x20was\x20150/90\x20mmHg\x20and\x20urine\x20dipstick\x20was\x202+\x20on\x20antenatal\x20checkup.\x20All\x20the\x20following\x20will\x20be\x20included\x20in\x20the\x20diagnostic\x20criteria\x20of\x20pre-eclampsia,\x20except\x20________.','setItem','931NPeCTJ','txsVX','\x22\x20data-option-index=\x22','questionStates','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','DwNzl','qVxHa','hIJyw','yxCLN','sWtEN','click','Membranous\x20nephropathy','A\x20patient\x20with\x20urine\x20protein\x20of\x20300\x20mg/day','nMPAt','QuGEd','qIBva','IgDWN','A\x20patient\x20is\x20being\x20evaluated\x20for\x20proteinuria\x20with\x20the\x20gold\x20standard\x20test.\x20What\x20test\x20was\x20he\x20likely\x20advised?','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','explanation_audio_eng','Interstitial\x20nephritis','IQrgy','bKYkb','A\x20child\x20presents\x20with\x20a\x20distended\x20abdomen\x20after\x20a\x20history\x20of\x20frothy\x20urine\x20for\x20the\x20last\x201\x20month.\x20Fluid\x20analysis\x20shows\x20a\x20growth\x20of\x20Streptococcus\x20pneumonia.\x20Other\x20investigations\x20are\x20normal\x20except\x20for\x20an\x20increase\x20in\x20serum\x20cholesterol.\x20What\x20is\x20the\x20likely\x20etiology\x20of\x20this\x20infection?','Seliwanoff\x27s\x20test','markReviewText','\x22\x20data-src=\x22','TEPoy','skiFj','Strenuous\x20exercise','notAttemptedResult','markReviewBtn','data-option-index','target','loadSource','HzxlC','notAttempted','choices','quizFile','Cyclosporin','63NgmnMJ','aVUUR','ySyte','ldncX','<p>The\x20given\x20clinical\x20features\x20of\x20<strong>proteinuria,\x20accelerated\x20hypertension,</strong>\x20and<strong>\x20oliguria</strong>\x20along\x20with\x20a\x20past\x20history\x20of\x20scleroderma\x20is\x20suggestive\x20of\x20a\x20<strong>scleroderma\x20renal\x20crisis.\x20ACE\x20inhibitors\u00a0</strong>like\u00a0<strong>captopril\u00a0</strong>are\x20the\x20first\x20line\x20drugs\x20in\x20the\x20management\x20of\x20a\x20scleroderma\x20renal\x20crisis.</p>\x0a<p>Scleroderma\x20renal\x20crisis\x20is\x20a\x20<strong>medical\x20emergency</strong>\x20characterized\x20by\x20acute\x20onset\x20malignant\x20hypertension\x20and\x20kidney\x20failure,\x20usually\x20in\x20the\x20absence\x20of\x20previous\x20evidence\x20of\x20significant\x20kidney\x20disease.\x20The\x20use\x20of\x20<strong>steroids</strong>\x20is\x20associated\x20with\x20an\x20<strong>increased</strong>\x20<strong>risk</strong>\x20of\x20scleroderma\x20renal\x20crisis.</p>\x0a<p\x20class=\x22p1\x22>Clinical\x20features\x20of\x20scleroderma\x20renal\x20crisis\x20are:</p>\x0a<ul>\x0a<li\x20class=\x22p1\x22><strong>Accelerated\x20hypertension\u00a0</strong>-\u00a0headache,\x20vomiting,\x20blurring\x20of\x20vision,\x20hypertensive\x20retinopathy,\x20and\x20hypertensive\x20encephalopathy.</li>\x0a<li\x20class=\x22p1\x22><strong>Acute\x20kidney\x20injury</strong>\x20-\x20oliguria,\x20mild\x20proteinuria,\x20microscopic\x20hematuria,\x20renal\x20failure.</li>\x0a<li\x20class=\x22p1\x22>Pulmonary\x20edema,\x20congestive\x20heart\x20failure.</li>\x0a<li\x20class=\x22p1\x22>Microangiopathic\x20hemolytic\x20anemia\x20(<strong>schistocytes</strong>),\x20thrombocytopenia.</li>\x0a</ul>\x0a<p>Risk\x20factors\x20for\x20scleroderma\x20renal\x20crisis\x20include\u00a0<strong>African-American\x20race,\x20male\x20sex,</strong>\x20and\x20<strong>diffuse\x20or\x20progressive\x20skin\x20involvement</strong>.\x20Up\x20to\x2050%\x20of\x20patients\x20with\x20scleroderma\x20renal\x20crisis\x20have\u00a0<strong>anti-RNA\x20polymerase\x20III\x20antibodies</strong>,\x20whereas\x20patients\x20with\x20<strong>anti-centromere\x20antibodies</strong>\x20appear\x20to\x20be<strong>\x20protected</strong>\x20from\x20this\x20complication.</p>\x0a<p>The\x20antibodies\x20tested\x20in\x20systemic\x20sclerosis\x20include:</p>\x0a<ul>\x0a<li><strong>Antinuclear\x20antibody\x20(ANA)\x20</strong>(Option\x201)\x20-\x20positive\x20in\x20most\x20cases\x20of\x20systemic\x20sclerosis.\x20The\x20absence\x20of\x20this\x20antibody\x20suggests\x20considering\x20an\x20alternate\x20diagnosis.\u00a0</li>\x0a<li><strong>Anticentromere\x20antibody\x20(ACA)</strong>\u00a0-\x20usually\x20positive\x20in<strong>\x20limited</strong>\x20cutaneous\x20systemic\x20sclerosis</li>\x0a<li><strong>Antitopoisomerase\x20I\x20(anti-Scl-70)\x20antibody</strong>\x20(Option\x202)-\x20usually\x20positive\x20with\x20<strong>diffuse</strong>\x20cutaneous\x20systemic\x20sclerosis\x20(Option\x202)</li>\x0a<li><strong>Anti-RNA\x20polymerase\x20III\x20antibody</strong>\x20(Option\x204)-\x20usually\x20positive\x20with\x20<strong>diffuse</strong>\x20cutaneous\x20systemic\x20sclerosis.</li>\x0a</ul>\x0a<p>Scleroderma\x20renal\x20crisis\x20is\x20a\x20medical\x20emergency\x20and\x20should\x20be\x20treated\x20with\x20<strong>angiotensin</strong>\x20<strong>II</strong>\x20<strong>receptor\x20blockers,\x20calcium\x20channel\x20blockers,</strong>\x20and\x20<strong>direct\x20renin\x20inhibitors.</strong>\x20Glucocorticoids\x20should\x20be\x20used\x20at\x20a\x20low\x20dose\x20only\x20when\x20necessary.\u00a0</p>','kNsBI','uxPBj','WETpq','<p><strong>Sulfosalicylic\x20acid</strong>\x20test\x20is\x20done\x20to\x20evaluate\x20for\x20protein\x20in\x20the\x20urine.\u00a0</p>\x0a<p>The\x20<strong>sulfosalicylic\x20acid\x20(SSA)</strong>\x20test\x20is\x20done\x20by\x20mixing\x20<strong>one\x20part</strong>\x20of\x20<strong>urine</strong>\x20with\x20<strong>three\x20parts</strong>\x20of\x20<strong>SSA</strong>\x20and\x20then\x20comparing\x20the\x20<strong>turbidity</strong>\x20that\x20develops\x20according\x20to\x20the\x20following:</p>\x0a<ul>\x0a<li>0:\x20no\x20turbidity\x20(0\x20mg/dL)</li>\x0a<li>Trace:\x20slight\x20turbidity\x20(1\x20to\x2010\x20mg/dL)</li>\x0a<li>1+:\x20turbidity\x20through\x20which\x20print\x20can\x20be\x20read\x20(15\x20to\x2030\x20mg/dL)</li>\x0a<li>2+:\x20white\x20cloud\x20without\x20precipitate\x20(40\x20to\x20100\x20mg/dL)</li>\x0a<li>3+:\x20white\x20cloud\x20with\x20fine\x20precipitate\x20(150\x20to\x20350\x20mg/dL)</li>\x0a<li>4+:\x20flocculent\x20precipitate\x20(&gt;500\x20mg/dL)</li>\x0a</ul>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Options\x20A\x20and\x20B:\x20Moore\x27s\x20test\x20and\x20Seliwanoff\x27s\x20test\x20are\x20done\x20to\x20test\x20to\x20distinguish\x20between\x20monosaccharides\x20and\x20disaccharides.\u00a0</p>\x0a<p>Option\x20C:\x20Muric\x20acid\x20test\x20is\x20done\x20to\x20test\x20for\x20galactose.</p>','jhBSW','markedForReview','oFYuT','FfFAO','nNMof','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','ZlyOq','Insufficient\x20dietary\x20intake','toggle','error','add','wNUPJ','Urine\x20protein\x20to\x20creatinine\x20ratio','log','classList','Bacterial\x20endocarditis','jSccI','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','rPEsi','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','In\x20which\x20of\x20the\x20following\x20cases\x20with\x20proteinuria\x20is\x20renal\x20biopsy\x20not\x20indicated?','hPDDc','WOsAp','acTYx','IELCk','accuracyScore','kxzBq','style','wqPFB','name','cwbiT','IgA\x20nephropathy','TmkrC','pdfQV','Fexvg','incorrectResult','No\x20solution\x20provided','wLePQ','Mopin','YYbUT','LSDXm','UOtoQ','incorrectCount','QPYUZ','CpEIX','totalTimeResult','correctResult','IhhcZ','correct','tKKvS','srCli','vSrCy','jDixS','fromCharCode','proteinuria-mini-test-tmt-457566d3.html','waWnf','hLeKH','nav-btn-bookmarked','floor','UXnVV','xGZjw','uJmHp','GGkgO','mbNso','YFDFg','</span></div>','dVDmZ','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','questionIndex','solutionImages','PoAYf','Microangiopathic\x20hemolytic\x20anemia','gjKhE','NEET\x20PG\x20Mini\x20Test\x20Series','Sulfosalicylic\x20acid\x20test','<p><strong>Nephrolithiasis</strong>\x20is\x20an\x20example\x20of\x20<strong>postrenal\x20proteinuria</strong>\x20which\x20occurs\x20due\x20to\x20an\x20<strong>insult</strong>\x20beyond\x20the\x20<strong>renal\x20tubules.</strong>\x20All\x20the\x20other\x20given\x20conditions\x20cause\x20proteinuria\x20due\x20to\x20an\x20increase\x20in\x20the\x20<strong>production</strong>\x20of\x20a\x20<strong>particular</strong>\x20type\x20of\x20<strong>protein;\x20light\x20chains</strong>\x20in\x20<strong>multiple\x20myeloma,\x20myoglobin</strong>\x20in\x20<strong>rhabdomyolysis,</strong>\x20and\x20<strong>hemoglobin</strong>\x20in\x20<strong>intravascular\x20hemolysis.</strong></p>\x0a<p>In\x20the\x20given\x20scenario,\x20the\x20patient\x20has\x20multiple\x20myeloma.\x20Thus\x20the\x20type\x20of\x20proteinuria\x20this\x20patient\x20is\x20likely\x20to\x20have\x20is\x20overflow\x20proteinuria.</p>\x0a<p>Various\x20types\x20of\x20proteinuria:</p>\x0a<ul>\x0a<li><strong>Glomerular</strong>\x20-\x20Increased\x20filtration\x20of\x20proteins\x20due\x20to\x20the\x20disruption\x20of\x20the\x20basement\x20membrane</li>\x0a<li><strong>Tubular</strong>\x20-\x20Impaired\x20protein\x20reabsorption\x20in\x20the\x20proximal\x20convoluted\x20tubule\x20(PCT)\x20due\x20to\x20damage\x20to\x20the\x20tubules\u00a0</li>\x0a<li><strong>Overflow</strong>\x20-\x20Excess\x20production\x20of\x20low-molecular-weight\x20proteins,\x20such\x20as\x20light\x20chains,\x20in\x20multiple\x20myeloma</li>\x0a<li><strong>Postrenal</strong>\x20-\x20Secretion\x20of\x20IgA\x20and\x20IgG\x20by\x20the\x20urinary\x20tract\x20due\x20to\x20infections\x20or\x20stones</li>\x0a</ul>\x0a<p>Normally,\x20the\x20following\x20mechanisms\x20prevent\x20proteinuria:</p>\x0a<p>The\x20<strong>glomerular\x20basement\x20membrane</strong>\x20acts\x20as\x20a\x20barrier\x20to\x20prevent\x20the\x20loss\x20of\x20negatively\x20charged\x20and\x20large\x20proteins.<br\x20/>Reabsorption\x20of\x20small\x20proteins\x20in\x20the\x20PCT</p>','qwaCA','eYGOA','forEach','dsiOt','wHDBY','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','PDKek','2,3,5'];_0x2210=function(){return _0x3150d9;};return _0x2210();}function toggleBookmark(){const _0x2a0b2d=_0x2877cd,_0x5b72f4={'vwFsY':function(_0x11c144,_0x5761dc){return _0x11c144===_0x5761dc;},'JQixf':function(_0x5e8869,_0x148e23){return _0x5e8869===_0x148e23;},'FPuTx':function(_0x1dd571,_0x2ed099){return _0x1dd571===_0x2ed099;},'VJUzt':'not_attempted','GzEKj':_0x2a0b2d(0x2a6),'ZcMeG':_0x2a0b2d(0x22c),'adrJd':function(_0x377edb){return _0x377edb();},'TfYKw':_0x2a0b2d(0x368)},_0x348b18=!questionStates[currentQuestionIndex][_0x2a0b2d(0x40f)];questionStates[currentQuestionIndex][_0x2a0b2d(0x40f)]=_0x348b18;let _0x1ab602=JSON['parse'](localStorage[_0x2a0b2d(0x331)](_0x2a0b2d(0x344)))||[];if(_0x348b18){if(_0x5b72f4[_0x2a0b2d(0x358)]!==_0x2a0b2d(0x368)){const _0x35a5d6=_0x21619c[_0x22b6e0],_0x4d45f4=_0x35a5d6[_0x2a0b2d(0x419)];if(_0x5b72f4[_0x2a0b2d(0x2eb)](_0x5c946b,null))return;const _0x2de6e4=_0x35a5d6[_0x2a0b2d(0x26a)][_0x56581a],_0x52c1a2=_0x5b72f4[_0x2a0b2d(0x46c)](_0x2de6e4['id'],_0x4d45f4);if(_0x5b72f4['FPuTx'](_0x5b241d[_0x40e4de][_0x2a0b2d(0x42a)],_0x5b72f4[_0x2a0b2d(0x487)])){_0x497d6a['totalAttempted']++,_0x460122[_0x2a0b2d(0x269)]--;if(_0x52c1a2)_0x1bc6a0[_0x2a0b2d(0x3a5)]++;else _0x82cdb0[_0x2a0b2d(0x3be)]++;}_0xb3ce12[_0x3f90c9][_0x2a0b2d(0x42a)]=_0x52c1a2?_0x5b72f4[_0x2a0b2d(0x451)]:_0x5b72f4[_0x2a0b2d(0x3f8)],_0x2e2e09(),_0x268acd(_0x52c1a2),_0x5b72f4[_0x2a0b2d(0x3d0)](_0x19a2f3);}else{const _0x266250={'quizName':quizName,'quizFile':window['location'][_0x2a0b2d(0x389)]['split']('/')[_0x2a0b2d(0x1d9)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x2a0b2d(0x316)]()};_0x1ab602[_0x2a0b2d(0x200)](_0x266250);}}else _0x1ab602=_0x1ab602[_0x2a0b2d(0x3ce)](_0x180023=>!(_0x180023[_0x2a0b2d(0x26b)][_0x2a0b2d(0x402)](quizName['toLowerCase']()['replace'](/ /g,'-'))&&_0x180023[_0x2a0b2d(0x2ba)]===currentQuestionIndex));localStorage['setItem'](_0x2a0b2d(0x344),JSON[_0x2a0b2d(0x41a)](_0x1ab602)),updateBookmarkButton(),updateQuestionNav();}function updateBookmarkButton(){const _0x325364=_0x2877cd,_0xc40303={'usqLv':_0x325364(0x3f9),'QaGzj':_0x325364(0x2c7),'kjVdE':_0x325364(0x223),'PoAYf':'Bookmark'},_0x2d7dc6=document[_0x325364(0x474)](_0xc40303[_0x325364(0x48e)]),_0x22d077=document[_0x325364(0x474)](_0x325364(0x2ee)),_0x45c441=questionStates[currentQuestionIndex][_0x325364(0x40f)];_0x2d7dc6[_0x325364(0x38a)]=_0x45c441?_0xc40303[_0x325364(0x22a)]:_0xc40303[_0x325364(0x1fd)],_0x22d077['textContent']=_0x45c441?'Bookmarked':_0xc40303[_0x325364(0x2bc)];}function toggleMarkForReview(){const _0x4b45a6=_0x2877cd,_0x13b769={'nOPCC':function(_0xaaeff){return _0xaaeff();},'hLeKH':function(_0x231059){return _0x231059();}};questionStates[currentQuestionIndex]['markedForReview']=!questionStates[currentQuestionIndex]['markedForReview'],_0x13b769['nOPCC'](updateMarkReviewButton),_0x13b769[_0x4b45a6(0x2ae)](updateQuestionNav);}function updateMarkReviewButton(){const _0x17e423=_0x2877cd,_0x230e7b={'wMetM':'markReviewBtn','oMXez':_0x17e423(0x25e),'Dfzcm':_0x17e423(0x249),'RtneO':_0x17e423(0x37c),'IuLmZ':_0x17e423(0x225)},_0x3e8541=document['getElementById'](_0x230e7b[_0x17e423(0x2fb)]),_0x2ce831=document[_0x17e423(0x474)](_0x230e7b[_0x17e423(0x363)]),_0x57b690=questionStates[currentQuestionIndex]['markedForReview'];_0x3e8541[_0x17e423(0x38a)]=_0x57b690?_0x230e7b[_0x17e423(0x3ba)]:_0x17e423(0x448),_0x2ce831['textContent']=_0x57b690?_0x230e7b[_0x17e423(0x439)]:_0x230e7b[_0x17e423(0x45f)];}function previousQuestion(){const _0x59649b=_0x2877cd,_0x126ebe={'ViAfB':function(_0x1adb44,_0x1c76f3){return _0x1adb44>_0x1c76f3;},'brYfC':function(_0x472f8f,_0x25615e){return _0x472f8f===_0x25615e;},'trGwy':_0x59649b(0x2ad),'iQeYa':function(_0x26b69b,_0x22960a){return _0x26b69b-_0x22960a;},'zfPXJ':function(_0x564bda){return _0x564bda();}};_0x126ebe[_0x59649b(0x398)](currentQuestionIndex,0x0)&&(_0x126ebe['brYfC'](_0x126ebe[_0x59649b(0x391)],_0x126ebe[_0x59649b(0x391)])?(questionStartTime&&(questionStates[currentQuestionIndex][_0x59649b(0x3a8)]+=_0x126ebe[_0x59649b(0x301)](Date['now'](),questionStartTime)),currentQuestionIndex--,_0x126ebe[_0x59649b(0x3f1)](displayQuestion),_0x126ebe[_0x59649b(0x3f1)](saveProgress)):(_0xb0de2d[_0x55a1a5][_0x59649b(0x42a)]=_0x59649b(0x370),_0x4a31b4[_0x59649b(0x46b)]++,_0x37073[_0x59649b(0x269)]--));}function nextQuestion(){const _0x33c0e9=_0x2877cd,_0x3c2426={'NgvVe':function(_0x458669){return _0x458669();},'EdzeC':_0x33c0e9(0x453),'wHDBY':_0x33c0e9(0x2e8),'oFYuT':function(_0x114de0,_0x2e1d3e){return _0x114de0(_0x2e1d3e);},'rNQMH':function(_0x4c2984,_0x4bf418){return _0x4c2984===_0x4bf418;},'AotMc':_0x33c0e9(0x360),'JhHez':function(_0x16bc81){return _0x16bc81();},'BVuEs':function(_0x33401b){return _0x33401b();},'IgDWN':function(_0x100477,_0x2a7726){return _0x100477-_0x2a7726;},'xjghs':function(_0x8a7bb6,_0x38749f){return _0x8a7bb6<_0x38749f;},'AgLmz':function(_0x53d8f1,_0x2b0e90){return _0x53d8f1===_0x2b0e90;},'aOADH':_0x33c0e9(0x43b),'Wttsa':function(_0x1ac269){return _0x1ac269();},'EaPBA':_0x33c0e9(0x3ef),'WLcIy':function(_0x1b3310,_0x21c97c){return _0x1b3310!==_0x21c97c;},'FfFAO':_0x33c0e9(0x294),'bINVt':_0x33c0e9(0x48f),'bmQHO':_0x33c0e9(0x1d8),'KlzWX':function(_0x5a4578,_0x550ba5){return _0x5a4578!==_0x550ba5;},'yxCLN':'bLnMn','fbovq':_0x33c0e9(0x2b1)};questionStartTime&&(questionStates[currentQuestionIndex][_0x33c0e9(0x3a8)]+=_0x3c2426[_0x33c0e9(0x255)](Date[_0x33c0e9(0x316)](),questionStartTime)),_0x3c2426[_0x33c0e9(0x374)](currentQuestionIndex,_0x3c2426[_0x33c0e9(0x255)](questionsData[_0x33c0e9(0x392)],0x1))?_0x3c2426[_0x33c0e9(0x220)](_0x3c2426[_0x33c0e9(0x3a0)],_0x3c2426[_0x33c0e9(0x3a0)])?(currentQuestionIndex++,_0x3c2426[_0x33c0e9(0x3f5)](displayQuestion),_0x3c2426['NgvVe'](saveProgress)):_0x3c2426[_0x33c0e9(0x324)](_0x28afa6):currentMode===_0x3c2426[_0x33c0e9(0x1f3)]||currentMode===_0x3c2426[_0x33c0e9(0x208)]?_0x3c2426['WLcIy'](_0x3c2426['FfFAO'],_0x3c2426[_0x33c0e9(0x279)])?_0x2f7be6[_0x33c0e9(0x474)](_0x3c2426[_0x33c0e9(0x361)])[_0x33c0e9(0x284)][_0x33c0e9(0x280)](_0x3c2426[_0x33c0e9(0x2c6)]):confirm(_0x3c2426[_0x33c0e9(0x2d0)])&&_0x3c2426[_0x33c0e9(0x324)](submitQuiz):_0x3c2426[_0x33c0e9(0x278)](confirm,_0x3c2426['bmQHO'])&&(_0x3c2426[_0x33c0e9(0x312)](_0x3c2426[_0x33c0e9(0x24d)],_0x3c2426[_0x33c0e9(0x442)])?(currentQuestionIndex=0x0,displayQuestion(),_0x3c2426['BVuEs'](saveProgress)):(_0x3c2426[_0x33c0e9(0x278)](_0x5345e4,_0x503e34),_0x3c2426[_0x33c0e9(0x34a)](_0x4533cc,_0x3c2426[_0x33c0e9(0x208)])?_0x3c2426['JhHez'](_0xae7a8a):_0x3c2426['BVuEs'](_0xba2e74)));}function startTimer(){const _0x2fc1e8=_0x2877cd,_0x58212e={'oKIlI':function(_0x3b5c7a,_0x57fd1c){return _0x3b5c7a<_0x57fd1c;},'wNUPJ':function(_0x5440e1){return _0x5440e1();},'QPYUZ':function(_0x5b4754,_0x31d503){return _0x5b4754!==_0x31d503;},'QOXbp':'KQNDG','CAuma':function(_0x2d622b){return _0x2d622b();},'ZPnvq':function(_0x3e2b4c,_0x8d715){return _0x3e2b4c<=_0x8d715;},'xNCEs':_0x2fc1e8(0x26e),'poPtd':'ALQfx','gAFvY':function(_0x5eaf4c,_0x20b015){return _0x5eaf4c(_0x20b015);},'IELCk':function(_0x1a873e,_0x4e3d77){return _0x1a873e===_0x4e3d77;},'JEVRy':_0x2fc1e8(0x360),'TEPoy':function(_0x1559de){return _0x1559de();},'yhHoE':function(_0x1903c6){return _0x1903c6();},'yYjUX':function(_0x5d4fa1,_0x3d9207,_0x5e80ac){return _0x5d4fa1(_0x3d9207,_0x5e80ac);}};if(timer)_0x58212e['gAFvY'](clearInterval,timer);timeRemaining=0x78,_0x58212e[_0x2fc1e8(0x3b9)](updateTimerDisplay),timer=_0x58212e[_0x2fc1e8(0x326)](setInterval,()=>{const _0x2b7adc=_0x2fc1e8;_0x58212e[_0x2b7adc(0x2a1)]('KQNDG',_0x58212e[_0x2b7adc(0x352)])?_0x3cd03f[_0x2b7adc(0x26b)][_0x2b7adc(0x402)](_0x19463b[_0x2b7adc(0x434)]()[_0x2b7adc(0x3ad)](/ /g,'-'))&&(_0x58212e[_0x2b7adc(0x33d)](_0x15fd6b['questionIndex'],_0x4f7580[_0x2b7adc(0x392)])&&(_0x4dcc2e[_0x3564de[_0x2b7adc(0x2ba)]][_0x2b7adc(0x40f)]=!![])):(timeRemaining--,_0x58212e[_0x2b7adc(0x36b)](updateTimerDisplay),_0x58212e[_0x2b7adc(0x31e)](timeRemaining,0x0)&&(_0x58212e[_0x2b7adc(0x2a1)](_0x58212e[_0x2b7adc(0x425)],_0x58212e['poPtd'])?(_0x58212e['gAFvY'](clearInterval,timer),_0x58212e[_0x2b7adc(0x28e)](currentMode,_0x58212e[_0x2b7adc(0x306)])?submitQuiz():_0x58212e[_0x2b7adc(0x260)](nextQuestion)):_0x58212e[_0x2b7adc(0x281)](_0x137021)));},0x3e8);}function updateTimerDisplay(){const _0x459d38=_0x2877cd,_0x28b99c={'Ewbvw':function(_0x3a9450,_0x2363b6){return _0x3a9450/_0x2363b6;},'YwIxg':function(_0x81531e,_0x6ca72f){return _0x81531e%_0x6ca72f;},'nLWzr':function(_0x19cef8,_0x4125b8){return _0x19cef8+_0x4125b8;},'wqPFB':function(_0x1fab93,_0x1aa020){return _0x1fab93+_0x1aa020;}},_0x7dc923=Math[_0x459d38(0x2b0)](_0x28b99c[_0x459d38(0x3d4)](timeRemaining,0x3c)),_0x36cced=_0x28b99c[_0x459d38(0x1da)](timeRemaining,0x3c);document[_0x459d38(0x474)](_0x459d38(0x3c7))['textContent']=_0x28b99c[_0x459d38(0x381)](_0x28b99c[_0x459d38(0x292)](_0x7dc923,':'),_0x36cced[_0x459d38(0x334)]()[_0x459d38(0x1db)](0x2,'0'));}function toggleSidebar(){const _0x28af68=_0x2877cd,_0x31e0eb={'WNokh':_0x28af68(0x45c),'ghHge':'open'};document[_0x28af68(0x474)](_0x31e0eb['WNokh'])[_0x28af68(0x284)][_0x28af68(0x27e)](_0x31e0eb[_0x28af68(0x36a)]);}document['addEventListener'](_0x2877cd(0x367),()=>{const _0x29ffcc=_0x2877cd,_0xd7495a={'BXrXd':_0x29ffcc(0x1fa),'UkzTn':_0x29ffcc(0x48b),'IbNlo':'zksXD','YmaoL':function(_0x234bdd){return _0x234bdd();},'xrZsF':_0x29ffcc(0x48d),'QaTOi':'none','wICUZ':function(_0x7a2107){return _0x7a2107();},'PYRZr':function(_0x5a5323){return _0x5a5323();},'NfAAv':'flex','zRKRz':_0x29ffcc(0x2e6),'HzxlC':function(_0x15e75b,_0x357f1d){return _0x15e75b===_0x357f1d;},'KZeNs':_0x29ffcc(0x216),'ZRzXV':'qpWKZ'};if(resume){if('FiETS'!==_0xd7495a['IbNlo'])_0xd7495a['YmaoL'](loadProgress)?(document[_0x29ffcc(0x474)](_0xd7495a[_0x29ffcc(0x2ec)])['style'][_0x29ffcc(0x48c)]=_0xd7495a[_0x29ffcc(0x39f)],_0xd7495a[_0x29ffcc(0x234)](initializeQuiz)):(_0xd7495a[_0x29ffcc(0x478)](clearProgress),document[_0x29ffcc(0x474)](_0xd7495a[_0x29ffcc(0x2ec)])[_0x29ffcc(0x291)][_0x29ffcc(0x48c)]=_0xd7495a['NfAAv']);else{const _0x4c17df=_0x3b5ee9[_0x29ffcc(0x41c)](_0xe6c29f['getItem'](_0xd7495a['BXrXd']))||{};_0x4c17df[_0xb10c29]&&(delete _0x4c17df[_0x549815],_0x271341['setItem'](_0xd7495a[_0x29ffcc(0x371)],_0x3c845b[_0x29ffcc(0x41a)](_0x4c17df)),_0x5ebe3d[_0x29ffcc(0x283)](_0xd7495a[_0x29ffcc(0x2fd)]));}}else!window[_0x29ffcc(0x2fc)][_0x29ffcc(0x389)]['endsWith'](_0xd7495a['zRKRz'])?(clearProgress(),document[_0x29ffcc(0x474)](_0xd7495a[_0x29ffcc(0x2ec)])['style'][_0x29ffcc(0x48c)]='flex'):_0xd7495a[_0x29ffcc(0x268)](_0xd7495a['KZeNs'],_0xd7495a['ZRzXV'])?_0x201738=_0x3eb09d:_0xd7495a[_0x29ffcc(0x234)](initializeQuiz);}),document[_0x2877cd(0x20d)]('keydown',function(_0x3b7334){const _0x55200e=_0x2877cd,_0x33db97={'YuZge':function(_0x532b3b,_0x14c59b){return _0x532b3b(_0x14c59b);},'fJCdm':function(_0x464cae){return _0x464cae();},'GvTWZ':function(_0x27343f,_0x36445f){return _0x27343f!==_0x36445f;},'FzKve':_0x55200e(0x48d),'gBKiv':_0x55200e(0x232),'qVxgg':function(_0x1c0de7,_0x496a14){return _0x1c0de7===_0x496a14;},'gensW':_0x55200e(0x453),'IVWmX':_0x55200e(0x2e8),'elUxP':function(_0x5f1d82,_0x411393){return _0x5f1d82-_0x411393;},'bYspk':function(_0x1be731,_0x5e9734){return _0x1be731(_0x5e9734);},'qqPRu':_0x55200e(0x404),'zfShH':function(_0x1d1c74,_0x15d44c){return _0x1d1c74<_0x15d44c;},'YhJmm':'ArrowLeft','aFscg':function(_0x21aeb5,_0xafb5cb){return _0x21aeb5===_0xafb5cb;},'Spudx':'timed_study','WQVUL':function(_0x25a8fb){return _0x25a8fb();},'kxzBq':function(_0x6d0587,_0x46d0d6){return _0x6d0587===_0x46d0d6;},'hPDDc':'test','ySyte':function(_0x46aa66){return _0x46aa66();},'xGZjw':function(_0x3b82c9,_0x10e859){return _0x3b82c9===_0x10e859;},'fTmKH':_0x55200e(0x360)};if(_0x33db97['GvTWZ'](document['getElementById'](_0x33db97[_0x55200e(0x464)])[_0x55200e(0x291)][_0x55200e(0x48c)],_0x33db97[_0x55200e(0x409)]))return;if(_0x33db97[_0x55200e(0x2e1)](document[_0x55200e(0x474)](_0x33db97['gensW'])['classList'][_0x55200e(0x45b)](_0x33db97[_0x55200e(0x3b8)]),![]))return;if(_0x3b7334[_0x55200e(0x3fa)]>='1'&&_0x3b7334[_0x55200e(0x3fa)]<='4'){const _0x33ec77=_0x33db97['elUxP'](_0x33db97[_0x55200e(0x3bd)](parseInt,_0x3b7334[_0x55200e(0x3fa)]),0x1),_0x1c72dc=document[_0x55200e(0x37a)](_0x33db97['qqPRu']);if(_0x33db97[_0x55200e(0x2ea)](_0x33ec77,_0x1c72dc[_0x55200e(0x392)]))_0x33db97['bYspk'](selectOption,_0x33ec77);}else{if(_0x33db97[_0x55200e(0x2e1)](_0x3b7334['key'],_0x33db97['YhJmm']))_0x33db97[_0x55200e(0x33c)](previousQuestion);else{if(_0x33db97[_0x55200e(0x2e1)](_0x3b7334[_0x55200e(0x3fa)],_0x55200e(0x345))||_0x33db97['qVxgg'](_0x3b7334[_0x55200e(0x3fa)],'\x20'))_0x3b7334[_0x55200e(0x302)](),_0x33db97[_0x55200e(0x33c)](nextQuestion);else{if(_0x33db97[_0x55200e(0x2e1)](_0x3b7334['key'][_0x55200e(0x434)](),'b')&&(_0x33db97[_0x55200e(0x406)](currentMode,'study')||_0x33db97[_0x55200e(0x406)](currentMode,_0x33db97[_0x55200e(0x31f)])))_0x55200e(0x42d)!==_0x55200e(0x42d)?_0x33db97[_0x55200e(0x430)](_0x5d8d48,'Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.')&&(_0x682952[_0x55200e(0x2fc)][_0x55200e(0x389)]['endsWith'](_0x55200e(0x2e6))&&_0x26a134[_0x55200e(0x46f)](_0x55200e(0x23d)),_0x33db97[_0x55200e(0x33c)](_0x6abcc3),_0xf331a[_0x55200e(0x41b)]()):_0x33db97[_0x55200e(0x330)](toggleBookmark);else{if(_0x33db97[_0x55200e(0x2e1)](_0x3b7334[_0x55200e(0x3fa)][_0x55200e(0x434)](),'m')&&(_0x33db97[_0x55200e(0x290)](currentMode,_0x33db97[_0x55200e(0x28b)])||_0x33db97[_0x55200e(0x406)](currentMode,_0x55200e(0x360))))_0x33db97[_0x55200e(0x26f)](toggleMarkForReview);else _0x3b7334[_0x55200e(0x3fa)][_0x55200e(0x434)]()==='s'&&(_0x33db97[_0x55200e(0x2b2)](currentMode,_0x55200e(0x3ef))||_0x33db97[_0x55200e(0x406)](currentMode,_0x33db97[_0x55200e(0x385)]))&&_0x33db97[_0x55200e(0x33c)](submitQuiz);}}}}});</script>

</body></html>